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Abstract 
The  thermal  and  metal-catalysed  aza-Claisen  rearrangement  of  allylic 
trichlororacetimidates  has  found  widespread  application  in  the  synthesis  of  nitrogen-
containing molecules including alkaloids, antibiotics and unnatural amino acids.
1 We have 
recently investigated the use of this reaction for the rearrangement of chiral molecules.
2 
This  has  led  to  the  development  of  a  highly  diastereoselective,  ether-directed 
palladium(II)-catalysed process which  has  been  used  for the  synthesis of β-hydroxy-α-
amino acids. To expand the scope and understanding of the rearrangement, a number of 
analogues  of  1  have  been  synthesised  and  subjected  to  a  palladium(II)-catalysed 
rearrangement (Figure 1). 
Gizzerosine 2 ((S)-2-amino-9-(4-imidazolyl)-7-azanonanoic acid) is a potent agonist for 
the  H2-receptor  (Figure  1).  It  brings  about  gizzard  erosion  and  ulceration  in  broiler 
chickens. This disease is colloquially known as ‘Black Vomit’ due to bleeding of lesions 
and subsequent regurgitation.
3 Its biological profile suggests it could be a promising drug 
candidate for gastric achlorhydria and osteoporosis, although only small amounts can be 
isolated from fish meal for biological studies. A short and highly efficient synthesis has 
been developed in ten steps and 31% overall yield. 
Protein-protein inteactions are the key to organising cellular processes in space and time. 
Protein-protein interactions are involved in viral fusion and so are promising targets for 
anti-viral  drugs.  Photoactivatable  amino  acids  have  been  used  to  identify  these 
interactions.
4  Activation  by  ultraviolet  light  induces  covalent  cross-linking  (known  as 
photo cross-linking) of the interacting proteins which can be detected with high specificity 
by simple western blotting. Significant progress has been made towards the development 
of a  stereoselective synthesis of photoactivatable amino acids  incorporating a diazirine 
ring, such as photo-leucine 3, which generate a reactive carbene after the light induced loss 
of nitrogen (Figure 1).   
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1  Introduction 
1.1  The Synthesis of α-Amino Acids 
Optically active α- and β-amino acids are fundamental building blocks for the preparation 
of  many  pharmaceutical  agents  as  well  as  natural  products.  Amino  acids  are  also 
extensively used as chiral starting materials, auxiliaries and catalysts in modern organic 
chemistry. Amino acids can exist in both natural (L) and unnatural forms (D). The twenty 
proteinogenic amino acids are L and all except cysteine have the (S) absolute configuration 
at  the  α-carbon.  In  the  field  of  protein  chemistry,  unnatural  amino  acids  can  be 
incorporated  into  proteins  to  study  protein  function  and  structure.  Over  700  naturally 
occurring amino acids are known.
5 
Most molecules in nature exist in either of two chiral enantiomers, forms that mirror each 
other in structure. In chemistry, chiral molecules are important because one enantiomer of 
a given compound  may  be  biologically  active,  whereas  its  mirror-image enantiomer  is 
inactive. For example, the common amino acid alanine has two chiral forms, (S)-alanine 
and (R)-alanine, but only (S)-alanine is prevalent in proteins. Enriching only the bioactive 
chiral form of a compound has been a major focus among chemists for decades. Presented 
here is an overview of four areas of the field of amino acid synthesis, exemplifying some 
traditional and more recent approaches. Catalytic asymmetric synthesis is an enzyme-like 
process that can rapidly produce an excess of one chiral compound form, a process with 
numerous practical applications. Several different catalytic asymmetric approaches to α-
amino acids involving carbon-carbon, carbon-nitrogen and carbon-hydrogen bond forming 
reactions  have  been  developed  (Scheme  1).
6  Recent  publications  have  highlighted  the 
advances  made  in  the  asymmetric  Strecker  reaction  (path  A),  catalytic  asymmetric 
synthesis of α-amino acids (path B), asymmetric carbon-nitrogen bond forming reactions 
(path C) and catalytic asymmetric hydrogenation of dehydroamino acids (path D). This 
introduction will mainly focus on the recent developments in the fields mentioned above. 
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Scheme 1 
1.2  Asymmetric Strecker Synthesis 
The Strecker amino acid synthesis generates amino acids from corresponding aldehydes 
and a general scheme is shown below (Scheme 2). It represents one of the simplest and 
most economical methods for the preparation of α-amino acids on a laboratory scale as 
well as on a technical scale.
7 This reaction was first reported by Strecker in 1850.
8 In the 
traditional Strecker synthesis, the aldehyde 4 is condensed with an amine e.g. ammonia to 
give a Schiff base which reacts with a nucleophile e.g. hydrogen cyanide to give a racemic 
mixture of α-aminonitriles 5. These precursors can then be hydrolysed to the corresponding 
α-amino acids 6.  
 
 
Scheme 2 
Stereocontrol can be incorporated into this reaction through chirality in the aldehyde, the 
amine, the nucleophile or by using a chiral catalyst. The catalytic asymmetric Strecker-type 
reaction offers one of the most direct and viable methods for the asymmetric synthesis of 
α-amino acids. Although unknown until the mid-1990s, current challenges still focus on 
the  development  of  enantioselective  catalysts  with  high  activity  and  broad  substrate 
generality,  which  leads  to  a  practical,  efficient,  and  environmentally  friendly  chemical 
synthesis. 
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1.2.1  The Strecker Reaction Using Organocatalysts 
There are usually fewer toxicity issues associated with organocatalysis, although little is 
known about the toxicity of many organic catalysts. Of particular importance is that most 
reactions are tolerant of water and air and are often easy to perform. These factors often 
affect  metal-catalysed  reactions  and  that  provides  a  significant  advantage  in  terms  of 
operational simplicity. Several versions of the Strecker reaction have been developed using 
completely different types of organic  molecules which were  found to possess catalytic 
hydrocyanation properties. The first asymmetric Strecker reaction was reported by Harada 
in 1963, over one hundred years after the introduction of the racemic version (Scheme 3).
9 
Chiral α-methylbenzylamine was condensed with an aldehyde 4 to form a chiral imine 7. 
The  stereogenic  center  was  able  to  direct the  addition  of  the  imine  with  enantiomeric 
excess ranging from 9 - 58%. Hydrolysis and hydrogenation gave the free amino acid 8.                
 
 
 
Scheme 3 
The first catalysed asymmetric Strecker reaction was reported by Lipton and co-workers 
using the cyclic chiral dipeptide 9 as an organocatalyst (Figure 2).
10 This approach avoids 
some problems encountered when using a chiral reagent e.g. cost and non-recoverability. 
Diketopiperazines  were  chosen  due  to  the  success  of  these  molecules  as  efficient 
organocatalysts in the previously developed hydrocyanation of aldehydes.
11 The catalyst 
was prepared from (S)-phenylalanine and (S)-α-amino-δ-guanidinobutyric acid. The basic 
guanidine side chain is a pre-requisite for asymmetric induction and the acceleration of 
proton transfer with hydrogen cyanide and the aldimine intermediate. 
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Studies were attempted initially using benzaldehyde, ammonia and hydrogen cyanide, but 
due  to  the  instability  of  the  intermediate,  2-aminophenylacetonitrile,  these  were 
unsuccessful.  Thus,  the  reactions  were  attempted  again  using  N-substituted  imines  10 
(Scheme 4). It was noted that the presence of alkyl groups on the imine nitrogen resulted 
in  the  formation  of  the  corresponding  (S)-α-amino  nitriles  11  in  high  yields  and 
exceptionally  high  enantiomeric  excesses.  The  nitriles  were  hydrolysed  using  6M 
hydrochloric  acid  to  give  the  (S)-α-amino  acids  12,  however,  only  the  benzhydryl-
protected  α-amino  nitrile  gave  satisfactory  results  without  loss  of  enantiomeric  excess. 
Benzaldyhyde can therefore be transformed to (S)-phenylglycine in three steps and in 92% 
yield with >99% e.e.
11  
 
 
 
Scheme 4 
Therefore,  a  number  of  N-benzhydryl  imines  13  were  subjected  to  reaction  with  the 
catalyst 9 (Scheme 5). In all cases, the (S)-isomer 14 was the major product. It was found 
that  the  products  derived  from  aromatic  aldehydes  generally  were  produced  in  high 
enantiomeric excess. In contrast to the aromatic substrates, the organocatalyst does not 
appear to be suitable for the hydrocyanation of imines derived from alkyl-substituted or 
heteroaromatic aldehydes. The catalytic abilities of the dipeptide were also very sensitive 
to various parameters such as solvent viscosity.  
 
 
 
Scheme 5 
Corey and Grogan also used a guanidine-derived chiral bifunctional organocatalyst 15 in a 
novel enantioselective Strecker reaction (Figure 3).
12 The catalyst is readily available in a 
multistep synthesis from D-phenylglycine. 
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Figure 3 
The reaction was carried out with achiral N-benzhydryl imines 13 as before to give (R)-α-
amino nitriles 16 (Scheme 6). The guanidine catalyst was easily recovered in 80-90% yield 
by  extraction  from  the  crude  reaction  mixture.  The  (R)-α-amino  nitriles  were  cleanly 
converted to the (R)-aryl glycines using 6M hydrochloric acid. Again, the N-benzhydryl 
group is a pre-requisite for good enantioselectivity. N-Benzyl and N-(9’-fluorenyl) groups 
resulted in poor enantioselectivity (0-25%). Compared to Lipton’s organocatalyst, aromatic 
substrates  gave  slightly  lower  enantioselectivities.
10  In  contrast  to  Lipton’s  catalyst, 
aliphatic aldimines led to high yields and good enantioselectivies (63-84%). 
  
 
 
 
Scheme 6 
Recently,  Corey  and  co-workers  have  developed  a  new  chiral  catalyst  for  the 
enantioselective Strecker reaction, a chiral ammonium salt 17 that has both an activating 
and a binding site for N-allyl aldimines (Figure 4).
13 The organocatalyst was developed 
from a previous catalyst 18, which had been used for the enantioselective dihydroxylation 
of olefins to form 1,2-diols (Figure 4).
14 It was thought that the U-shaped binding pocket 
in 17 could  hold the aldehyde-derived part of the aldimine through hydrogen-bonding. 
Attack of the cyanide ion on the carbon of the hydrogen-bonded imine would give an α-
amino nitrile.  
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The catalyst was employed in the reaction of a series of N-allylbenzaldimines 19 to give 
the corresponding (S)-α-amino nitrile 20 (Scheme 7). Allyl was preferred to benzyl as the 
N-protecting  group.  The  catalyst  was  also  recovered  through  silica  column 
chromatography.  
 
 
Scheme 7 
The  asymmetric  Strecker  reaction  can  be  catalysed  by  a  urea-derived  Schiff  base 
organocatalyst,  as  demonstrated  by  Sigman,  Jacobsen  and  Vachal.
15  Following  the 
synthesis of a Schiff base library, 21 was identified as an effective and soluble catalyst for 
the asymmetric hydrocyanation of aromatic imines (Figure 5). The elements of the catalyst 
that are responsible for the high enantioselectivity are the bulky substituents at the amino 
position and at the 3-position of the salicylimine moiety.   
 
 
 
 
 
 
Figure 5 
This catalyst was used in the formation of the Strecker adduct 23 in 75% yield and 95% 
e.e. (Scheme 8). This catalyst not only displays high enantioselectivity but also displays 
broad substrate scope, giving good enantioselectivities with aromatic imines bearing  N-
allyl substituents, acyclic aliphatic N-allyl imines 22, cycloalkyl imines and cyclic imines. 
Z-imines can also be employed efficiently.  
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Scheme 8 
With  this  highly  selective  reaction,  it  is  also  possible  to  synthesise  enantiomerically 
enriched α-amino acids. The catalyst 21 was employed in the Strecker reaction of the imine 
24 to give the α-amino nitrile intermediate (Scheme 9). Hydrolysis to yield the α-amino 
acid,  D-tert-leucine  25  was  attempted.  Unfortunately,  the  harsh  conditions  resulted  in 
significant  decomposition  of  25.  Therefore,  the  amino  nitrile  was  protected  as  the 
formamide 26 (85% overall yield). Hydrolysis and deformylation was carried out in a one-
pot procedure using concentrated hydrochloric acid at 70 
oC but some racemisation was 
observed. Hydrolysis of 26 was therefore carried out to the corresponding acid 27 using 
concentrated  sulfuric  acid  at  45 
oC  (99%  yield).  Deformylation  was  carried  out  using 
concentrated hydrochloric acid and the benzyl group was removed by hydrogenation to 
yield the α-amino acid 25 in >99% e.e. and 84% overall yield.  
 
 
 
 
 
 
 
 
 
 
Scheme 9 
Following these successful results, Jacobsen and co-workers developed an superior urea-
derived  organocatalyst  28  (Figure  6).
16  When  using  aliphatic  as  well  as  aromatic 
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aldimines, excellent enantioselectivities (96-99%) were achieved (Scheme 10). All results 
obtained when using the previous urea-derived organocatalyst were improved upon. The 
Jacobsen-type  α-amino  acid  synthesis  is  used  in  industry  by  Rhodia  ChiRex  for  the 
synthesis of optically active α-amino acids. 
 
 
 
 
 
 
Figure 6 
 
 
 
Scheme 10 
Recently,  List  and  Pan  employed  a  thiourea-derived  Jacobsen  catalyst  31  in  the  first 
organocatalytic asymmetric three-component Strecker reaction (Figure 7).
17 There has only 
been  one  previously  reported  direct  asymmetric  catalytic  three-component  Strecker 
reaction.
18  A  series  of  α-amido  nitriles  were  formed  in  excellent  yields  and 
enantioselectivies from aldehydes, amines and acyl cyanides.   
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Optimal reaction conditions were established and a number of reactions of aldehydes 4 
with benzyl amine and acetyl cyanide were carried out (Scheme 11). Particularly high 
enantioselectivities  were  observed  with  aromatic  aldehydes,  α,β-unsaturated  aldehydes, 
aliphatic  branched  and  unbranched  aldehydes.  Similar  results  were  achieved  using 
benzaldehyde with different amines and acyl cyanides. This newly developed variant of the 
Strecker reaction avoids the use of highly toxic hydrogen cyanide and does not require pre-
formation of the intermediate.  
   
 
 
 
Scheme 11 
1.2.2  The Strecker Reaction using Metal Catalysts 
Despite the ability of chiral  metal complexes to act as versatile catalysts being widely 
known,  it  was  1998  before  the  first  asymmetric  metal-catalysed  Strecker  reaction  was 
reported by Sigman and  Jacobsen.
19 It was already known that salen complexes  act as 
efficient  catalysts  for  asymmetric  epoxidation  and  kinetic  resolution  (salen  =  N,N’-
bis(salicylidene)-ethylenediamine  dianion).
20,21  After  a  screening  process  using  various 
metal complexes of the readily available salen ligand, it was found that the best results 
were achieved with aluminium(III) 33 (Figure 8). The product was isolated in 45% e.e. 
 
 
 
 
 
 
 
 
 
 
Figure 8 
A  variety  of  N-allyl  imines  34  were  subjected  to  a  reaction  with  the  catalyst  33  and 
substituted aryl imines appear to be the best substrates (Scheme 12). In contrast, alkyl-
substituted  imines  underwent  the  addition  of  HCN  with  considerably  lower 
enantioselectivity. Despite varying both the steric and electronic properties of the ligand 
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and  changing  the  N-substituent,  no  significant  improvement  in  enantioselectivity  was 
observed for alkyl-substituted imines.  
 
 
 
 
Scheme 12 
A  range  of  BINOL-derived  phosphoric  acids  also  catalyse  a  number  of  interesting 
processes involving imines. Mannich reactions seem to be ideally suited to this class of 
organocatalysts. Aluminium has also been employed in a binaphthol-based phosphinoyl-
containing catalyst 36, as reported by the Shibasaki group (Figure 9).
22 For a number of 
asymmetric  catalytic  reactions,  it  has  been  found  that  bifunctional  complexes  are 
promising catalysts due to the attachment of both electrophilic and nucleophilic substrates 
to the chiral catalyst in the transition state complex.
23  
 
 
 
 
Figure 9 
It had been a particular focus of the Shibasaki group to use α,β-unsaturated imines as they 
had not been used before and aliphatic N-aldimines which had thus far given unsatisfactory 
results. Through a series of reactions, it was found that the N-substituent had a significant 
effect  on  the  outcome  of  the  reaction  and  that  N-fluorenyl  gave  the  best  results.  The 
reaction had been further optimised when a significant solvent effect was found. In the 
presence of achiral protic additives a beneficial effect was observed in relation to the rate 
of reaction. Thus, a number of N-fluorenyl aldimines 37 were subjected to hydrocyanation 
with the catalyst 36 and TMSCN in phenol and DCM (Scheme 13). Of note is the broad 
range of substrates tolerated by this catalyst. The reaction proceeds well for both aliphatic 
N-aldimines and α,β-unsaturated imines and is the first example of catalytic asymmetric 
hydrocyanation of α,β-unsaturated imines. 
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Scheme 13 
The group of Kobayashi have reported the use of a chiral zirconium(IV) complex as a 
catalyst for the enantioselective Strecker reaction (Figure 10).
24 The catalyst 39 includes a 
1:1 mixture of 2 binaphthols, (R)-3,3’-dibromo-1,1’-binaphthol and (R)-6,6’-dibromo-1,1’-
binaphthol. 
 
 
 
 
Figure 10 
The substrate 40 is derived from benzaldehyde to give N-o-hydroxyphenol (Scheme 14). 
This  N-substituent  was  found  to  be  beneficial  in  previous  reactions  with  Kobayashi’s 
zirconium catalysts.
25 The imine is able to coordinate to the zirconium through the hydroxy 
group  and  the  imino  group.  Due to the  more  rigid  conformation  that  is  produced, the 
enantioselectivites  are  higher.  Tributyltin  cyanide  was  used  as  the  cyanide  donor.  The 
substrate  range  for  this  catalyst  is  quite  high,  including  aromatic,  heteroaromatic  and 
aliphatic imines. In comparison to the aromatic imines, the aliphatic imines were converted 
to the corresponding α-amino nitriles with lower enantioselectivities in the range of 74-
83%.  
 
 
 
 
 
Scheme 14 
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The tin oxide formed as a by-product during this reaction is recovered quantitatively and 
re-converted into the cyanide source. Unfortunately, the price of this cyanide source is 
considerably higher than HCN or TMSCN and the atom economy is lower. 
The  Shibasaki  group  has  also  developed  a  lanthanide(III)  complex  42  for  use  in  the 
asymmetric Strecker reaction of ketoimines.
26 Prior to this, there were two examples of the 
catalytic  enantioselective  Strecker  reaction  using  ketoimines  as  substrates.
16,27,28  The 
catalyst was developed with a view to increasing the substrate generality e.g. disubstituted 
α-amino acids which are of considerable biological importance.
29 The active catalyst is 
based on Gd(O
iPr)3 and D-glucose-derived ligand in a 2:3 ratio (Figure 11). Studies show 
that one of the lanthanide species acts as a Lewis acid and the other acts as a nucleophile. 
 
 
 
 
Figure 11 
The N-substituent again had a bearing on the enantioselectivity of the reaction and it was 
found  that  diphenylphosphinoyl  43  gave  the  best result.  High  enantioselectivities  were 
achieved using aryl methyl ketoimines and primary alkyl-substituted ketoimines, although 
secondary  alkyl-substituted  ketoimines  gave  moderate  enantioselectivity  (Scheme  15). 
Most of the products 44 could  be directly  subjected to acid  hydrolysis to produce the 
corresponding α,α-disubstituted α-amino acids.    
 
 
 
Scheme 15 
Following on from this successful result, the catalyst was found to be just as effective in a 
1:2  Gd(O
iPr)3:  D-glucose-derived  ligand  ratio  when  using  1  equivalent  of  2,6-
dimethylphenol (DMP) as an additive.
30 New, more economical reaction conditions were 
also subsequently reported which allowed the catalyst loading to be reduced to as low as 
0.1 mol%.     
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A  multitude  of  catalysts  and  chiral  ligands  have  been  developed  for  the  asymmetric 
Strecker synthesis of α-amino acids and those discussed above are only a short selection.  
1.3   The Use of Glycine Equivalents 
Glycine templates have a dominant role in the synthesis of α-amino acids and chirality can 
be introduced through two major strategies. Either glycine is coupled to a chiral auxiliary 
that can direct the formation of the new stereogenic centre or a chiral catalyst can be used. 
The  number  of  chiral  auxiliaries  that  can  be  attached  to  glycine  to  induce  chirality  is 
constantly growing. The templates can act as nucleophiles, electrophiles or through radical 
mechanisms. Some of the first efficient examples of a nucleophilic derivatisation were by 
Schöllkopf and co-workers using a bis-lactim ether glycine enolate.
31 They developed this 
heterocycle to act as a chiral auxiliary and induce the desired structure and conformation in 
the target molecule. The heterocyclic intermediate is necessarily more rigid that its open 
chain analogue and as such, should lead to greater asymmetric induction. A number of 
silylated  aldehydes  were  added  to  the  lithiated  bis-lactam  ether  45  to  give  aldol-type 
products 46 in >95% d.e. (Scheme 16). On acid hydrolysis, the ester 47 is liberated and is 
converted to the corresponding α-amino acid 48 by treating with 5M HCl under reflux. 
Bis-lactam  ethers  can  also  be  used  to  synthesise  α,α-disubstituted  α-amino  acids  by 
cyclising the chiral auxiliary with racemic alanine instead of glycine. The disubstituted 
amino acids are produced in good yields and enantiomeric excess in most cases.
32    
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Following the work of Schöllkopf, in 1988 Williams and co-workers developed a similar 
system in which a cyclic optically active lactone consisting of a glycine equivalent and a 
chiral auxiliary was used as a glycine template.
33 This was deprotonated to form the enolate 
which underwent condensation with electrophiles. 
 
Lu and co-workers have published another example of a chiral glycine enolate in which a 
tricyclic iminolactone 50 derived from (1R)-(+)-camphor 49 was coupled with glycine to 
give the chiral template (Figure 12).
34 Camphor  is a versatile and  inexpensive starting 
material and the Lu group have investigated its use previously in asymmetric synthesis.
35 
Again, due to the cyclic nature of the template the transition state will be more rigid and 
thus, should enhance the steric effect of the auxiliary. Lactones only give rise to the Z-
enolates  which  will  therefore  provide  a  single  alkylated  product  if  the  electrophile 
approaches specifically from one of the reaction faces. 
 
 
 
Figure 12 
The template 50 could then be deprotonated at the α-carbon to form the enolate (Scheme 
17). Alkylation of the iminolactone gave the α-substituted products 51 in good yields (74-
96%) and excellent diastereoselectivities (>98%). The combination of LDA as base and 
HMPA/THF as a solvent system gave the  best yields. This chiral auxiliary directs the 
formation of the endo-product in high diastereomeric excess, serving as a strong indication 
that the alkylation occurs exclusively from the bottom face. Hydrolysis of the alkylated 
products was performed in 8M HCl to give the corresponding D-amino acids 52 in good 
yields. The chiral auxiliary was also recovered in excellent yield. 
 
 
 
 
 
 Scheme 17 
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In theory,  L-amino acids can be similarly synthesised using the chiral template derived 
from the opposite enantiomer of camphor, (1S)-(-)-camphor. Unfortunately, the unnatural 
camphor is significantly more expensive. Lu and co-workers have gone on to synthesise 
the L-amino acids simply by exchanging the position of the lactone on the chiral template 
50  derived  from  the  natural  (1R)-(+)-camphor  49.
36  This  new  chiral  template  53  was 
subjected to a number of alkylations with alkyl halides as before (Scheme 18). LDA as 
base gave the best yields and diastereomeric excesses of >98%. Again, the chiral template 
directs the formation of the endo-product. Upon hydrolysis of the alkylated iminolactones 
54 in 8M HCl, the corresponding α-amino acids 55 were produced. 
 
 
 
 
 
 
Scheme 18 
A nickel(II) complex of the chiral non-racemic Schiff base of glycine with (S)-o-[N-(N-
benzylprolyl)amino]benzophenone  ((S)-BPB)  56  was  introduced  by  Belokon  and  co-
workers  and  has  significant  advantages  over  other  chiral  equivalents  of  nucleophilic 
glycine in terms of cost and availability (Figure 13).
37 It is also distinguished from other 
commercially  available  chiral  equivalents  of  glycine  by  the  fact  that  its  alkylation  is 
usually conducted under thermodynamically controlled conditions at room temperature in 
the presence of potassium hydroxide or sodium hydroxide. Soloshonok and co-workers 
have  developed  an  alkylation  of  this  Schiff  base  complex  to  synthesise  (S)-2’,6’-
dimethyltyrosine (DMT)  58 (Figure 13) which  is a  component of the ultraselective δ-
opioid dipeptide antagonist.
38,39 The alkylating agent 57 was chosen due to the O-benzyl-
protecting group which is stable towards moderate nucleophilic and electrophilic reactions 
but can be easily removed by hydrogenation.  
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Figure 13 
Benzylation of 56 by 57 gave the (R)- diastereomer (R)-59 and (S)-diastereomer (S)-59 in 
an 8:1 ratio and 95% yield (Scheme 19). The desired (R)-diastereomer was decomposed in 
3M HCl and the benzyl group was removed under hydrogenation conditions. This yielded 
the free amino acid 58 along with quantitative recovery of the chiral auxiliary 60 which 
can be recycled to 56. 
 
 
 
 
 
 
 
 
 
 
 
Scheme 19  
The  same  group  have  gone  on  to  synthesise  pyroglutamic  acids  using  the  nickel(II) 
complex 56.
40 These acids can be readily transformed into glutamic acids, glutamines and 
prolines.
41 Michael addition reactions were carried out between the Schiff base complex 56 
and 4-substituted N-(E-enoyl)oxazolidinon-2-ones 62 at room temperature in the presence 
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of DBU (Scheme 20). The 4-phenyl-oxazolidin-2-ones have been used previously and are 
superior in controlling the stereochemistry of the addition compared to 4-benzyl and 4-
isopropyl  analogues.
42,43  In  virtually  all  cases,  yields  for  the  addition  were  ≥97%  and 
diastereomeric excesses was >98%.  Considering these results, the steric and/or electronic 
nature of the substituents does not influence the stereochemical outcome, only the reaction 
rate. The addition products 63 were decomposed with 2M HCl and concentrated ammonia 
to give the chiral auxiliary in 87-95% yield and the corresponding pyroglutamic acids 64 in 
93-95% yield.   
 
 
 
 
 
 
 
 
 
Scheme 20 
Soloshonok  also  developed  an  improved  synthesis  of  the  nickel(II)  complex  56  used 
previously including two new analogues 69 and 70.
44 The method involves application of 
inexpensive reagents and operationally convenient conditions
 (Scheme 21). The previous 
synthesis reported by Belokon and co-workers began from enantiomerically pure proline 
and  while  it  does  generate  the  desired  complex,  it  is  not  amenable  to  large  scale 
preparation due to, for example, the problems associated with the control of pH, the use of 
excess thionyl chloride and the use of almost 50% excess 67 during the amidation step. 
Thus,  starting  from  (S)-proline  66,  commercially  available  and  cheap  NaOMe  was 
employed as base. For the amidation, cheaper methanesulfonyl chloride was used in place 
of p-toluenesulfonyl chloride  which  is  harder to handle. The complexes were prepared 
using previously reported conditions.
37 
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Scheme 21 
This  group  has  also  gone  on  to  evaluate  a  new  generation  of  nucleophilic  glycine 
equivalents, still maintaining the nickel(II) complex of the Schiff base of glycine.
45 The 
complex 71 proved to be the most synthetically useful (Figure 14). Recently, Soloshonok 
and co-workers have employed this nickel(II) complex in the synthesis of new thalidomide 
derivatives, 73 and 74 (Figure 14).
46 Thalidomide 72 was marketed as a sedative in 1956, 
though the racemic mixture has teratogenic activity.
47 It has been widely thought that the 
(S)-enantiomer exhibits this activity, though this has remained uncertain as optically active 
thalidomide  undergoes  rapid  racemisation,  via  the  formation  of  the  corresponding 
enolate.
48,49  Therefore  the  design  and  synthesis  of  stable  analogues  of  thalidomide  has 
recently become an important area of development, as thalidomide has selective inhibitory 
activity of tumour necrosis factor-α which is a clinically important activity against serious 
diseases such as rheumatoid arthritis, Crohn’s disease, leprosy, AIDS, etc.
50,51 
 
 
 
 
Figure 14 
It was thought that β-substituted pyroglutamic acids 64, synthesised previously, would be 
appropriate precursors for the preparation of the corresponding derivatives of 4-substituted 
thalidomide.  Unfortunately,  the  methodology  developed  previously  would  yield  trans-
pyroglutamic acids which would not be suitable precursors.
45 The cis-pyroglutamic acids 
are  very difficult to prepare  in optically  active  form. However, considering that  cis-4-
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substituted thalidomides might be conformationally unstable, together with the suggestion 
that the C3 proton acidity would be as high as in thalidomide, it was assumed that upon 
glutarimide formation, the phthalimide group at C3 would undergo eperimisation giving 
rise to the target trans-products 73 and 74. 
Therefore, (2R,3S)-β-phenyl pyroglutamic acid 75 was synthesised. Hydrolysis with 6M 
HCl yielded the corresponding 3-phenylglutamic acid 76 (Scheme 22).
52 Using a literature 
procedure, 76 was transformed  into N-phthaloyl anhydride 77 which was  isolated as a 
single  diastereomer  in  67%  yield  over  two  steps.
53  Determination  of  the  relative 
stereochemistry  revealed  a  3,4-trans  relationship  and  there  was  no  trace  of  the  cis-
diastereomer. A condensation reaction of the intermediate dicarboxylate 78 was employed 
to yield the target molecule 74, which was isolated in 68% yield over two steps as a single 
diastereomer  with  >98%  enantiomeric  excess.  The  alkyl  derivative,  (3S,4R)-4-methyl 
thalidomide was synthesised following the same route in 51% overall yield.  
 
 
 
 
 
 
 
Scheme 22 
1.3.1  Phase-Transfer Catalysis 
The use of chiral phase transfer catalysts has had a major impact on synthesis over the 
years,  especially  for  the  synthesis  of  unnatural  amino  acid  derivatives  via  asymmetric 
alkylation reactions. A number of groups have worked on developing new catalysts for 
enantioselective  alkylation  since  the  first  report  of  alkylation  of 
tbutyl  glycinate 
benzophenone  Schiff  base  79  with  a  cinchona  alkaloid-type  phase  transfer  catalyst  by 
O’Donnell and co-workers (Scheme 23).
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Scheme 23 
Following  this,  Lygo  and  co-workers  reported  a  phase  transfer  catalyst  which  was  a 
cinchona  alkaloid  derivative  81  (Figure  15).
55  The  introduction  of  the  bulky  N-
anthracenylmethyl group led to an enhancement of the stereoselectivity. The catalyst was 
subsequently used in the enantioselective synthesis of α-amino acids via the alkylation of 
glycine  imines  under  liquid-liquid  phase  transfer  conditions.
56  The  catalyst  was  also 
employed in the enantioselective synthesis of bis-α-amino acids which can act as cross-
linking agents in plants and bacteria. Unnatural bis-α-amino acids have also been applied 
in the synthesis of novel analogues of biologically active peptides.
57 
 
 
 
 
 
 
Figure 15 
Initial  investigations  involving  the  alkylation  of  the  glycine  equivalent  79  with  the 
dibromide  82  demonstrated  that  either  the  mono-  or  di-alkylated  product  could  be 
produced depending on the reaction conditions (Scheme 24). With excess dihalide, the 
mono-alkylated product 83 was obtained in a 10:1 ratio over the di-alkylated product 84. 
Using stoichiometric quantities of the dihalide reversed this selectivity. Hydrolysis of 84 
led to the α-amino ester 85 being produced in 72% diastereomeric excess and >95% e.e. A 
variety of other dihalides were used and all produced the corresponding bis-α-amino acids 
in >95% e.e.  
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Scheme 24 
The Maruoka group continued to develop a chiral phase transfer catalyst for the double 
alkylation of a Schiff base of glycine.
58 Their optimised catalyst is a chiral ammonium 
bromide salt 86 (Figure 16).   
 
 
 
Figure 16 
Alkylation reactions were carried out using 1-3 mol% of the above catalyst with various 
alkyl  halides  (Scheme  25).  It  was  found  that  the  reactions  proceeded  with  high 
enantioselectivity and yields. Of note is the fact that if the halides are added in reverse 
order, the absolute configuration of the alkylated product was confirmed to be opposite, 
indicating  the  intervention  of  the  expected  chiral  ammonium  enolate  in  the  second 
alkylation.  
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Scheme 25 
The  group  then  extended  the  scope  of  their  chiral  phase  transfer  catalyst  to the  aldol 
reaction  of  glycine  Schiff  base  79  with  aldehydes  4  under  organic/aqueous  biphasic 
conditions.
59 The structural motif of the modified (R,R)-catalyst 89 remained the same but 
the substituent was changed to 3,5-bis(3,5-bis(trifluoromethyl)phenyl)phenyl (Figure 17). 
In this system, the modifications enhanced both the diastereo- and enantioselectivities.  
 
 
 
 
 
Figure 17 
Generally, the aldol reaction of a variety of aldehydes 4 with the above catalyst and the 
glycine  Schiff  base  79  proceeded  well  giving  predominantly  the  anti-isomer  90  with 
excellent enantioselectivity for the α-stereocentre (Scheme 26).  
 
 
 
 
 
Scheme 26  
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Following these positive results, it became clear that although the conformationally rigid 
binaphthyl structure was a characteristic feature of the catalyst and seemed essential for 
attaining high enantioselectivity, modifications to the structure proved to be difficult. A 
new chiral ammonium bromide salt catalyst 92 was reported by Maruoka and co-workers 
(Figure 18).
60 The new design features an achiral biphenyl moiety which has scope for 
substituents. The most effective catalyst was found to have 3,5-diphenylphenyl substituents 
as R1 and phenyl groups as R2. 
 
 
 
 
 
Figure 18 
 
The catalyst was evaluated in a phase transfer alkylation with various alkyl halides and the 
previously employed glycine Schiff base 79 (Scheme 27). Good to high yields (61-95%) 
and  excellent  enantioselectivites  (92-95%)  were  obtained.  The  (R)-diastereomer  93 
predominated. 
 
 
 
 
Scheme 27  
The catalytic enantioselective aldol reaction of glycine derivatives with aldehydes has also 
been  investigated  by  Kobayashi  and  co-workers.
61  A  chiral  zirconium  catalyst  was 
employed,  as  this  group  had  previously  demonstrated that  chiral  zirconium  complexes 
activate  both  azomethine  compounds  and  aldehydes  effectively  and  various  catalytic 
reactions have been carried out.
62 The catalyst is prepared from the BINOL-derived ligand 
94 and Zr(O
tBu)4 (Figure 19). Initial investigations were carried out with benzaldehyde 
and a glycine-derived silicon enolate 95, which in this case was easily prepared on a large 
scale from glycine methyl ester and can be stored over a long period (Figure 19). The most 
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successful result obtained with benzaldehyde was 92% yield and 95% e.e. for the anti-
diastereomer. 
 
 
 
 
 
Figure 19 
Following this, the group investigated the aldol reaction of other benzaldehyde derivatives 
using the same silicon enolate 95 (Scheme 28). Both electron-withdrawing and donating 
groups  at  the  para  or  meta  positions  were  found  to  be  good  substrates.  An  efficient 
asymmetric  synthesis  of  L-erythro-sphingosine  97  was  carried  out  to  demonstrate  the 
application  of  this  methodology.  Sphingosine  is  part  of  an  essential  cell  membrane 
component,  sphingolipid.
63  The  initial  aldol  condensation  gave  the  desired  anti-
diastereomer in 95% yield and 97% e.e. for the α-stereocenter. 
 
 
 
 
 
 
 
Scheme 28 
Recently, Shibasaki and co-workers have developed novel two-centre organocatalysts 98, 
99 and 100 which are tartrate-derived diammonium salts named TaDiAS (Figure 20).
64 
The catalysts all contain a 2,6-disubstitued cyclohexane spiroacetal, to affect the chiral 
environment more strongly around the quaternary ammonium salts. Previously, this type of 
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catalyst was found to catalyse the asymmetric Michael reaction of a glycine-derived Schiff 
base with an α,β-unsaturated ketone with modest selectivity (60% e.e.).
65  
 
 
 
 
 
 
 
 
 
 
 
Figure 20 
Asymmetric  Michael  reactions  were  carried  out  with  the  second  catalyst  99  and  α,β-
unsaturated  ketones  102  (Scheme  29).  It  was  found  that  the  highest  selectivity  was 
achieved  with  the  benzyl  ester  of  the  glycine-derived  Schiff  base  101  in  1,3-
difluorobenzene (93% yield, 80% e.e.). This catalyst is also suitable for acrylates though 
the reactions generally proceeded in good yield and higher enantioselectivies with the first 
catalyst 98.  
 
 
 
 
Scheme 29 
The catalytic asymmetric Mannich-type reaction was also investigated using these phase-
transfer  catalysts.  The  catalytic  asymmetric  reaction  in  general  is  less  common  in  the 
literature. An N-Boc protected imine 104 was employed and it was found that the first 
catalyst 98 gave the best reactivity as well as enantioselectivity. The syn-product 105 was 
isolated in 96% yield (anti:syn 1:99) and 90% e.e. for the α-stereocenter (Scheme 30). 
Enolisable alkyl imines were also suitable.  
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Scheme 30 
1.4  Asymmetric Carbon-Nitrogen bond forming reactions 
1.4.1  Nucleophilic Amination 
The amine functionality is one of the most ubiquitous in organic chemistry. Its importance 
is exemplified by the diverse nature of molecules that contain this functional group, which 
includes  natural  products,  pharmacological  agents  and  fine  chemicals.  For  this  reason 
carbon-nitrogen  bond  formation  is  of  great  interest.  Naturally,  this  field  is  constantly 
growing and only a small selection of recent results will be presented here. The generation 
of α-amino acids by introducing the amino group through the use of nucleophilic aminating 
reagents is generally based on SN2 substitutions. Carbon-nitrogen bonds are often formed 
by the attack of a nucleophilic nitrogen atom 107 on an electrophilic carbon centre 106 
bearing a  leaving group (Scheme 31). Chirality  is  introduced prior to the nucleophilic 
amination.  Generally,  the  process  involves  reacting  a  compound  having  a  primary  or 
secondary amino or amido group with an arylating compound, in the presence of a weak 
base and a transition metal catalyst, under reaction conditions effective to form an N-aryl 
amine or N-aryl amide compound.  
 
 
 
Scheme 31 
Allylic amines are fundamental building blocks in organic chemistry and the allyl fragment 
can be encountered in many natural products. Allylic amines can be transformed into many 
different products such as α- and β-amino acids, alkaloids and carbohydrate derivatives.
66 
The amination of alkenes 109 bearing a carbon-heteroatom or carbon-halide bond is one if 
the simplest ways of synthesising these allylic amines 111 (Scheme 32). 
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Scheme 32 
The  allylic  amines  can  then  be  converted  into the  corresponding  N-protected  α-amino 
esters  113  by  oxidative  cleavage  (Scheme  33).  The  conversion  has  been  previously 
achieved though ozonolysis in the presence of methanolic sodium hydroxide (2.5M) at -78 
oC without loss of stereochemical purity.
67  
 
 
 
 
Scheme 33 
The Mitsunobu reaction offers one of the most attractive ways to transform allylic alcohols 
in allylic amines with inversion of stereochemistry as the reaction can be performed under 
mild  conditions  with  a  wide  range  of  amine  nucleophiles  (Scheme  34).
68  Suitable 
nucleophiles  include  phthalimide  and  sodium  azide.  Hydrolysis  (Gabriel  reaction)  or 
selective reduction (Staudinger reaction) makes the amines accessible.     
 
 
 
 
Scheme 34 
Lee  and  co-workers  have  reported  the  synthesis  of  both  syn  and  anti-2,3-diamino-
phenylpropionic acids 120a and 120b using a Mitsunobu reaction to install the 2-amino 
group (Scheme 35).
69 Isopropyl cinnamate 116 was converted into the syn-acetylamino 
alcohol  117a  using  Sharpless’  asymmetric  amino-hydroxylation  procedure  (81%  yield, 
>99%  e.e.).  This  was  further  transformed  to  give  the  corresponding  anti-acetylamino 
alcohol 117b. A Mitsunobu reaction was attempted on these amino alcohols, however an 
oxazoline product was obtained. Therefore the acetyl group was exchanged for a Boc-
group and concomitant transesterification of the isopropyl ester to the methyl ester also 
occurred.  The  new  substrates  118a  and  118b  for  the  Mitsunobu  reaction  gave  the 
corresponding α-azide products 119a and 119b with clean inversion of stereochemistry. 
Finally, selective hydrogenation furnished the desired diamino acids. 
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Scheme 35 
Asymmetric  allylic  substitution  has  been  shown  to  be  a  powerful  technique  for  the 
preparation of a wide range of chiral molecules (Scheme 36). The metal-catalysed reaction 
uses  palladium  most  often  and  the  regiochemistry  normally  favours  the  linear  product 
123.
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Scheme 36 
More recently, increasing interest has been shown in iridium-catalysed allylic substitutions 
which  normally  favour  the  branched  products  122.
71,72  Alexakis  and  co-workers  have 
reported  the  phosphoramidite  ligand  124  (R  =  OMe)  which  was  applied  in  iridium-
catalysed allylic aminations (Figure 21).
73 It had been previously shown that monodentate, 
strong π-accepting ligands such as 125 (R = H) were very efficient in iridium-catalysed 
allylic substitutions (Figure 21).
74   
 
 
 
 
Figure 21 
As was expected, the branched product  127 was  favoured over the  linear product  128 
(Scheme 37). Yields and enantioselectivities were excellent.    
 
 
 
 
Scheme 37 
Simultaneously, Helmchen and co-workers also reported the above ligand and the results 
that  they  achieved  in  the  iridium-catalysed  allylic  amination  with  sulfonamides  as 
nucleophiles (Scheme 38).
75 The reactions were performed using LiN(CH2Ph)p-Ts as the 
nucleophile and good to excellent results were obtained. Again, the branched product 129 
was preferred over the linear product 130. p-Nosylamides were investigated in an attempt 
to reduce steric effects.  
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Scheme 38 
Since then, Alexakis and co-workers have generated a new ligand where R = Me and with 
this a spectacular increase in the rate of reaction was observed in the asymmetric allylic 
amination  with  benzylamine.
76  The  enantioselectivity  was  improved  also  to  98.3%  e.e. 
Very recently, Carreira and co-workers have introduced the use of sulfamic acid H2NSO3H 
as an ammonia equivalent in allylic substitutions.
77 In general, primary amines can only be 
prepared through protected forms of ammonia. The iridium-catalysed reactions proceeded 
with complete regioselectivity in yields of up to 82%. 
Recently, Plietker introduced the first iron-catalysed regioselective allylic amination.
78 The 
catalyst was [Bu4N][Fe(CO)3NO] 132 and the amination in the presence of primary amines 
proceeded  with  high  regioselectivity  in  favour  of  the  ipso-substitution  product  133 
(Scheme 39). Unfortunately, catalyst decomposition in the reaction of less substituted allyl 
carbonates led to low yields but this was improved upon addition of piperidinium chloride. 
In the case shown below the yield was increased from 36% to 84%. 
 
 
 
 
Scheme 39 
Another efficient method for the synthesis of allylic amines is Overman’s 3,3-sigmatropic 
rearrangement (Scheme 40). This was first introduced by Overman in 1974 and transforms 
allylic  alcohols  135  into  allylic  amines  138.
79  The  reaction  can  be  catalysed  by  heat, 
mercury(II) and palladium(II) and Overman himself has developed a number of complex 
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catalysts  for  this  purpose.
80  Very  recently,  Gonda  and  co-workers  have  reported  their 
results from microwave accelerated rearrangements.
81 
 
 
 
Scheme 40 
Walsh and co-workers introduced an efficient and highly diastereoselective route to D or L 
α-amino  acids  from  terminal  alkynes  139  using  the  (3,3)-sigmatropic  thermal 
rearrangement.
82 An attractive  feature of this  methodology  is that  it provides access to 
sterically hindered allylic amines that may be difficult to synthesise otherwise. Reaction of 
benzaldehyde  with  terminal  alkynes  catalysed  by  the  ligand  MIB  (3-exo-
morpholinoisoborneol) 144 gave allylic alcohols 141 with excellent enantioselectivity of 
88-97% and yields of 65-94%. The alcohols 141 were converted into the protected allylic 
amines 142 by thermal rearrangement (Scheme 41). The stereochemistry that was set from 
the  vinylation  reaction  is  transferred  to  the  allylic  amines.  The  enantioselectivity  was 
maintained and yields for this step were 64-96%. Oxidative cleavage of the allylic amines 
gave amino acids 143 in 57-92% yield for the ruthenium pathway and 75-94% for the 
ozonolysis pathway.  
 
 
 
 
 
 
 
 
Scheme 41 
R
OH
Cl3CCN
NaH
R
O
CCl3
HN
R
O
CCl3
HN
R
NH2
H Catalyst * *
135
136 137
138
R
1. Cy2BH
2. Me2Zn MeZn
R MIB 2 mol%
PhCHO Ph R
OH
1. DBU, 
Cl3CCN
2. Toluene,

Ph R
NH Cl3C
O
RuCl3.xH2O,
NaIO4
O3,
NaOH/MeOH
HO
R
O
NH
O
Cl3C
MeO
R
O
NH
O
Cl3C
(+)-MIB (144) =
N
O
OH
139 140 141
142
143K. N. Fanning, Chapter 1, Page 41 
1.4.2  Electrophilic Amination 
The electrophilic amination of carbonyl compounds is a conceptually attractive method for 
the  synthesis  of  nitrogenous  compounds.  However,  the  small  number  of  suitable  N-
electrophiles  also  limits  its  popularity.  Electrophilic  amination  provides  a  great 
improvement with respect to the classical methods such as those based on the attack of the 
nucleophilic nitrogen atom to an electrophilic carbon, which are hampered by the difficulty 
in  accessing  electrophilic  precursors  and  the  frequent  difficult  reaction  conditions.
83 
Electrophilic  amination  essentially  is  the  reverse  of  nucleophilic  amination  in  that  the 
carbon nucleophile 145 replaces a good leaving group on the electrophilic nitrogen 146 
(Scheme 42). 
 
 
Scheme 42 
Electrophilic  reagents  of  the  type  X-NR1R2  146  usually  contain  halogens  or  oxygen 
functions as leaving groups. Other reagents can act as amino cation equivalents and some 
examples are given in Figure 22. Azides 147 and oximes 148 can react with Grignard or 
organolithium  species to  yield the triazene salts and  imines respectively  which can  be 
converted  to  the  corresponding  amines.  Reaction  of  enolates  with  dialkyl 
azodicarboxylates 149 yields the α-hydrazido compounds which can be hydrogenated to 
the  α-amino  compounds.  N-protected  oxaziridines  150  can  transfer  the  N-protected 
fragment  under  mild  conditions  to  N-nucleophiles,  but  give  moderate  yields  with  C-
nucleophiles.
84  
 
 
 
 
Figure 22 
The  first example of an asymmetric electrophilic amination using a chiral reagent was 
reported in 1992 by Oppolzer and co-workers.
85 They developed chiral α-chloro-α-nitroso 
reagents  151  and  152  which  aminated  prochiral  ketone  enolates  with  high 
enantioselectivity (Figure 23). Zinc enolates of ketones also reacted with these α-chloro-α-
nitroso reagents to give nitrones with high diastereomeric excess.  
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Figure 23 
Evans and Vederas both published enantioselective synthetic routes to α-amino acids using 
chiral  N-acyloxazolidinone  enolates  153  and  commercially  available  di-
tbutyl 
azodicarboxylate 154.
86 In the case of Evans and co-workers, the lithium enolates derived 
from the N-acyloxazolidinones reacts readily with di-
tbutyl azodicarboxylate to give the 
hydrazide  products  155  in  excellent  kinetic  ratios  and  yields  (Scheme  43).  These  are 
practical precursors for α-amino acids. 
 
 
 
 
 
 
Scheme 43 
The first enantioselective amination of N-acyloxazolidinones in the presence of a chiral 
catalyst was described by Evans and co-workers.
87 The catalyst that was developed was a 
magnesium bis(sulphonamide) complex 156 (Figure 25). Aryl-substituted carboximides 
were used as they were expected to be moderately active towards enolisation and would 
give structurally well-defined enolate complexes. 
 
    
 
 
Figure 25 
Using 10 mol% of this catalyst, which had been developed through a screening library, N-
acyloxazolidinone 157 was aminated in the presence of di-tert-butyl azodicarboxylate 154. 
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This  gave  the  hydrazide  158  with  an  enantiomeric  ratio  of  2S:2R  93:7  in  93%  yield 
(Scheme 44). Recyrstallisation leads to enantiomeric enrichment (99% e.e.). A number of 
aryl-substituted imides can be used including those with electron-withdrawing or donating 
substituents and disubstituted aryl substituents.  
 
 
Scheme 44 
A  new  chiral  3-aryl-N-alkyloxycarbonyloxaziridine  159  derived  from  (-)-menthol  was 
reported  in  2001  by  Armstrong  and  co-workers  (Figure  25).
88  The  chemistry  of 
oxaziridines has been widely studied and it has been shown that the attack of a nucleophile 
occurs at either the oxygen or nitrogen of the ring depending on the nucleophile and the 
substituents on the ring. This reagent was synthesised based on the work of Vidal and 
Collet  who  showed  previously  that  N-alkoxycarbonyloxaziridines  such  as  160  transfer 
nitrogen rather than oxygen to a number of nucleophiles.
84a,84b 
 
 
 
 
Figure 25 
Compound 159 was tested as a reagent for the electrophilic amination of lithium enolates 
and while yields were good, the maximum diastereoselectivity achieved was only 21% 
(Scheme  45).  The  low  selectivity  is  possibly  due  to  the  low  facial  selectivity  in  the 
approach of the oxaziridine to the enolate.  
 
 
 
 
 
 
 
Scheme 45 
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The first stable enantiomerically pure chiral N-H oxaziridines 163 and 164, derived from 
(1R)-(+)-camphor  and  (1R)-(-)-fenchone  respectively,  was  described  by  Page  and  co-
workers  in  2002  (Figure  26).
89  They  were  investigated  as  asymmetric  sources  of 
electrophilic nitrogen for the amination of various carbon nucleophiles such as esters and 
nitriles. Yields were moderate to good but in general, enantioselectivity was moderate    
 
 
Figure 26 
Azodicarboxylates have been used extensively as aminating reagents that give hydrazine 
derivatives,  which  are  direct  precursors  of  amines.  Some  of  the  aminations  discussed 
previously included azodicarboxylates as the nitrogen source. Apart from sulfonyl azides, 
azodicarboxylates  have proven to be the  most successful aminating reagents. They are 
widely  available,  relatively  cheap  and  highly  reactive  and  have  been  used  in  the  α-
amination of a number of substrates. 
Evans  described  the  use  of  copper(II)  complexes  as  chiral  Lewis  acids.
90  The  chiral 
copper(II) complex [Cu-(S,S)-
tBu-box](OTf)2 167 catalysed the electrophilic amination of 
the isomerically pure enolsilanes of aryl ketones 165 with azodicarboxylate derivatives 166 
(Scheme 46). Trifluoroethanol was needed as an additive to promote catalyst turnover. As 
the  R  group  increased  in  size,  reaction  times  also  increased.  The  methodology  was 
extended to cyclic enolsilanes and acylpyrrole enolsilanes with similar success. 
 
 
 
 
 
Scheme 46 
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Proline has also been to found to catalyse the direct asymmetric α-amination of carbonyl 
compounds  with  azodicarboxylates.
91  Particular  advantages  of  the  use  of  proline  as  a 
catalyst include non-toxicity and the ready availability of both enantiomeric forms. List 
described the direct α-amination of aldehydes and found this to be highly efficient and 
enantioselective process.
91a The methodology could give access to a wide range of optically 
active molecules including α-amino aldehydes, α-amino alcohols and α-amino acids. In the 
reaction of isobutyraldehyde 169 with dibenzyl azodicarboxylate 170 using (S)-proline as 
catalyst, the expected 2-hydrazino alcohol 171 was obtained in 99% yield and 96% e.e. 
after in situ NaBH4 reduction (Scheme 47). The reactions that were carried out were found 
to be time-dependent and extended reaction times led to partial racemisation. 
 
 
 
 
 
Scheme 47 
Simultaneously, Jørgensen and co-workers also reported the direct proline-catalysed α-
amination of aldehydes to yield the corresponding α-aminated aldehydes.
91b These were 
also reduced in situ with NaBH4 as this prevents the decrease in e.e. due to the acidity of 
the α-position next to the carbonyl group. The conversion of the aminated aldehydes 172 to 
N-Boc-protected α-amino esters 173 was also demonstrated (Scheme 48). The aldehyde 
172 was oxidised with KMnO4 to the acid which was esterified. Hydrolysis of the Boc-
groups, reduction and Boc-protection produces the N-Boc-protected valine methyl ester 
173.  Shortly  after,  Jørgensen  and  co-workers  extended  the  substrate  range  to  include 
ketones, again using azodicarboxylates as the nitrogen source.
92  
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H
O
R
N
N
BnO2C
CO2Bn
(S)-Proline
(10 mol%)
DCM
0 
oC to r.t., 3 h
then
NaBH4, EtOH
HO
N
N
H
CO2Bn
CO2Bn
R
R
iPr
nBu
Me
Bn
Yield
99%
94%
97%
95%
e.e.
96%
97%
>95%
>95%
169 170 171
H
N
N
H
Boc
Boc
iPr
O
1. KMnO4
2. TMSCH2N2
3. TFA
4. H2, Raney-Ni
5. Boc2O, DMAP
MeO
O H
N
Boc
iPr
172 173K. N. Fanning, Chapter 1, Page 46 
While proline is a very efficient catalyst, it has recently been shown that other amino acids 
can catalyse the asymmetric α-amination of aldehydes and ketones. The enantioselectivity 
observed  with  the  proline-catalysed  reaction  was  explained  with  a  proline-enamine 
transition state 174 and it was thought that by modifing the nature and size of the catalytic 
heterocycle, the outcome of the reaction would be affected (Figure 27).
91c Greck and co-
workers  have  investigated  the  corresponding  4-membered  heterocycle,  L-azetidine 
carboxylic  acid  175,  as  a  catalyst  (Figure  27).
93  Yields  and  enantioselectivity  were 
comparable to those obtained with proline.   
 
 
 
Figure 27 
1.5  Catalytic Asymmetric Hydrogenation  
Catalytic enantioselective hydrogenation employs dihydrogen and small amounts of chiral 
transition-metal complexes and is one of the most efficient methods for producing a wide 
range  of  enantiomerically  pure  compounds.
94  Hydrogenation  is  economical  and 
environmentally friendly and provides an ideal route to amines. Typically, rhodium(I) and 
ruthenium(II) complexes are  most often used and these will  be the  main  focus of this 
section.  The  scope  of  this  reaction  has  been  gradually  extended  in  terms  of  reactant 
structure  and  catalyst  efficiency  over  many  years.  The  ideal  catalyst  combines  high 
enantioselectivity with high catalytic activity and wide substrate scope. 
The  development  of  asymmetric  hydrogenation  was  first  introduced  by  Knowles  and 
Horner in the 1960s after the discovery of Wilkinson’s homogenous hydrogenation catalyst 
[RhCl(PPh3)3].
95,96 Knowles reported that the monophosphine CAMP ligand 177, which 
replaced the triphenylphosphine in Wilkinson’s catalyst provided enantiomeric excesses of 
up  to  88%  in  the  hydrogenation  of  dehydroamino  acids  (Figure  28).
97  Knowles  also 
reported the chelating bisphosphine ligand DiPAMP 178 (Figure 28).
98 DiPAMP has been 
employed in the industrial synthesis of L-DOPA (Knowles-Monsanto synthesis) due to its 
high catalytic efficiency in rhodium-catalysed asymmetric hydrogenation of dehydroamino 
acids.
99 This work led to Knowles being awarded the Nobel Prize in 2001, along with 
Noyori and Sharpless. Work in the 1980s focussed on chiral rhodium catalysts and the 
substrate scope was limited to α-dehydroamino acids. Since then, many chiral phosphorus 
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ligands have been developed and many other transition metals have been used for catalytic 
asymmetric hydrogenation, for example ruthenium, iridium, platinum, titanium, zirconium 
and palladium.   
1.5.1  Rhodium 
Rhodium-catalysed asymmetric hydrogenation has famously been used in the commercial 
production of the amino acid, L-3,4-dihydroxyphenylalanine (L-DOPA), which is used to 
treat Parkinson's disease. In 1968, Knowles and his group replaced the triphenylphosphine 
in  Wilkinson's  rhodium  catalyst  with  a  chiral  phosphine  and  hydrogenated  a  prochiral 
olefin.
96a  Their  first  hydrogenations  gave  only  15%  e.e.  but  continued  modifications 
resulted in the creation of methylphenyl-o-anisylphosphine (PAMP) 176, which gave 58% 
e.e.  (Figure  28).  Finally,  when  the  phenyl  group  in  PAMP  was  modified  to  a  more 
hindered cyclohexyl to give  methylcyclohexyl-o-anisylphosphine (CAMP) 177, the e.e. 
increased to 88%. Later, the e.e. was  further  improved to 95% using DiPAMP 178, a 
dimeric form of PAMP (Figure 28). 
   
 
 
 
Figure 28 
These ligands are still being used widely today, for example, in the asymmetric synthesis 
of  the  isomeric  nonproteinogenic  (S)-(-)-acromelobic  acid  185  by  Adamczyk  and  co-
workers.
100  The  synthesis  begins  from  commercially  available  citrazinic  acid  and  2,5-
lutidine  respectively.  Citrazinic  acid  179  was  converted to  180  in  four  steps  and  23% 
overall yield (Scheme 49). The alcohol was oxidised to the corresponding aldehyde 181 in 
30%  yield  and  this  was  then  treated  with  N-(benzyloxycarbonyl)phosphonoglycine 
trimethyl ester to yield the dehydroamino acid derivative 182. This was then subjected to 
the  asymmetric  hydrogenation  with  a  catalytic  amount  of  Knowles’  catalyst,  (R,R)-
[Rh(DiPAMP)(COD)]BF4 183, to give (S)-(+)-184 in 89% yield and >98% e.e. (Figure 
29). The protecting groups were then removed in one step to yield 185.   
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Scheme 49 
 
 
 
 
Figure 29 
Burk  later  introduced  a  range  of  chiral  hydrogenation  catalysts  based  on  the  highly 
successful  1,2-bis(phospholano)benzene  (DuPHOS)  and  1,2-bis(phospholano)ethane 
(BPE) ligands.
101 These were (S,S)-Me-DuPHOS 186 and (R,R)-Me-BPE 187 (Figure 30). 
These were used in the rhodium-catalysed hydrogenation of a series of β,β-disubstituted 
enamides and enantioselectivities of 85-99% were achieved. 
 
  
Figure 30 
The group of Shieh have further demonstrated the synthetic usefulness of the BPE ligand 
in  rhodium-catalysed  hydrogenation  by  preparing  the  unnatural  α-amino  acid  (R)-4-
piperidinylglycine  195.
102  This  amino  acid  is  an  important  building  block  in  novel 
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pharmaceuticals  such  as  thrombin  inhibitors.
103  Excellent  enantioselectivity  had  been 
reported previously in the synthesis of N-Cbz-protected enamides which are precursors for 
the asymmetric hydrogenation.
100a,104 Thus the required N-Cbz–protected enamide 190 was 
prepared from commercially available N-Cbz-phosphonoglycine trimethyl ester 188 and N-
Boc-4-piperidinone 189 in 61% yield (Scheme 50). At this point a recrystallisation was 
performed,  so  as  to  eliminate  any  impurities  that  may  have  poisoned  the  catalyst. 
Asymmetric hydrogenation of 190 in the presence of the commercially available rhodium 
catalyst 191 generated the (R)-enantiomer of 192 in 99% yield and 94% e.e. The ester was 
converted to the corresponding acid 193 with LiOH in 98% yield. Hydrogenation removed 
the Cbz-protecting group and the Boc-protecting group was then removed with HCl to give 
195 in 49% overall yield. 
 
 
 
 
 
 
 
 
 
 
Scheme 50 
Dynamic kinetic resolution (DKR) is a powerful technique for synthesising one enantiomer 
from  a  racemic  starting  material  with  a  labile  stereocenter.
105  Noyori  and  co-workers 
originally  described  the  ruthenium-catalysed  DKR  of  α-substituted  β-keto  esters  which 
yielded  syn-β-hydroxy-α-amino  acid  esters.
106  In  more  recent  times,  Hamada  and  co-
workers  have  demonstrated  that  a  ruthenium-BINAP  complex  can  catalyse  the  anti-
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selective  asymmetric  hydrogenation  of  α-amino-β-keto  ester  hydrochlorides  in  the 
synthesis  of  anti-β-hydroxy-α-amino  acid  esters  with  high  diastereoselectivities  and 
enantiomeric excesses.
107 This will be discussed further within the ‘ruthenium’ section.    
Recently,  rhodium-catalysed  asymmetric  hydrogenation  of  α-amino-β-keto  ester 
hydrochlorides through DKR  was described  by  Hamada and co-workers.
108 This  yields 
anti-β-hydroxy-α-amino acid esters. This had been previously described by two groups but 
gave low conversion and/or poor selectivity.
109 Following optimisation of the catalyst and 
reaction conditions, asymmetric hydrogenations were carried out on a number of aromatic 
substrates 196 (Scheme 51). While the yields achieved are moderate, good selectivity and 
enantioselectivies were obtained. The e.e.’s in Scheme 51 refer to the α-stereocenter of the 
anti-β-hydroxy-α-amino acid esters 
 
 
 
 
 
 
 
Scheme 51 
1.5.2  Ruthenium 
As mentioned before, asymmetric hydrogenation is more often carried out with rhodium or 
ruthenium catalysts with diphosphine-cased chiral ligands. In 1986 a major breakthrough 
was  made  in  ruthenium-BINAP  chemistry  when  Noyori  and  co-workers  prepared  a 
ruthenium-BINAP  dicarboxylate  complex  for  asymmetric  hydrogenation  of  various 
functionalised  ketones.
110  Subsequently  Noyori  and  co-workers  also  showed  that 
ruthenium-BINAP/diamine complexes effectively catalyse the asymmetric hydrogenation 
of  some  unfunctionalised  ketones.
111  Importantly,  this  system  can  selectively  reduce 
ketones in the presence of carbon-carbon double bonds.
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Noyori and co-workers originally described the ruthenium-catalysed DKR of α-substituted 
β-keto esters which yielded syn-β-hydroxy-α-amino acid esters.
106 The catalyst used was a 
ruthenium-(R)-BINAP  complex.  It  was  found  that  appropriate  modification  of  the 
substrate, a simple 2-substitued 3-oxo-carboxylic ester, led to clear differentiation of anti 
and syn transition states. For example, the racemic cyclic ketone 198 was hydrogenated to 
give  the  corresponsing  trans-hydroxy  ester  199  in  92%  e.e.  (Scheme  52).  In  contrast, 
certain acyclic substrates bearing an amide or a carbamate group led to the syn products in 
excellent e.e. 
 
 
Scheme 52 
This combination of DKR with a ruthenium-(S)-BINAP catalyst was used more recently by 
Hamada and co-workers to synthesise β-hydroxy-α-amino acids from the corresponding β-
keto-α-amino  esters.
107  The  ‘β-hydroxy-α-amino’  fragment  can  be  found  in  many 
biologically active natural or unnatural products. Based on the methodolgy of Noyori, all 
four  stereoisomers  of  3-hydroxyleucine  were  synthesised  previously.
113  Following 
optimisation of the reaction conditions, the hydrochloride salts of a number of β-keto-α-
amino esters 196 were hydrogenated (Scheme 53). The substrates bearing a secondary 
alkyl  carbon,  cyclobutyl,  cyclopentyl,  cyclohexyl  or  cycloheptyl  substituent  at  the  α-
position  of  the  ketone  gave  the  anti-products  200  in  high  diastereoselectivity  and 
enantioselectivity. However, a drawback of this hydrogenation was that the substrate scope 
was limited to those with alkyl groups at the C-4 position. The e.e’s in Scheme 53 refer to 
the α-stereocenter of the anti-products 200. 
 
 
 
 
Scheme 53 
DKR has also been used by Genet and co-workers to synthesise anti-β-hydroxy-α-amino 
esters 201 via ruthenium-SYNPHOS
®-catalysed hydrogenation.
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β-hydroxy-α-amino esters 196 were selectively hydrogenated under optimised conditions 
(Scheme 54). It was found that DCM with a small percentage of alcoholic solvent slowed 
the reaction rate and favoured better discrimination of the catalyst which in turn improved 
the chiral induction. Only 2 mol% of catalyst was required to ensure complete conversion. 
This combination worked well for both branched and unbranched substrates with excellent 
yields. High levels of anti-diastereoselectivity (86-99%) and enantioselectivity at the α-
stereocenter (91-97%) were observed.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Scheme 54 
Very recently, Genet and co-workers have extended this work and reported a new synthesis 
of the marine natural product dolastatin 10.
115 The (S)-SYNPHOS
® ligand 202 was used 
again and gave excellent diastereoselectivity of 98:2 (R):(S) in the ruthenium-catalysed 
hydrogenation of β-ketoesters. Of  note is the recyclable  catalyst (R)-Digm-BINAP 203 
reported by Genet and co-workers in 2001 (Figure 31).
116 This catalyst is based on the very 
successful  BINAP  structure  with  guanidinium  functionalisation.  One  of  the  main 
challenges  in  catalysis  is  the  separation  of  product  and  catalyst  and  the  subsequent 
recycling  of  the  catalyst.  Genet  has  also  focused  on the  development  of  water-soluble 
catalysts.  The  ruthenium-catalysed  asymmetric  hydrogenation  of  β-keto  esters  in  water 
gave e.e.’s of up to 62% which increased up to 99% in ethylene glycol. The catalyst was 
recovered and was recycled three times without loss of activity.   
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Figure 31 
Based  on  the  structure  of  BINAP,  a  new  chiral  bis(diarylphosphine)  ligand  known  as 
BICHEP 204 was introduced by Miyashita and co-workers (Figure 32).
117 It was used in 
the ruthenium-catalysed asymmetric hydrogenation of prochiral olefins and ketones and 
very high enantioselectivites of up to >99% were achieved.  
 
 
 
 
 
Figure 32 
Subsequently,  the  group  of  Chan  and  co-workers  introduced  a  new  highly  effective 
dipyridylphosphine ligand P-Phos 205 (Figure 33).
118 This new catalyst and its derivative, 
Xyl-P-Phos 206, had been previously employed in the hydrogenation of 2-(6’-methoxy-2’-
naphthyl)propenoic acid, β-ketoesters and aromatic ketones (Figure 33).
 The tuning of the 
original P-Phos ligand by the introduction of a 3,5-dimethyl group on each of the phenyl 
rings  yielded  Xyl-P-Phos,  a  much  more  effective  ligand  in  the  ruthenium-catalysed 
asymmetric  hydrogenation of β-ketoesters. Another advantage of these catalysts  is that 
they are air-stable even in solution state, in contrast to most air-sensitive metal phosphine 
catalysts. 
 
 
 
 
 
 
Figure 33 
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These were applied in the ruthenium-catalysed asymmetric hydrogenation of the methyl 
esters  of  a  variety  of  (Z)-2-acetamido-3-arylacrylic  acids  207  (Scheme  55).
  After 
optimisation of the reaction conditions, it was found that the original catalyst Ru-(R)-P-
Phos(C6H6)Cl2 produced consistently higher enantioselectivity of up to 90% e.e. for the 
(R)-enantiomer  208.  Further  studies  on  derivatives  of  the  (Z)-2-acetamido-3-arylacrylic 
acids, where the phenyl ring was replaced by a range of other substituents, confirmed that 
the original catalyst consistently gave the higher enantioselectivities of up to 97% e.e. 
 
 
 
 
 
 
 
 
Scheme 55 
1.6  Conclusions 
The work presented here represents only a focused section from the recent literature in the 
field of α-amino acid synthesis. Other approaches not discussed here include enzymatic 
synthesis and use of the chiral pool. Many more chiral catalysts, both in situ generated 
catalysts and preformed catalysts are constantly being reported.  
This thesis describes the use of some of the methods discussed above in order to synthesise 
α-amino  acids  such  as  the  Overman  rearrangement,  α-amination  and  the  use  of  the 
Schöllkopf bis-lactim ether as a chiral auxiliary.  
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2  Use of the 3,3-aza-Claisen Rearrangement 
2.1  Introduction 
The 3,3-sigmatropic aza-Claisen rearrangement  of allylic trichloroacetimidates into allylic 
trichloroacetamides (also known as the Overman Rearrangement) has been widely used for 
the  stereoselective  synthesis  of  nitrogen-containing  compounds  including  alkaloids, 
unnatural  amino  acids  and  antibiotics  (over  180  publications  report  the  use  of  this 
rearrangement).
80c,119 Natural products often suffer from hindered chemical environments 
during their synthesis and the use of intramolecular rearrangement reactions is a popular 
approach to enhance reactivity. The resulting allylic  amine structures from aza-Claisen 
rearrangements  can  be  transformed  into  many  chemically  and  biologically  important 
natural products, as they can generate defined, configured carbon centres and also complex 
carbon-heteroatom bonds.
120 
 
The general thermal rearrangement is shown below (Scheme 56). Reaction of an allylic 
alcohol  135  with  sodium  hydride  and  trichloroacetonitrile  yields  the  rearrangement 
precursor 136. 1,8-Diazabicyclo[5.4.0]undec-7-ene (DBU) can also be used as base in this 
reaction. The precursor 136 is then exposed to elevated temperatures and rearranges to give 
a  racemic  mixture  of  allylic  trichloroacetamides  137.  Acidic  or  basic  cleavage  of  the 
trichloroacetyl group yields the allylic amine 138. Mumm and Möller first reported this 
thermal transformation in 1937.
121 The thermal rearrangement leads to a racemic mixture of 
trichloroacetamides which can be undesirable in pharmaceutical terms. Only one of the 
stereoisomers  may  have  the  desired  beneficial  effect  and  the  other  may  have  toxic 
properties.  Currently,  about  80%  of  drugs  entering  development  are  enantiomerically 
pure.
122 
 
 
 
Scheme 56 
The  rearrangement  can  also  be  carried  out  at  room  temperature  in  the  presence  of 
mercury(II) or palladium(II) catalysts.
80c,121 Overman reported that mercury(II) catalysed 
the reaction 10
12 times faster than the thermal rearrangement.
80a The driving force of ~14 
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kcal mol
-1 for the imidate to amide reorganisation alleviates the problem of reversibility 
inherent in many sigmatropic rearrangements.
123 Henry originally proposed the cyclisation-
induced  rearrangement  mechanism  for  the  palladium(II)-catalysed  acetate  migration  in 
allyl acetates.
124 This mechanism has subsequently been developed by Overman to explain, 
among others, the palladium(II)-catalysed aza-Claisen rearrangement (Scheme 57).
125 The 
catalyst is believed to activate the C-C bond for attack by the internal nitrogen nucleophile 
by coordinating to the allylic C-C -bond to give the key cyclic carbocation intermediate 
210. Elimination of the palladium yields the trichloroacetamide 137 (thermodynamically 
favourable).
126 
 
 
 
 
 
 
Scheme 57 
More recently, Overman has developed a number of chiral palladium(II) catalysts which 
allow for differentiation between the two faces of the palladium square plane, therefore 
effecting an enantioselective reaction. The catalyst coordinates to and blocks one face of 
the alkene, allowing attack of the internal nitrogen nucleophile solely at the unhindered 
face.
80b,80d  This  asymmetric  version  of  the  rearrangement  leads  to  the  generation  of 
predominantly  one  stereoisomer  of  the  trichloroacetamide.  Ferrocenyloxazoline  (FOP) 
palladacycles 212 and cobaltocenyloxazoline (COP) palladacycles 213 have been used, 
leading to enantiomeric excesses of up to 99% (Figure 34).
127 
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These catalysts were successfully employed in a number of rearrangements, an example of 
which  is  the  synthesis  of  the  anti-convulsant  (S)-vigabatrin  217  (Scheme  58).
80c  This 
compound is a GABA aminotransaminase inhibitor and is used for the treatment of drug-
resistant epilepsy, complex partial seizures and infantile spasms due to West Syndrome.
128 
It is marketed as a racemic mixture under the name of Sabril® in Canada, Mexico and the 
United Kingdom, although only the (S)-isomer is pharmacologically active. The E-allylic 
alcohol 214  is converted to the trichloroacetimidate  215 using trichloroacetonitrile and 
DBU. The rearrangement is carried out using 5 mol % of COP-Cl catalyst 213 at room 
temperature and leads to the (S)-trichloroacetamide 216 in 73% yield over 2 steps and 95% 
e.e. Acidic cleavage of the trichloroacetyl and ester groups yields 217 in 75% yield. This 
synthesis illustrates the potential applications of this asymmetric rearrangement.  
 
 
 
 
 
 
 
Scheme 58 
It  is  also  noted  that  the  rearrangements  have  sometimes  been  unsuccessful  due  to 
competing elimination reactions, slow reaction rates and  competing 1,3-rearrangements 
(anti-Claisen). 1,3-Rearrangements are known to be promoted by palladium(0) catalysts 
(Scheme 59).
80c 
 
 
 
 
Scheme 59 
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Our group has recently reported the synthesis of (2S,3S,4R)--hydroxyisoleucine 222 using 
a palladium(II)-catalysed aza-Claisen rearrangement to create the (3S)-stereogenic centre 
(Scheme 60).
2a The rearrangement was also carried out under thermal conditions  in  p-
xylene at 140 
oC. This led to the undesired (3R)-isomer 221b being the major product. 
Under  the  palladium(II)-catalysed  conditions  at  room  temperature,  the  desired  (3S)-
stereoisomer 221a was favoured in a 7:1 ratio over the (3R)-stereoisomer. This was used to 
produce (2S,3S,4R)--hydroxyisoleucine 222 which is the amino acid component of the 
natural product funebrine 223, a pyrrole alkaloid (Figure 35).  
 
 
 
 
 
 
 
Scheme 60 
 
 
 
Figure 35 
The stereoselectivity of this rearrangement can be explained by considering the transition 
states.
120,129 In  both the thermal and palladium(II)-catalysed rearrangements, a chair-like 
transition state is formed in which the 1,3-allylic strain is minimised (Figure 36). In the 
case of the thermal rearrangement 224a, intramolecular attack occurs at the least hindered 
face  giving  predominantly  the  (3R)-stereoisomer.  With  the  palladium(II)-catalysed 
rearrangement 224b, initial coordination of the catalyst to the least hindered face of the 
alkene  blocks  this  from  intramolecular  attack  of  the  internal  nitrogen  nucleophile. 
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Therefore, attack has to take place from the back face of the alkene, giving predominantly 
the (3S)-stereoisomer. 
 
 
 
   
 
 
Figure 36 
Following  on  from  this  work,  our  group  also  developed  an  ether-directed  aza-Claisen 
rearrangement.
2b It was thought that small, sterically unhindered groups could effectively 
coordinate to the catalyst and direct it towards a particular face of the alkene. A series of 
trichlororacetimidates 231 were prepared from ethyl (S)-lactate 225 (Scheme 61). 
 
  
 
 
 
 
 
 
 
Scheme 61 
The  precursors  were  then  subjected  to  a  palladium(II)-catalysed  rearrangement  using 
bis(acetonitrile)palladium(II)-chloride catalyst. (Scheme 62) As was expected, the bulky 
ether groups such as TBDMS and benzyl gave low selectivities as they prevent effective 
coordination of the catalyst to the alkene. The smaller and less sterically hindered methyl 
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ether resulted in increased diastereoselectivity. It was then shown that the MOM ether, 
which contained a second oxygen, gave a diastereoselectivity of 10:1 anti:syn. A third 
oxygen was then introduced using the MEM ether in an attempt to further increase the 
directing effect and the selectivity. However, compared to the MOM-group, a decrease was 
observed in the selectivity to 8:1 anti:syn.  
 
 
 
 
 
 
 
 
Scheme 62 
To  prove  that  the  positive  influence  observed  with  the  MOM-group  stems  from  the 
presence  of  oxygen,  a  carbon  analogue  234  was  synthesised  and  subjected  to  the 
palladium(II)-catalysed rearrangement (Scheme 63). The major diastereomer was obtained 
in only a 2:1 ratio, showing that the oxygen is necessary for the directing effect.   
 
 
 
 
 
Scheme 63 
As this general scheme had worked well  for the synthesis of trichloroacetimidates, we 
wanted to continue to use it in our work towards the synthesis of β-hydroxy-α-amino acids. 
We  also  wanted  to  use  the  general  method  to  further  investigate  the  effect  of  other 
directing groups on the rearrangement.  
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2.2  Use of the Directed Rearrangement for the Synthesis of β-
hydroxy-α-amino acids 
As discussed, preliminary studies have shown that chiral ether groups can be used to direct 
the stereoselectivity of these aza-Claisen rearrangements.
2b We wanted to investigate the 
effects of other directing groups and additional stereogenic centres within the substrate to 
improve results already obtained. We wanted to incorporate a large bulky side chain and 
see what effect this would have on the stereoselective outcome of the rearrangement. We 
also wanted to continue to use the general flexible route which had previously been used to 
synthesise  rearrangement  precursors  with  great  success.  To  this  end,  we  modified  the 
general route to derive the bulky side chain from L-phenylalanine 236 (Scheme 64). The 
synthesis begins with  L-phenylalanine 236 and the amino acid is converted into the α-
hydroxy analogue 237. Following this, the acid is protected as the methyl ester to give 238. 
The hydroxy group is then MOM-protected to give 239 and the methyl ester is reduced to 
the corresponding aldehyde 240. Aldehyde 240 is transformed to the α,β-unsaturated ethyl 
ester 241 via a Horner-Wadsworth-Emmons reaction, and the subsequent ester is reduced 
to the E-allylic alcohol 242 using diisobutylaluminium hydride (DIBAL-H). Finally, the 
trichloroacetimidate group is incorporated to yield the rearrangement precursor 243.   
 
 
 
 
 
 
 
 
 
Scheme 64 
Thus, L-phenyalanine 236 was converted to the α-hydroxy analogue via the diazonium salt 
244, by reaction with sulfuric acid (H2SO4) and sodium nitrite (Scheme 65).
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1M H2SO4 was used and the mixture was stirred at 0 
oC for 1 hour and then at room 
temperature for 12 hours, however this led to a complex mixture of compounds. Following 
optimisation, 2.5M H2SO4 was used and the reaction mixture was stirred at 0 
oC for 3 
hours and at room temperature for 48 hours. α-Hydroxy acid 237 was isolated in 64% yield 
as a crystalline solid and this was used in the next step without further purification. In the 
1H NMR spectrum of 237 the 3-CH2 protons are seen as 2 separate signals, due to the 
influence of the adjacent chiral centre pushing these protons into non-equivalent chemical 
environments. These two doublet of doublets appear at 2.92 and 3.13 ppm in the 
1H NMR 
spectrum. This is a feature that is generally maintained throughout the 
1H NMR spectra of 
this series of compounds. 
 
 
 
 
 
 
 
 
Scheme 65 
α-Hydroxy  acid  237  was  used  in  the  second  step  of  the  synthesis,  which  involved 
esterification of the acid. Two methods were used to attempt this conversion. Initially, we 
used potassium carbonate and methyl iodide in acetone and the reaction was heated under 
reflux  for  24  hours  (Scheme  66).
131  While  this  was  successful  to  some  degree,  the 
maximum  isolated  yield  of  238  following  purification  was  34%.  The  second  method 
attempted was a modification of the method by Kano and co-workers.
132 Methanol, toluene 
and  concentrated  hydrochloric  acid  were  heated  under  reflux  with  237  for  24  hours. 
Following  purification  by  Kugelrohr  distillation,  238  was  isolated  in  79%  yield,  a 
significant improvement from before. 
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MOM-protection of 238 was initially attempted by treating 238 with dimethoxymethane, 
lithium  bromide and p-toluenesulfonic acid (Scheme 67).
133 The  mixture was stirred at 
room temperature overnight and then, following TLC, warmed to 40 
oC for 5 hours to 
drive  the  reaction  to  completion.  Unfortunately,  following  purification  by  column 
chromatography, only 47% of 239 was isolated along with starting material. The reaction 
was attempted again by treating 238 with sodium hydride and chloromethylmethyl ether 
(MOM-Cl).  This  solution  was  stirred  at  room  temperature  for  24  hours  and  239  was 
isolated in 60% yield. Due to difficulty in obtaining MOM-Cl and also the toxic nature of 
this reagent, a third method was attempted using more readily available and less volatile 
bromomethylmethyl ether (MOM-Br). Reaction of 238 with MOM-Br in the presence of 
diisopropylethylamine (DIPEA  – Hünig’s  base) under reflux  for 24 hours gave  239  in 
quantitative yield.  
 
 
 
 
 
Scheme 67 
Following protection of the hydroxy group, the next step was reduction of the methyl ester 
to  the  aldehyde  240.  This  was  initially  attempted  using  approximately  one  molar 
equivalent of a DIBAL-H (Scheme 68). Unfortunately, the reaction was very difficult to 
control and resulted in mixtures of the aldehyde 240 and the corresponding alcohol 246. In 
some reactions, some of the starting ester 239 was left unreduced. These compounds were 
very difficult to separate by column chromatography.  
 
 
 
Scheme 68 
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Thus, it was decided that reduction of the ester 239 to the corresponding alcohol 246 would 
be easier to control. The alcohol 246 would then be re-oxidised to the aldehyde 240 and the 
Horner-Wadsworth-Emmons reaction could be carried out, as was planned initially. The 
reduction  was  carried  out  using  2.2  molar  equivalents  of  DIBAL-H  (Scheme  69). 
Following purification by column chromatography, 246 was isolated in 57% yield. 
 
  
 
 
 
Scheme 69 
To  transform  the  alcohol  246  to  the  α,β-unsaturated  ethyl  ester  241  a  one-pot 
Swern/Horner-Wadsworth-Emmons reaction was used so that the aldehyde 240 would not 
have  to  be  isolated  (Scheme  70).  The  Swern  reaction  was  carried  out  under  standard 
oxidation conditions with dimethyl sulfoxide, oxalyl chloride and triethylamine to give the 
aldehyde 240. Following this, the Horner-Wadsworth-Emmons reaction was carried out 
under Masamune-Roush conditions.
134 These milder conditions are particularly useful for 
base-sensitive substrates, such as the aldehyde 240. Standard Horner-Wadsworth-Emmons 
conditions  use  sodium  hydride  as  base  to  deprotonate  the  phosphonate.  However, 
Masamune-Roush conditions enable the use of DBU as base. Addition of lithium chloride 
enhances  the  acidity  of  the  phosphonate  and  therefore,  a  weaker  base  and  ambient 
temperature can be employed. The change in conditions does not affect the E-selectivity of 
the reaction. Following purification by column chromatography, 241 was isolated in 81%. 
In the 
1H NMR spectrum the signals for the CH2 and CH3 protons of the ethyl ester are 
observed at 4.23 and 1.32 ppm respectively. The protons of the E-alkene are seen as a 
doublet at 6.01 ppm for 2-H and a doublet of doublets at 6.90 ppm for 3-H. The coupling 
constant between these signals (15.6 Hz) confirms the formation of the E-alkene. 
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The  α,β-unsaturated  ethyl  ester  241  was  then  reduced  to  the  corresponding  E-allylic 
alcohol 242. Just as with the reduction before, DIBAL-H was used and 242 was isolated in 
83% yield (Scheme 71). 
 
 
 
 
Scheme 71 
The  last  step  to  synthesise  the  rearrangement  precursor  was  incorporation  of  the 
trichloroacetimidate  group.  This  was  carried  out  by  reaction  of  242  with 
trichloroacetonitrile and DBU (Scheme 72). Initially, sodium hydride was used as the base, 
but it was found that DBU gave reliably higher yields. This was followed by flash column 
chromatography through a plug of silica. This gave 243 which was used immediately in the 
rearrangement without further purification, as 243 decomposes over a short period of time.
  
 
 
 
 
Scheme 72 
The  rearrangement  was  carried  out  by  treating  243  with  0.1  molar  equivalents  of 
bis(acetonitrile)palladium(II) chloride catalyst in THF (Scheme 73). This was stirred at 
room temperature for 24 hours. The desired anti-product 247 was produced with a 12:1 
diastereoselectivity, which is an excellent 85% d.e. The yield of the two diastereomers 
combined is 54% over 2 steps. The CH2 and CH protons of the terminal alkene can be 
observed in the 
1H NMR spectrum of the anti-product at 5.43-5.45 and 5.93-6.02 ppm 
respectively. This was confirmed as the  anti-product through correlation  with previous 
spectra.
2b The corresponding signals in the 
1H NMR spectrum of minor syn-product are 
observed at 5.25-5.29 and 5.55-5.60 ppm respectively. Also observed in trace amounts was 
the  1,3-rearrangement  by-product  249,  normally  seen  when  a  palladium(0)  catalyst  is 
used.
135 It was believed that the palladium(0) was formed by a competing β-elimination 
process during the slow palladium(II)-catalysed rearrangement. 
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Scheme 73 
The palladium catalyst coordinates to both oxygens in the MOM-group and also to the 
alkene as shown in Figure 37. This effectively blocks the back face of the alkene and 
directs the attack to take place from the front face.  
 
.  
Figure 37 
Addition  of  the  mild  oxidant  p-benzoquinone  to  the  reaction  mixture  effectively  re-
oxidised any palladium(0) formed back to palladium(II) (Scheme 74). This resulted in a 
greater yield of the 3,3-products though the stereoselectivity remains the same. The yield 
of 247 and 248 combined increased to 70% over 2 steps when the re-oxidant was used. 
 
 
 
Scheme 74 
The desired diastereomer 247 was then to be oxidised to the corresponding amino acid 251 
(Scheme 75). To achieve this, the terminal double bond of 247 is oxidised to the acid using 
the method of Sharpless and then the trichloroacetamide and MOM-protecting groups are 
removed with 6M HCl.
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Allylic amide 247 was therefore treated with ruthenium trichloride and sodium m-periodate 
at  room  temperature  (Scheme  76).  Following  a  short  silica  column  to  remove  any 
ruthenium resides, 250 was isolated in 69% yield. In the 
1H NMR spectrum, the signals 
seen previously for the terminal alkene are no longer observed. In the 
13C NMR spectrum, 
a new quaternary peak is seen at 172.3 ppm which corresponds to the carbonyl carbon of 
the acid. 
 
 
 
Scheme 76 
Removal of the trichloroacetamide and MOM-protecting groups was achieved by heating 
250 and 6M HCl under reflux for 24 hours (Scheme 77). The amino acid 251 was isolated 
in 80% yield. The spectroscopic data and optical rotation for this amino acid corresponds 
to the literature data, confirming the stereochemical outcome of the rearrangement.
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Scheme 77 
2.3  Investigation  of  New  Substrates  for  the  Directed 
Rearrangement 
Due to the success of this route involving an E-alkene in the synthesis, it was decided to 
change this to a Z-alkene to see how this would affect the outcome of the rearrangement. 
The  MOM-protecting  group  and  the  benzyl  side  chain  were  not  changed.  Thus,  the 
synthesis begins with L-phenylalanine 236 again which is converted to the MOM-protected 
alcohol 246 as before (Scheme 78). This will be oxidised to the corresponding aldehyde 
240  using  a  Swern  reaction  and  then  the  α,β-unsaturated  methyl  ester  252  will  be 
synthesised using a Horner-Wadsworth-Emmons reaction. Following the same steps as for 
the synthesis involving the E-alkene, the α,β-unsaturated ester 252 is reduced to the Z-
allylic alcohol 253 using DIBAL-H and the trichloroacetimidate is incorporated to give the 
rearrangement precursor 254. 
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Scheme 78 
Therefore, 246 was treated with dimethyl sulfoxide, oxalyl chloride and triethylamine to 
give the aldehyde 240 as before (Scheme 79). To convert 240 to the corresponding Z-
alkene, the Still modification of the Horner-Wadsworth-Emmons reaction was employed.
138 
Using  phosphonates  with  electron-withdrawing  groups,  such  as  trifluoroethyl,  together 
with  strongly  dissociating  conditions  (such  as  KHMDS  and  18-crown-6)  favours  rapid 
elimination and almost exclusive Z-alkene selectivity. Therefore, 240 was treated with 18-
crown-6,  bis(2,2,2-trifluoroethyl)(methoxycarbonylmethoxy)phosphonate  and  potassium-
bis(trimethylsilyl)amide  at  -78 
oC  for  2  hours.  Following  purification  by  column 
chromatography, 252 was isolated in 27% over two steps. The coupling constant of 11.6 
Hz between the alkene signals in the 
1H NMR spectrum, confirmed that the Z-alkene had 
been synthesised.  
 
 
 
Scheme 79 
Due to the rather low yield of this reaction, it was decided to attempt to synthesise 252 
using a Swern and a Wittig reaction (Scheme 80). Thus, the Swern reaction was carried 
out as before to give 240. The Wittig reaction can be carried out using stable ylides to give 
E-alkenes. More reactive (unstable) ylides give rapid reactions and subsequent rapid ring 
opening to give the Z-alkene. In our Wittig reaction, a stable ylide was used under kinetic 
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conditions to give the Z-alkene. The reason for this is that non-stabilised ylides tend to 
require  strong  base  under  inert  conditions  and  this  would  not  be  suitable  for  our 
intermediate 240. Thus, methyl (triphenylphosphoranylidene)acetate bromide was treated 
with NaOH to give the Wittig reagent, methyl (triphenylphosphoranylidene)acetate. The 
crude aldehyde 240 was then treated with the Wittig reagent in methanol at 0 
oC for 7.5 
hours.
139 After purification, 252 was isolated in just 16% yield.  
 
 
 
Scheme 80 
Despite neither of these reactions being particularly successful in terms of yield, at this 
point we had enough material to continue to the next step. Reduction of the α,β-unsaturated 
methyl ester 252 to the Z-allylic alcohol 253 was carried out using DIBAL-H (Scheme 81). 
Following work-up, 253 was isolated in 79% yield.  
 
 
 
 
Scheme 81 
The allylic trichloroacetimidate was synthesised using the same method as before, with 
trichloroacetonitrile  and  DBU  (Scheme  82).  Again,  254  is  unstable  and  prone  to 
decomposition so it was used directly in the rearrangement step. This was carried out using 
the same catalyst as before, bis(acetonitrile)palladium(II) chloride. The reaction was stirred 
for 17 days (an extra 5 mol % of catalyst was added after 3 days). After purification, the 
major product isolated resulted from 1,3-rearrangment to give 255 in 19% yield over 2 
steps.  
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As stated before, the 1,3-rearrangement is normally catalysed by palladium(0).
135 When the 
reaction  progresses  slowly,  the  palladium  can  be  eliminated  through  competing  β-
elimination and reduce to palladium(0). Unusually, the stereochemistry of the Z-alkene 
was retained, as normally one would expect it to convert to the more stable E-configuration 
during  the  1,3-rearrangement.  This  however,  is  prevented  by  the  coordination  of  the 
palladium as can be seen in the transition state 256 (Scheme 83).  
 
 
 
 
 
Scheme 83 
Following this interesting result, we progressed to another aspect of the rearrangement, 
namely substituting the MOM-protecting group for one that should coordinate to palladium 
more  strongly.  During  the  MOM-ether  directed  rearrangements,  the  MOM  group 
coordinates to the catalyst and directs it towards to back face of the alkene. Due to the 
palladium(II)  blocking  this  face  of  the  alkene,  the  internal  nitrogen  nucleophile 
preferentially  attacks  at  the  less-hindered  front  face  of  the  alkene.  It  was  therefore 
proposed  that  a  stronger  bond  to  the  palladium(II)  catalyst  may  produce  a  more 
diastereoselective rearrangement.  
Firstly,  we  investigated  the  outcome  of  the  rearrangement  of  the  unprotected  hydroxy 
precursor 263. The initial route to this rearrangement precursor is outlined below (Scheme 
84). Again, we wanted to maintain the bulky side chain and so the synthesis began from L-
phenylalanine  236.  It  was  decided  to  use  the  TBDMS-group  throughout  the  synthetic 
scheme  as  it  can  be  removed  effectively  and  mildly  when  needed.  As  before,  L-
phenylalanine 236 is converted to the α-hydroxy acid 237 and then to the methyl ester 238. 
The methyl ester 238 is protected with a TBDMS-group, by reaction with TBDMS-Cl and 
imidazole to give 257. This is reduced to the alcohol 258 using DIBAL-H and this is then 
converted  to  the  α,β-unsaturated  ester  260  using  a  one-pot  Swern/Horner-Wadsworth-
Emmons reaction as before. Ester 260 is again reduced to the E-allylic alcohol 261 using 
DIBAL-H and the trichloroacetimidate group is incorporated to give 262. The TBDMS-
group is then removed using TBAF to give the unprotected rearrangement precursor 263.  
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Scheme 84 
Thus, L-phenylalanine was converted to the methyl ester 238 as before. Following this, 238 
was  protected  with  a  TBDMS-group  by  treating  238  with  TBDMS-Cl  and  imidazole 
(Scheme 85).
140 Following purification, 257 was isolated in 88% yield.  
 
 
Scheme 85 
Following  this,  the  methyl  ester  257  was  reduced  to the  alcohol  258  using  DIBAL-H 
(Scheme 86). This reaction worked well and 258 was isolated in 74% yield.  
 
 
 
Scheme 86 
The alcohol 258 was converted to the α,β-unsaturated ethyl ester 260 without isolating the 
sensitive  aldehyde  259  via  a  one-pot  Swern/Horner-Wadsworth-Emmons  reaction  as 
before  (Scheme  87).  Standard  Swern  reaction  conditions  were  used  to  synthesise  the 
aldehyde, which was then converted to the α,β-unsaturated ethyl ester under Masamune-
Roush conditions. Following purification by column chromatography, 260 was isolated in 
91% yield. The signals in the 
1H NMR spectrum for the alkene protons are observed at 
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6.07  and  7.02  ppm.  The  coupling  constant  between  these  signals  is  15.4  Hz,  which 
confirms the formation of the E-alkene.  
 
 
Scheme 87 
The α,β-unsaturated ethyl ester 260 was reduced to the E-allylic alcohol 261 using DIBAL-
H  (Scheme  88).  One  of  the  concerns  here  was  that  there  could  be  protecting  group 
migration from the secondary to the primary alcohol but this was not observed. Following 
purification by column chromatography, 261 was isolated in an excellent 94% yield.  
 
 
 
Scheme 88 
Following this, the remaining steps to the unprotected precursor involve addition of the 
trichloroacetimidate  group  and  removal  of  the  TBDMS-group.  The  allylic 
trichloroacetimidate was prepared as before, using trichloroacetonitrile and DBU (Scheme 
89). The precursor 262 was used in the deprotection step without further purification. To 
remove the TBDMS-group, 262 was treated with TBAF. Again, 263 is not a particularly 
stable compound and is prone to decomposition and as such, it was passed through a short 
silica plug and used in the rearrangement without further purification.  
 
 
 
Scheme 89 
Finally,  the  hydroxy  precursor  263  was  subjected  to  a  palladium(II)-catalysed 
rearrangement  (Scheme  90).  Allylic  acetimidate  263  was  treated  with 
bis(acetonitrile)palladium(II) chloride in THF at room temperature for 48 hours. Following 
purification by column chromatography, it was found that ratio of anti:syn diastereomers is 
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6:1. This corresponds to a good 71% d.e. The yield of this reaction is 12% over three steps. 
The CH2 and CH signals for the anti-product are observed in the 
1H NMR spectrum at 
5.32-5.37 and 5.87-5.96 ppm respectively. The corresponding signals for the syn-product 
are seen at 5.22-5.27 and 5.74-5.85 ppm. This result shows that the MOM-group has a 
positive  influence  on  the  reaction  as  it  increases  the  diastereoselectivity  for  the  anti-
diastereomer. Subsequent work has been carried out by our group which shows that the 
second oxygen in the MOM-group is critical for high diastereoselectivity.
2b It is believed 
that the  palladium(II)  coordinates  to  both  oxygens  of  the  protecting  group  which  then 
direct the catalyst to the back face of the alkene to give increased selectivity. 
 
 
 
 
Scheme 90 
Out of curiosity, we attempted the rearrangement of the TBDMS-protected precursor 262, 
as we had already synthesised it during the route to the unprotected precursor 263, even 
though  it  is a  hindered ether. Thus,  262 was  subjected to the rearrangement using the 
bis(acetonitrile)palladium(II) chloride catalyst as before (Scheme 91). Unfortunately, there 
was no reaction observed after 3 days at room temperature. In this case, it was thought that 
the combination of the  bulky TBDMS-protecting group and the benzyl side chain was 
preventing  the  palladium(II)  catalyst  from  coordinating  to the  alkene  and  inducing  the 
rearrangement. 
 
 
 
Scheme 91 
Another protecting group was chosen with which to perform the rearrangement. We chose 
a group that was less bulky than the TBDMS-group and that had two oxygens in it. The 
acetate group fitted this profile well and its structure is quite similar to that of the MOM-
group  with  which  we  had  achieved  excellent  selectivity.  Again,  we  wanted  to  use  a 
variation on the optimised route we had already developed with some protecting group 
manipulation. Thus, it was decided that the acetate-protected rearrangement precursor 271 
should be synthesised as outlined below (Scheme 92). The synthesis is the same as that 
OH
O HN
CCl3
OH
O HN
CCl3
PdCl2(MeCN)2,
MeCN
r.t., 48 h,
12% (3 steps)
OH
O HN
CCl3
263 264 265
OTBDMS
O HN
CCl3
OTBDMS
O HN
CCl3
PdCl2(MeCN)2,
MeCN
r.t., 72 h
X
262 266K. N. Fanning, Chapter 2, Page 74 
used to obtain the unprotected and TBDMS-protected precursors to the point where the 
trichloroacetimidate group is added. As stated before, the precursors for the rearrangement 
are unstable and prone to decomposition. Therefore, we wanted to incorporate the acetate 
group  before  we  incorporated  the  trichloroacetimidate  group,  so  we  could  proceed 
immediately to the rearrangement itself, without risking decomposition of the precursor. 
Beginning  from the TBDMS-protected allylic  alcohol 261, which was derived  from  L-
phenylalanine 236 as before, the alcohol is MOM-protected to give 267. The TBDMS-
group is then removed using TBAF to give 268. The exposed alcohol is re-protected with 
an  acetate  group  using  acetic  anhydride  to  give  269.  The  MOM-group  can  then  be 
removed, in the presence of the acetate group, using trifluoroacetic acid to give the E-
allylic alcohol 270. The trichloroacetimidate is synthesised under the usual conditions to 
give  the  unstable  rearrangement  precursor  271, which  can  be  used  immediately  in  the 
rearrangement step without the need for further manipulation.   
 
 
 
 
 
 
 
 
 
 
Scheme 92 
Therefore, the E-allylic alcohol 261 was subjected to a MOM-protection using MOM-Br 
and DIPEA (Scheme 93). The solution was heated under reflux for 24 hours. Following 
purification, 267 was isolated in 91% yield.  
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Scheme 93 
Compound 267 was used in the next step, which involved removal of the TBDMS-group. 
Silyl  ether  267  was  treated  with  TBAF
  and  the  solution  was  then  stirred  at  room 
temperature  for  24  hours  (Scheme  94).  Following  purification,  268  was  isolated  in  a 
quantitative yield.  
 
 
Scheme 94 
The next step was re-protection of the hydroxy group with an acetate group. We performed 
this by modifying the method of Dauben and co-workers in which pyridine is used as a 
base.
141 In our case we used DIPEA, which is milder and less toxic. Thus, 268 was treated 
with  acetic  anhydride  and  DIPEA  and  stirred  at  20 
oC  for  24  hours  (Scheme  95). 
Following purification, 269 was isolated in 89% yield. The CH3 of the acetate-protecting 
group is observed as a singlet at 2.03 ppm in the 
1H NMR spectrum. Also of note is the 
significant shift that has occurred with the 4-H proton moving from 4.46-4.52 to 5.49-5.53 
ppm.  
 
 
Scheme 95 
The  last  protecting  group  manipulation  that  had  to  be  carried  out  was  removal  of  the 
MOM-group. This was achieved by treating 269 with trifluoroacetic acid and heating the 
solution under reflux for 24 hours (Scheme 96). Following purification, 270 was isolated 
in 61% yield.  
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The  trichloroacetimidate  271  was  synthesised  using  the  same  conditions  as  before 
(Scheme  97).  The  rearrangement  was  carried  out  using  bis(acetonitrile)palladium(II) 
chloride catalyst. A very unusual and interesting result was obtained. 272 was isolated in 
17% yield over two steps and this is believed to be the result of two 1,3 rearrangements 
followed by hydrolysis of the acetate group. 
 
 
Scheme 97 
The mechanism of this rearrangement is thought to be that shown below (Scheme 98). As 
previously  stated,  a  slow  reaction  can  cause  the  palladium(II)  to  eliminate  and  form 
palladium(0), which is known to catalyse the 1,3-rearrangement.
135 The 1,3-rearrangement 
takes place initially between the trichloroacetimidate group and the alkene. If it happened 
between the acetate and the alkene first, the double bond would then not be available for 
the second rearrangement. After this 1,3-rearrangement, the alkene is perfectly positioned 
to undergo a 1,3-rearrangement with the acetate group. Finally, hydrolysis occurs to leave 
the rearranged product 272 which was confirmed by COSY NMR spectroscopy. 
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2.4  Use of Nitrogen for the Directed Rearrangement 
During  our  studies  on  ether-directed  rearrangements,  it  had  come  to our  attention  that 
Belluš and co-workers had performed a similar rearrangement to us, using instead a Boc-
protected amine 277.
142 For them, this gave a selectivity of ≥ 99:1 for the anti-diastereomer 
(Scheme 99). The best result we had achieved using a protected alcohol group and the 
bulky  L-phenylalanine  side  chain  was  12:1  anti:syn  selectivity.  Thus,  we  decided  to 
synthesise the Boc-protected amine precursor, again using a variation of our optimised 
route and rearrange this using the same conditions as before.   
 
 
Scheme 99 
The variation of the optimised route to 277 is outlined below (Scheme 100). We began the 
synthesis  from  N-Boc-phenylalanine 280 as  it  is commercially available, though  it can 
easily  be  derived  from  L-phenylalanine  236.  This  mono-protected  compound  is  then 
converted to the methyl ester 281 using potassium carbonate and iodomethane.
131 The ester 
is reduced to the corresponding alcohol 282 using DIBAL-H. Following this, the carbon 
chain is elongated using a one-pot Swern/Horner-Wadsworth-Emmons reaction to give the 
α,β-unsaturated ethyl ester 284. Ester 284 is reduced to the E-allylic alcohol 285 using 
DIBAL-H  and  the  trichloroacetimidate  group  is  introduced  as  before,  using 
trichloroacetonitrile and DBU to give the rearrangement precursor 277.  
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Thus, the acid group of 280 was converted to the corresponding methyl ester to give 281. 
This was achieved by reacting 280 with potassium carbonate and iodomethane (Scheme 
101). After purification by column chromatography, 281 was isolated in 84% yield.  
  
 
Scheme 101 
This  ester  was  then  reduced  to the  alcohol  282  using  DIBAL-H  (Scheme  102).  After 
purification, 282 was isolated in a quantitative yield.  
 
 
Scheme 102 
The alcohol 282 was used in the one-pot Swern/Horner-Wadsworth-Emmons reaction to 
give the α,β-unsaturated ethyl ester 284 (Scheme 103). The Swern reaction was carried out 
first, as detailed previously, followed by the Horner-Wadsworth-Emmons reaction using 
Masamune-Roush conditions.
134 Following purification, 284 was isolated in 70% yield. It 
was expected that the E-alkene would be produced due to these conditions and from the 
1H 
NMR spectrum, it can be seen that indeed the expected alkene is the one that has been 
formed. The signals for 2-H and 3-H, the protons on either side of the alkene, are seen at 
5.88  (doublet)  and  6.93  ppm  (doublet  of  doublet)  respectively.  The  coupling  constant 
between these signals is 15.6 Hz, which confirms that the E-alkene has been synthesised. 
 
 
 
 
Scheme 103 
The α,β-unsaturated ethyl ester 284 was reduced to the E-allylic alcohol 285 using DIBAL-
H (Scheme 104). However, with this approach the DIBAL-H was coordinating to both the 
ethyl ester and the alkene and thus, was inducing a 1,4-conjugate addition to give 286, as 
well as 1,2-addition to give the alcohol 285. A combination of boron trifluoride diethyl 
etherate and DIBAL-H was then used, as the Lewis acid should coordinate to the Boc-
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protected amino group and allow the DIBAL-H to cleanly react with the ester, to give the 
desired 1,2-addition.
143 This solution was allowed to stir at -78 
oC for 45 minutes. Using 
this approach, the E-allylic alcohol 285 was isolated cleanly in 65% yield.  
 
 
 
 
Scheme 104 
The rearrangement precursor 277 was synthesised as described before and was used in the 
rearrangement step without further purification (Scheme 105). 
 
 
 
Scheme 105 
 
The rearrangement was carried out using bis(acetonitrile)palladium(II) chloride (Scheme 
106).  The  reaction  was  allowed  to  stir  at  room  temperature  for  24  hours.  Following 
purification, the major anti-diastereomer 278 was isolated in 30% yield over 2 steps. The 
CH2 and CH signals of the terminal alkene are observed in the 
1H NMR spectrum at 5.28-
5.36 and 5.68-5.77 ppm respectively. The corresponding signals for the syn-diastereomer 
are observed at 5.28-5.32 and 5.62-5.66 ppm. These siganls however, are obscured in the 
1H NMR spectrum of the crude mixture by side products, thus giving the appearance of 
only one diastereomer. We found the ratio of anti:syn distereomers to be 3:1 following 
purification and separation  and not ≥ 99:1, as Belluš and co-workers found.
142 We believe 
that perhaps Belluš and co-workers determined their ratio from the 
1H NMR spectrum of 
the crude reaction mixture. 
 
 
 
Scheme 106 
In conclusion, a number of rearrangements were attempted and some unusual results were 
obtained. The table below summarises the protecting groups used and the outcome of the 
rearrangements (Table 1). The most successful protecting group used was the MOM-group 
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OMOM
O HN
CCl3
OMOM
O HN
CCl3
in conjunction with an E-alkene. With this substrate we obtained 12:1 selectivity for the 
anti-diastereomer 247 and a 70% yield over 2 steps. No rearrangement occurred with the 
TBDMS-protected substrate. This was due to the size and bulky nature of the protecting 
group and sidechain. The most unusual result was obtained with the acetate protecting 
group, in which two 1,3-rearrangements and then hydrolysis of the acetate group occured 
to give 272 in 17% yield over 2 steps. This rearrangement is being further investigated by 
our group. The amino acids this rearrangement can produce are very valuable in the field 
of natural product synthesis, as they contain defined and configured carbon centres, that 
otherwise, may be difficult to introduce.  
Rearrangement 
Precursor 
Outcome of 
Rearrangement  Yield over 2 steps 
 
 
243  12:1 anti:syn  70% 
 
 
 
254 
 
1,3-rearrangement  19% 
 
 
263 
 
 
6:1 anti:syn  12% 
 
 
262  No rearrangement   n/a 
                
 
271 
 
 
 
2 x 1,3-rearrangement  17% 
 
 
277  3:1 anti:syn  30% 
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3  The Synthesis of (S)-Gizzerosine 
3.1  Introduction 
Black vomit is a serious disease in chickens and is a problem in poultry production all over 
the world.
144 This disease is accompanied by gizzard erosion and, in severe cases, gizzard 
ulceration and mortality. Other effects are decreased weight gain and feed consumption.
145 
Although the condition was described as early as 1930, fish meal was only implicated in 
the pathogenesis since 1971.
144a  
Pelagic fish and cannery waste (heads, tails and guts) that are unfit for human consumption 
are  converted  into  meal  with  high  nutritional  value  for  use  in  animal  feed.  The  meal 
produced is added to chicken feed in level of 3-10% and is considered an irreplaceable 
component due to the unique amino acid composition. There are high levels of free lysine, 
which  animals  cannot  synthesise  themselves,  found  in  the  fish  muscle.
146  The  meal  is 
normally blended with proteins and carbohydrates from vegetable origin and the biggest 
exporters are Peru, Chile and Denmark.
147,148  
To produce meal, fish is exposed to steam in the cooker and then heat in the dryer until it 
can be ground down. Drying is the vulnerable part of the process and scorching can occur. 
Elevated temperatures (130 
oC or higher) also give rise to undesirable side reactions and 
can  increase  levels  of  biogenic  amines  such  as  histamine  (derived  from  histidine), 
putrescine and cadaverine. Biogenic amines are derived from the corresponding amino acid 
when the carboxylic acid is removed by decarboxylase enzymes present in bacteria (e.g. 
Proteus morganii, Pseudomonas sp. etc.).
149   
Levels of histamine above 100 mg kg
-1 show that the fish have been mishandled during 
storage and/or processing. The presence of histamine at high levels has been shown to be 
toxic and the presence of putrescine and cadaverine can potentiate the effects of histamine 
in vivo by inhibiting intestinal histamine-catabolising enzymes. However a relatively large 
amount of histamine (0.4-0.5%) needs to be included in feeds to induce gizzard erosion 
and Naito and co-workers realised this during their investigations in 1983.
150   
The active substance named gizzerosine 2 (Figure 38) was produced in a model system by 
heating casein with histidine and was isolated from the protein fraction (2 mg from 10 kg 
of  mackerel  meal).  It  is  produced  during  the  heat  treatment  of  fish  meal.
150,151  Further K. N. Fanning, Chapter 3, Page 82 
studies have proved that only the (S)-isomer is active (Figure 38).
152 It was found to be 300 
times more potent than histamine at inducing gizzard erosion in 3-day old chicks on a diet 
including 6.25 ppm of the amino acid.
153 (S)-Gizzerosine 2 is also metabolised and secreted 
at a far slower rate than histamine, thus having a more prolonged effect.
154 
 
 
 
 
Figure 38 
(S)-Gizzerosine  2  is  a  potent  agonist  for  the  H2-receptor  of  histamine.  On  binding,  it 
stimulates the release of cyclic adenosine-3’,5’-monophosphatase (cAMP). The increase in 
cAMP in turn stimulates the secretion of excess gastric acid from the proventricular gland, 
which degrades the protective lining of the gizzard. This leaves the mucosal cells exposed 
to the hyperacidic conditions, causing ulceration.
155  
Unusually, (S)-gizzerosine 2 did not show any visible effects on rat stomach, though the 
gastric secretions had been promoted.
150,156 This biological profile suggests that 2 could be a 
possible drug candidate for conditions such as gastric achlorhydria (lack of HCl in stomach 
fluid) and osteoporosis. With osteoporosis, an acid-alkaline balance is vital as too much 
stomach acid can encourage calcium loss and too little acid promotes excessive calcium 
storage. 
3.2  Previous Syntheses 
The  first  synthesis  of  both  the  racemic  and  optically  active  forms  of  gizzerosine  was 
carried out by Mori and co-workers.
152 4-Methyl-3-pentenyl bromide 287 was treated with 
sodium cyanide to give 288 (Scheme 107). Alkaline hydrolysis of this nitrile 288 gave the 
acid 289 which was subjected to a reduction with lithium aluminium hydride to give the 
alcohol 290. This was converted to the corresponding tosyl group to give 291 and to the 
iodide 292 using sodium iodide in acetone (57% yield from 4-methyl-3-pentenyl bromide 
287).  
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Scheme 107 
Alkylation of diethyl acetaminomalonate 293 with 292 in the presence of sodium ethoxide 
and ethanol gave the alkylated product 294 in 86% yield (Scheme 108). This was then 
oxidised to the epoxide 295 with m-chloroperbenzoic acid. 
 
 
 
Scheme 108 
The epoxide 295 was treated with hydrated hydrogen m-periodate to give the somewhat 
unstable aldehyde 296 in a quantitative yield over 2 steps (Scheme 109). The aldehyde 296 
was  subjected  to  a  reductive  amination  with  histamine  dihydrochloride  and  sodium 
cyanoborohydride  to  give  the  coupled  diester  297  in  87%  crude  yield.  Following 
hydrolysis with aqueous hydrochloric acid which concurrently results in decarboxylation 
of the di-acid, the amino acid was purified to give (±)-gizzerosine 2a.  
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To produce the optically active form of gizzerosine, Mori and co-workers started with (S)-
2-aminoadipic acid 299 shown below, which was obtained by enzymatic resolution from 
the racemic precursor 298 (Scheme 110). 
 
 
 
 
Scheme 110 
(S)-2-aminoadipic acid 299 was protected with a Cbz group (Scheme 111) and the α-acid 
was converted to the benzyl ester 302 using the procedure of Baldwin and co-workers.
157 
The side-chain acid was reduced to the alcohol 303 using borane.THF and then oxidised to 
the unstable aldehyde 304 using a Swern reaction.
158 
 
 
 
 
 
 
Scheme 111 
This  was  used  immediately  in  the  reductive  amination  step,  again  using  histamine 
dihydrochloride and sodium cyanoborohydride to give the coupled product 305 in 69% 
yield from the alcohol 303 (Scheme 112). Hydrogenation over palladium/carbon followed 
by  acidification  using  hydrochloric  acid  gave  the  salt  which  was  recrystallised  from 
methanol to give pure (S)-gizzerosine 2 in 33% yield from the coupled product 305.  
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Scheme 112 
Similarly, the (R)-enantiomer was prepared from 301 and bioassays were carried out on 
both enantiomers. The (R)-enantiomer caused no damage to chicks when added to their 
diets  in  3  or  6  ppm,  whereas  (S)-gizzerosine  caused  severe  gizzard  erosion,  clearly 
indicating it is the active form.  
The second synthesis of (S)-gizzerosine 2 was carried out by Kiyota and co-workers using 
successive zinc and palladium-mediated coupling reactions.
3,159 Both the alcohol 303 and 
unstable aldehyde 304 from Mori’s earlier synthesis were targeted. Beginning from (S)-
serine 306, the iodide 310 was produced in 4 steps and 87% yield (Scheme 113).
160  
 
 
 
 
 
Scheme 113 
The iodide 310 was then converted to Mori’s aldehyde 304 via a zinc-mediated coupling 
reaction.  This  reaction  was  attempted  with  acrolein,  however  only  the  corresponding 
alanine derivative 312 could be isolated (Scheme 114). Use of propargyl bromide gave the 
undesired  allenyl  compound  313,  but  reaction  with  allyl  bromide  afforded  the  desired 
olefin 314 (Scheme 114). Hydroboration-oxidation of 314 gave 304 which was converted 
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to (S)-gizzerosine 2 using Mori’s procedure.
152 The target compound was achieved in 58% 
yield from (S)-serine 306.  
 
 
 
 
 
 
 
 
 
Scheme 114
 
While  preparing  the  aldehyde  304,  it  was  noticed  that the  coupling  of  the  organozinc 
iodide  311  with  3-bromo-1-propenyl  acetate  gave  the  allylic  acetate  315  as  a  2:1 
diastereomeric mixture at the 4-position in 98% yield (Scheme 115). This was expected to 
be a good substrate for the palladium-catalysed coupling with nitrogen nucleophiles such 
as histamine, but this was not the case. 
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Histamine  was  protected  with  a  number  or  electron  withdrawing/donating  protecting 
groups.  Unsuccessful  protection  through  nucleophilic  substitution  led  to  protection  via 
reductive  amination.  The  coupled  product  318  was  achieved  using  piperonyl-protected 
histamine 317, in 71% yield, when a mixture of triphenylphosphine and palladium(II) was 
used  (Scheme  116).  Hydrogenation  and  hydrolysis  using  an  excess  of  palladium 
hydroxide/carbon gave (S)-gizzerosine 2 in 47% yield, and 26% overall yield in seven 
steps from (S)-serine 306.  
 
 
 
 
 
 
  Scheme 116   
3.3  Aims  
As (S)-gizzerosine 2 can only be isolated from brown fishmeal in very small amounts (0.2 
mg per kg), a chemical approach is needed to facilitate further biological testing.
150 We 
wanted to generate a novel synthetic approach that is more efficient than those already 
published. Also, we were interested in eliminating very toxic reagents from the scheme, 
such as the cyanides in Mori’s synthesis.
152  
Our approach was designed with flexibility in mind, and to this end, we have proposed the 
introduction of the histamine side chain late in the synthesis (Scheme 117). This allows for 
introduction of other amino acids in place of histamine and thus, the synthesis of a library 
of (S)-gizzerosine analogues that could be used for drug discovery. Also of note is the fact 
that  the  histamine  in  the  proposed  synthesis  is  unprotected.  This  will  mean  less 
deprotection  steps and  hopefully a  higher overall  yield  for this synthetic route. It also 
avoids problems that could arise when attempting to introduce other protected amines at 
this point in a library synthesis, such as incompatibility of those protecting groups.  
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3.4  The Synthesis of (S)-Gizzerosine 
The initially proposed scheme for the synthesis is outlined below (Scheme 117). As with 
other  projects  discussed  in  this  thesis,  the  scheme  was  designed  around  a  key  semi-
aldehyde intermediate which could be a focal point for new divergent syntheses to other 
non-proteinogenic  amino  acids.  The  semi-aldehyde  intermediate  in  the  synthesis  of 
gizzerosine could be obtained in four steps from commercially available  L-aspartic acid 
Starting from  L-aspartic acid 319, the amino acid functionality is fully protected as an 
oxazolidinone ring with a benzyloxycarbonyl (Cbz) protecting group. This will allow for 
manipulation  of  the  β-acid  without  compromising  the  α-acid  or  the  amino  group. 
Following borane reduction of the acid to the alcohol 322 and PCC oxidation to the semi-
aldehyde intermediate 323, chain elongation will be performed using a Wittig reaction to 
yield the α,β-unsaturated aldehyde 324. The molecule is then ideally suited to a reductive 
amination  with  unprotected  histamine  to  yield  the  coupled  product  325,  which  after 
reduction of the imine, hydrogenation and hydrolysis will yield (S)-gizzerosine 2. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Scheme 117 
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Commercially  available  Cbz-protected  L-aspartic  acid  320  was  reacted  in  benzene, 
paraformaldehyde and a catalytic amount of p-TsOH, the mechanism of which is shown 
below (Scheme 118). There are two potential pathways that this reaction could follow. In 
the first, Pathway A, the lone pair on nitrogen attacks the bond next to it and displaces 
water to give 329. The lone pair on oxygen then attacks the iminium species to cyclise to 
the  oxazolidinone  321.  This,  according  to  Baldwin’s  guidelines,  is  a  5-endo-trig 
cyclisation, as a five-membered ring is formed, the bond being broken is inside the ring 
(endo) and the electrophilic carbon is trigonal (sp
2). Due to orbital overlap requirements, 
this is an unfavoured cyclisation. In Pathway B, the lone pair on oxygen attacks the carbon 
adjacent to nitrogen and water  is displaced to give 321. This  is  classed as a 5-exo-tet 
cyclisation as a 5-membered ring is formed, the bond being broken is outside the ring (exo) 
and the electrophilic carbon is tetrahedral (sp
3). This is a favoured reaction according to 
Baldwin’s guidelines and thus, this  is the  most likely  mechanism. The water that was 
generated  was  removed  by  azeotropic  distillation  using  a  Dean-Stark  apparatus,  hence 
pushing the equilibrium towards the oxazolidinone 321 in 87% yield.  
 
 
 
 
 
 
 
 
 
Scheme 118 
Oxazolidinone 321 was then subjected to a borane reduction to the alcohol 322 using a 1M 
solution  of  borane.THF  complex.
161  Initially,  the  reaction  was  brought  back  to  room 
temperature after addition of the reductant at -15 
oC. This however resulted in degradation 
of 322. When the reaction was maintained at -4 
oC for 20 hours, 322 was recovered in a 
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moderate 53% yield following purification by silica gel column chromatography (Scheme 
119).  The 
1H  NMR  spectrum  shows  two  sets  of  signals  for  the  new  CH2  due  to  the 
stereogenic  centre.  These  signals  appear  at  4.84  and  4.96  ppm  and  the  single  proton 
attatched to the chiral centre has shifted upfield by approximately 0.4 ppm.  
 
 
Scheme 119 
The alcohol 322 was then oxidised to the key aldehyde intermediate 323 using PCC in 
DCM  and  a  77%  yield  was  achieved  after  purification  by  column  chromatography 
(Scheme  120).  The 
1H  NMR  spectrum  clearly  showed  a  new  signal  for  the  aldehyde 
proton at 9.26 ppm.  
 
 
 
 
Scheme 120 
The  aldehyde  323  was  then  reacted  with  (triphenylphosphoranylidene)acetaldehyde  in 
THF at room temperature in a Wittig reaction but only starting  material was recovered 
(Scheme  121).  An  attempt  was  also  made  to  react  323  with  carbomethoxymethylene 
triphenylphosphorane,  initially  thinking  that  our  original  ylide  had  decomposed.  Once 
again, only the aldehyde 323 was recovered. It was believed then that the inability of 323 
to  undergo  a  Wittig  reaction  was  due  to  both  the  Cbz-protecting  group  and  the 
oxazolidinone ring sterically hindering the aldehyde. 
 
 
Scheme 121 
A new strategy was therefore needed in order to prepare a semi-aldehyde intermediate 
which would undergo a Wittig reaction with (triphenylphosphoranylidene)acetaldehyde. It 
was decided to make an analogous L-aspartic acid compound without the oxazolidinone 
ring, where it was believed part of the problem lay. In the new scheme, the amino acid 
functionalities will be protected separately, with a Boc-group and an ester respectively, 
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instead of incorporating them into a ring (Scheme 122). It was hoped that this strategy 
would leave the aldehyde more exposed to react with the ylide. Starting with  L-aspartic 
acid, the acid groups are methylated and the amine is mono-protected as before to give 
330. The amine is then fully protected with a second Boc-group to yield 331. The addition 
of the second Boc-group is  necessary,  not only to fully protect the amide, but also to 
provide selectivity during the reduction step. The β-ester will be converted to an aldehyde 
in a DIBAL-H reduction as before, to give the key intermediate 332 for the Wittig reaction. 
 
 
 
 
Scheme 122 
In the first step, L-aspartic acid 319 was reacted with TMSCl to yield the di-ester (Scheme 
123).
162 After 24 hours at room temperature, NEt3 and Boc2O were added to mono-protect 
the amine.
163 This reaction was complete after 2 hours and 330 was isolated in 83% yield. 
The experimental data corresponds well with that from the literature.
164 Due to the adjacent 
stereogenic centre, the 3-H2 protons are therefore in chemically different environments, and 
thus appear as two separate doublet of doublet peaks in the 
1H NMR spectrum, instead of a 
single peak integrating for 2 protons. 
 
 
 
Scheme 123 
The di-Boc protected amino acid 331 was then prepared in quantitative yield using Boc2O 
and DMAP (Scheme 124).
165 This reaction was stirred for 24 hours at room temperature. 
The NH peak seen at 5.5 ppm in the 
1H NMR spectrum for 330 is now not observed and 
the peak for the 
tbutyl groups now integrates for 18 protons. The optical rotation obtained 
corresponds exactly with the literature.
164 The second protection step is necessary in order 
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to make the following reduction regioselective for the β-ester.
164,166 The added bulk of the 
second Boc-group effectively shields the α-ester, thus only leaving the β-ester exposed 
during the reduction. 
 
 
 
 
Scheme 124 
The reduction of 331 to 332 was carried out using 1.4 equivalents of DIBAL-H at -78 
oC 
(Scheme 125). Initially, the reaction was stirred at -78 
oC for between 5 minutes and 2 
hours (according to literature), but both of these attempts led to a mixture of 331 and 332. 
Next, the reaction was also allowed to warm to room temperature overnight but this led to 
partial over-reduction of the β-ester to the corresponding alcohol and these mixtures were 
extremely difficult to separate. Following a number of attempts, the optimum conditions 
were found to be maintenance of the reaction at -78 
oC for 24 hours. This ensured that no 
starting  material  remained  and  that  there  was  no  over-reduction  of  the  β-ester  to  the 
corresponding  alcohol.  The  semi-aldehyde  intermediate  332  was  isolated  in  79%.  The 
experimental data corresponded well with that obtained from literature.
164 A new peak for 
the aldehyde proton was seen at 9.82 ppm in the 
1H NMR spectrum and at 198.5 ppm in 
the 
13C NMR spectrum.  
 
  
Scheme 125 
This aldehyde 332 was then reacted with (triphenylphosphoranylidene)acetaldehyde in a 
Wittig  reaction  to  extend  the  carbon  chain  in  preparation  for  coupling  with  histamine 
(Scheme 126). The reaction proceeded very slowly and after 3 days under reflux, only 
13% of the α,β-unsaturated aldehyde 333 was isolated. The new aldehyde proton peak 
appeared at 9.50 ppm in the 
1H NMR spectrum. A stabilised ylide was used to produce the 
E-alkene. The coupling constants prove this has been formed, with J4H-5H equal to 15.6 Hz.  
It was believed that the reaction was slow, and therefore low yielding, due to the steric 
hindrance of the two Boc-protecting groups on the amino functionality.  
Recently, Martín and co-workers have shown that LiBr can be used for selective cleavage 
of  one  Boc-group  in  N,N-di-protected  amino  compounds.
167  It  was  decided  to  use  this 
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procedure to selectively remove one of the Boc-groups that was believed to be slowing the 
Wittig reaction. Aldehyde 332 was therefore reacted with LiBr in MeCN to yield the less 
hindered mono-protected semi-aldehyde 334 in 89% yield (Scheme 126). A broad signal is 
seen in the 
1H NMR spectrum at 5.41 ppm, corresponding to the new NH. Also, the signal 
for the α-proton, which shifted downfield to 5.57 ppm when the second Boc-group was 
added, has moved upfield again to approximately 4.63 ppm. This new semi-aldehyde 334 
was subjected to a Wittig reaction at 35 
oC for 2 days using the same ylide as before, 
(triphenylphosphoranylidene)acetaldehyde. The α,β-unsaturated aldehyde 335 was isolated 
in 92% yield, a vast improvement on the previous Wittig reaction. Again, the E-alkene was 
produced as expected, with J4H-5H equal to 15.4 Hz (Figure 39).  
 
 
 
 
 
 
Scheme 126 
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Figure 39 
 
In previous syntheses of (S)-gizzerosine 2, both Mori and co-workers and Kiyota and co-
workers have used a reductive amination with histamine in the latter stages, with much 
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success, to make the backbone of the target material.
3,152 Following this, both groups used 
NaBH4 to reduce the imine double bond formed. Due to this literature precedent, the next 
stage of our synthesis required reductive amination of 335 with histamine and reduction of 
the imine double bond with NaBH3CN (Scheme 127). Finally, reduction of the alkene and 
deprotection will give (S)-gizzerosine 2. 
 
 
 
 
 
 
Scheme 127 
The coupling reaction was attempted with the α,β-unsaturated aldehyde 335 and histamine, 
using MgSO4 to ensure a dry reaction.
168 However, only 335 was recovered.
 The reductive 
amination was then attempted in the presence of NaBH3CN to reduce the imine formed in 
situ (Scheme 128).
152 4Å Molecular sieves were also added to the reaction to eliminate any 
water, however, again only starting material 335 was recovered. 
 
 
 
Scheme 128 
As this approach had failed, an alternative route was proposed in which the double bond of 
the  α,β-unsaturated  aldehyde  is  reduced  by  hydrogenation  to  corresponding  saturated 
aldehyde 338 prior to the reductive amination with histamine to yield the saturated coupled 
compound 339 (Scheme 129).  
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The hydrogenation was carried out on α,β-unsaturated aldehyde 335 using 10% palladium 
on carbon as catalyst. Hydrogen was bubbled through the solution and then the reaction 
was placed under a hydrogen atmosphere for 24 hours. Unfortunately, following isolation 
by column chromatography, the desired saturated aldehyde 338 was not produced. Instead 
the major product observed was the cyclised piperidine 340 which was isolated in 44% 
yield  (Scheme  130).
169  The  broad  peak  for  the  NH  stretch  seen  previously  in  the  IR 
spectrum is no longer observed and the 
1H NMR spectrum is broad with rotamers (2 sets) 
normally seen in cyclic N-carbamate-protected compounds. These peaks were resolved to 
some degree using high temperature 
1H NMR experiments. All other experimental data for 
340 corresponds well with the literature data.
169   
 
 
 
Scheme 130 
We believe that when the double bond is reduced during the hydrogenation, it introduces a 
large degree of flexibility into the carbon chain. This allows the lone pair on the nitrogen to 
attack the aldehyde via a condensation reaction which forms the enamine 342. Further 
hydrogenation during the reaction leads to reduction of the enamine to give 340 (Scheme 
131). 
 
 
 
 
 
 
 
Scheme 131 
To overcome this issue, a variation on the scheme was proposed in order to synthesise the 
saturated  aldehyde  338  (Scheme  132).  It  was  proposed  that  reduction  of  the  α,β-
unsaturated aldehyde 335 using NaBH4 would give the allylic alcohol 343.
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this, hydrogenation of the double bond and oxidation of the alcohol to the aldehyde should 
yield the saturated aldehyde 338.  
 
 
 
 
 
 
Scheme 132 
Thus, 335 was reduced to the unsaturated alcohol 343 using NaBH4. The reaction was 
stirred  for 2 hours at -42 
oC (MeCN/dry  ice  bath) and 343 was  isolated  in 87%  yield 
(Scheme 133). The 
1H NMR showed a new signal, integrating for 2 protons at 4.03 ppm, 
which corresponds to CH2OH. Also, the protons of the double bond (5-H and 4-H) have 
shifted upfield, from 6.1 and 6.65-6.72 ppm respectively, to 5.68 and 5.48-5.56 ppm. This 
is because the electron withdrawing effect of the aldehyde group is lost to these protons.  
 
 
 
Scheme 133 
 
Removal  of  the  double  bond  to  yield  the  saturated  alcohol  344  was  carried  out  in  a 
standard hydrogenation reaction using 0.2 molar equivalents of 10% palladium on carbon 
catalyst over 24 hours. Surprisingly, although  not unknown, the hydroxyl group of the 
allylic  alcohol  343  was  also  reduced  during  the  course  of  the  reaction,  and  following 
purification by column chromatography the major product isolated was 345 in 44% yield 
(Scheme 134 – Route A).
171 This reduction was attempted using  both 5% rhodium on 
carbon and palladium hydroxide catalysts, but again, the major product recovered was 345 
(Scheme 134 – Route B).
172 The 
1H NMR spectrum has a characteristic triplet (integrating 
for 3 protons) for the new terminal CH3 at 0.90 ppm. There is also a new peak at 1.30-1.36 
ppm,  integrating  for  4  protons,  for  4-H2  and  5-H2.  All  other  experimental  data  are 
consistent with the literature.
173  
 
H
O
CO2Me
NHBoc
HO CO2Me
NHBoc
NaBH4
HO CO2Me
NHBoc
H2, Pd/C
H
O
CO2Me
NHBoc
Swern
335
338
343
344
H
O
CO2Me
NHBoc
HO CO2Me
NHBoc
NaBH4, MeOH
-42 
oC, 87%
335 343K. N. Fanning, Chapter 3, Page 97 
The reduction was then carried out using 0.05 molar equivalents of platinum oxide and 
fortunately, this reaction yielded the desired saturated alcohol 344 in 97% yield after 2 
hours at room temperature (Scheme 134 – Route C).
174 The 
1H NMR spectrum shows a 
triplet  (integrating  for  2  protons)  at  3.64  ppm,  and  all  other  experimental  data  are  in 
keeping with the literature values.
175 
 
 
 
 
 
Scheme 134 
The last stage of the synthesis involved re-oxidation of the saturated alcohol 344 to the 
saturated aldehyde 338, followed by reductive amination of this aldehyde with histamine. 
A standard Swern oxidation was employed for conversion of the alcohol to the aldehyde, 
stirring for 18 hours at room temperature (Scheme 135). However, only starting material 
was recovered. It was thought that possibly the oxalyl chloride has decomposed somewhat, 
giving HCl and this was interfering with our acid-sensitive compound. The oxalyl chloride 
was distilled, yet the same result was produced. This was very unusual, as this reaction had 
been carried out previously in the literature with a similar compound (protected with a 
Cbz-group) and a 91% yield was achieved.
158 This oxidation was also attempted with Dess-
Martin  periodinone,  stirring  at  room  temperature  for  3  hours,  but  a  similar  result  was 
achieved (Scheme 135).
176  
 
 
 
Scheme 135 
Another approach was needed to couple our compound with histamine. In a publication by 
Gokel and co-workers histamine was coupled with a mesylate-protected macrocycle in a 
moderate  yield.
177  Thus,  it  was  decided  to  activate  the  saturated  alcohol  344  with  a 
mesylate group in order to make it a better leaving group, and then react this directly with 
histamine to yield the saturated coupled compound 337 (Scheme 136). 
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Scheme 136 
The mesylation was performed under standard conditions using MeSO2Cl and the reaction 
was allowed to stir at room temperature for 24 hours. Following purification by column 
chromatography, 346 was isolated in 86% yield (Scheme 137). A new singlet peak is seen 
at 3.01 ppm (integrating for 3 protons) in the 
1H NMR spectrum, corresponding to the 
mesylate.  
 
 
Scheme 137 
Initially,  346  was  coupled  with  histamine  using  sodium  carbonate  in  MeOH  and  this 
reaction was stirred at room temperature for 13 hours.  In this case, only starting material 
was recovered. The reaction was repeated, heating the mixture to 50 
oC for 24 hours but 
again, only 346 was recovered. The solvent was changed to EtOH because of the higher 
boiling point, and the reaction was heated under reflux for 24 hours. However, this led to 
hydrolysis of the α-ester. The base was switched from sodium carbonate to milder DBU 
and the solvent was also changed to MeOH (Scheme 138). Again, the reaction was heated 
under reflux for 24 hours. This was successful and gave the saturated coupled product 339 
in 66% yield.  
 
 
Scheme 138 
Finally, deprotection of 339 by reflux in 6M hydrochloric acid for 24 hours, gave (S)-
gizzerosine 2 in quantitative yield (Scheme 139). A Dowex® 55WX ion-exchange column 
was  used  for  purification  with  a  5%  ammonia  solution  as  eluent.  The  optical  rotation 
obtained ([α]D
23 +10.0 (c 0.2, H2O)) is almost identical to the literature value (lit.
152 [α]D
22 
+10.3 (c 1.3, H2O)). All other experimental data obtained correlates well with that from the 
literature.
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Scheme 139 
To summarise, (S)-gizzerosine 2 was prepared from commercially available L-aspartic acid 
319 in 10 steps and 31% overall yield (Scheme 140). This optimised scheme could be used 
to  prepare  a  number  of  other  unusual  amino  acids,  with  two  areas  having  scope  for 
diversity. The key semi-aldehyde intermediate can be generated from a number of readily 
available amino acids (e.g. L-glutamic acid) and histamine in the case of (S)-gizzerosine 
could also be substituted for a number of other nucleophiles.  Other advantages of this 
synthesis  are  the  use  of  less  toxic  materials  and  the  lack  of  any  inefficient  late-stage 
enzymatic resolution, as discussed previously.  
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4  The Synthesis of Photo-Acids 
4.1  Detecting Protein-Protein Interactions 
Protein-protein  interactions are key to organising cellular processes  in space and time. 
They  are  involved  in  viral  fusion  or  in  growth  factor  signalling  and  so  are  promising 
targets for antiviral or anticancer drugs.
178 There are a number of methods to detect these 
interactions,  each  of  which  has  strengths  and  weaknesses.  An  example  is  co-
immunoprecipitation,  where  endogenous  proteins  are  isolated  with  a  specific  antibody. 
Interaction partners that stick to the protein are identified by western blotting. However 
this method can only verify suspected interactions and is not a screening process. Another 
method often used is chemical cross-linking. Protein interactions are ‘fixed’ in place before 
trying to isolate and identify the interacting partners. Common cross-linkers used include 
the non-cleavable, membrane-permeable N-hydroxysuccinimide ester LC-SMCC 347 and 
the  cleavable  imidoester  dimethyl  dithiobispropionimidate  (DTBP)  348  (Figure  40). 
Unfortunately, chemical cross-linking often results in smears on the gel or unresolvable 
aggregates during western blotting. 
 
 
 
                 
Figure 40 
Photo cross-linking is one of the most informative biochemical approaches in studying 
interactions of biological molecules and was initially put forward by Westheimer and his 
group.
179 Photo cross-linking requires the introduction of a photoactivatable (photoreactive 
or photolabile) group into a protein to produce a precursor, which upon irradiation with 
ultraviolet light generates highly reactive species in situ. This photoactivatable group needs 
to be stable to peptide synthesis and must not disturb the interaction of the protein with the 
receptor.  The  precursor  should  photolyse  at  wavelengths  clear  of  protein  absorption.
180 
Upon  irradiation, the photoactivatable group  incorporated  into the  molecule transforms 
into  a  highly  reactive  species  (nitrene,  carbene  or radical)  which  attacks  neighbouring 
groups to produce a covalent bond. The covalent bond formed must be stable to proteolysis 
and  chemical  degradation.  Also,  high  yielding  cross-linking  reactions  are  needed  with 
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picomole amounts of receptor. The covalently cross-linked interacting proteins can then be 
detected with high specificity using simple western blotting.  
4.2  Photo Cross-Linking With Diazirines 
Diazirines were first proposed as potential reagents for photo cross-linking by Smith and 
Knowles in 1973.
180 The diazirine functionality is surprisingly inert and stable; acid and 
alkali have no effect on the group at room temperature. Irradiation of a diazirine precursor 
349 has  been  shown to produce a reactive  carbene 351  after the  light  induced  loss of 
nitrogen  via  the  corresponding  diazo  compound  350  (Scheme  141).
4  Because  of  their 
electron  deficiency,  the  (singlet)  species  are  powerful  electrophiles  and  reactions  with 
double bonds or heteroatoms possessing non-bonding electron pairs are extremely rapid.
181 
Cross-linking is also very specific due to the short half-life of the activated carbene.  
 
 
 
 
Scheme 141 
The diazirine group is generally introduced by oxidation of the diaziridine obtained from 
the corresponding ketone 352 by treatment with ammonia and hydroxylamine-O-sulfonic 
acid or chloramine (Scheme 142).
182 Previously, the oxidation was effected using silver 
oxide. However, certain functional groups such as amines can interfere with the reagent 
and the reaction is often sluggish due to competing side reactions. It also forms a silver 
mirror  with  potential  explosive  character  on  the  inside  of  the  reaction  vessel  as  the 
oxidation proceeds. In 1970, Church and Weiss reported that iodine as an oxidant (in basic 
media) produced a faster, cleaner and safer reaction. The mechanism for the formation of 
the diazirine is shown in Scheme 143. 
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Scheme 143 
The diazirine functionality has been used previously to detect a number of protein-protein 
interactions. Balwin and co-workers have used the diazirinyl-containing substrate 2-[3-(3-
trifluoro-methyl-3H-diazirin-3-yl)-phenoxy]acetyl-(S)-methyloxycarbonylsulphenyl-L-
cysteinyl-D-valine  (DCV)  356  in  a  study  with  the  enzyme  isopenicillin  N  synthetase 
(IPNS) 357 (Scheme 144).
183 The enzyme has been shown to catalyse the conversion of a 
number of substrates into the corresponding β-lactams, thereby providing routes to a new 
range  of  antibiotics.  The  selective,  light-dependant  covalent  incorporation  of  the 
radiolabelled  [
14C]DCV  into  IPNS  was  demonstrated,  although  the  low  specific 
radioactivity of the [
14C]DCV made it impracticable to localise the point of insertion. 
 
 
Scheme 144 
4.3  Photo Cross-Linking With Photoacids 
Chemical  synthesis  of  large  proteins  bearing  a  photoactivatable  group  is  generally  not 
viable  due  to  the  complexity  involved.  Since  amino  acids  are  the  building  blocks  for 
proteins, if instead the tRNA of a cell is supplied with only an amino acid that is modified 
with a photoactivatable group, these groups can be easily incorporated into larger proteins 
that are not amenable to chemical synthesis. The modified amino acids are so similar, both 
in structure and in properties, to the unmodified ones, they can escape the stringent identity 
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control  mechanisms  during  protein  synthesis.  Examples  of  this  are  rare  and  usually 
confined to bacteria.
181  
This  method  has  previously  been  applied,  using  a  photoactivatable  diazirine  ring,  to 
discover a direct interaction of the progesterone-binding membrane protein PGRMC1 with 
Insig-1, a key regulator of cholesterol homeostasis.
4 The three modified amino acids used 
to identify this interaction are photo-leucine 3, photo-isoleucine 359 and photo-methionine 
360, so called because of their similarity to the natural amino acids (Figure 41). 
 
 
 
Figure 41 
Photo-leucine 3 was obtained by α-bromination of the respective azi-carboxylic acid 362 
according to the procedure described by Haarp and co-workers (Scheme 145).
184 This was 
followed  by  aminolysis of the azi-bromo-carboxylic acid 363. Acetylation  followed  by 
enzymatic kinetic resolution using porcine kidney acylase I gave L-photo-leucine 3.  
 
 
 
 
Scheme 145  
The corresponding azi-carboxylic acid 367 for photo-methionine was achieved by Strecker 
synthesis. This was followed again by acetylation and enzymatic kinetic resolution to yield 
L-photo-methionine  360  (Scheme  146).  In  the  case  of  photo-isoleucine  359,  the  azi-
carboxylic acid was produced by the procedure of Church and Weiss.
182 This was followed 
again by bromination and aminolysis but no attempt was made to resolve the enantiomers 
of photo-isoleucine.
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Scheme 146 
Following  radio-labelling  to  determine  the  uptake  of  modified  amino  acids,  it  was 
concluded that there were 3-4 photoactivatable positions in an average 500-amino acid 
protein. It was also found that the photo-acids do not affect cell viability or impair the 
function of the proteins. The PGRMC1 and the Insig-1 were cultured with and without 
photo-methionine and were cross-linked. When cells were grown in the absence of photo-
methionine, no cross-linked band was detected by western blotting. In cells grown with 
photo-methionine, a strong band appeared at the expected molecular weight of the Insig-1-
PGRMC1 cross-linked complex. 
We wanted to develop a stereoselective flexible new route to diazirine-containing amino 
acids that would allow the synthesis of many different analogues using the same general 
pathway. We also wanted to generate an approach that had no highly toxic reagents, such 
as the hydrogen bromide or cyanides used by Thiele and co-workers (Scheme 145 and 
146).
4 It was important to increase the overall yield of the scheme by not using inefficient 
kinetic resolution, where the maximum yield for the desired enantiomer is only 50%. The 
three  photo-acids  initially  synthesised  were  to  be  used  by  Dr.  Fraser  Rixon  in  the 
Department of Virology, who was going to incorporate them into viral proteins and then 
investigate viral protein-protein interactions through photo cross-linking.  
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4.4  Progress Towards the Synthesis of Photo-Acids 
As stated before, we wanted to develop a flexible route to these photo-acids and, with this 
in  mind,  the  initial  route  used  is  outlined  below  (Scheme  147).  This  route  uses  the 
commercially available Schöllkopf bis-Lactim ether ((2R)-(-)-2,5-dihydro-3,6-dimethoxy-
2-isopropylpyrazine) 45 as a chiral auxiliary to insert the amino acid functionality, with the 
required chirality, at the desired position on the compound. This scheme focuses on the 
synthesis  of  photo-methionine  360,  due  to  the  commercial  availability  of  the  starting 
alcohol, 3-ketobutanol 369. This will be converted to the corresponding diazirine 370 using 
the  procedure  of  Church  and  Weiss.
182  The  alcohol  will  then  be  mesylated  using 
methanesulfonyl chloride and triethylamine. The mesylate 371 will be converted to the 
iodide 372 using sodium iodide, in order to make it more labile during the reaction with the 
chiral auxiliary.  Following alkylation of the auxiliary,  hydrolysis with 6M HCl  should 
furnish the desired photo-acid. This scheme could then be manipulated for the synthesis of 
the other two photo-acids, photo-leucine and photo-isoleucine, simply  by  changing the 
starting alcohol. 
 
 
 
 
 
 
 
 
Scheme 147 
3-Ketobutanol 369 was converted to the corresponding diazirine 370 using Church and 
Weiss’ conditions (Scheme 148).
182 The alcohol was dissolved in MeOH and cooled to -78 
oC. Liquid NH3 was condensed into the flask and this was then allowed to stir at -78 
oC for 
4 hours. Hydroxylamine-O-sulfonic acid was added and the mixture was allowed to warm 
to room temperature for 1 hour, with a dry ice condenser. This gave the diaziridine which 
was then re-dissolved in MeOH and triethylamine and solid iodine were added to oxidise 
the diaziridine to the diazirine. This gave 370 in 67% yield after purification. In the 
1H 
NMR spectrum of 370, the signal corresponding to
 3-CH3 has shifted upfield from 2.20 
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ppm  to  1.48  ppm.  In  the 
13C  NMR  spectrum,  the  characteristic  quaternary  peak  of 
diazirines is observed at 24.3 ppm.    
 
 
Scheme 148 
From here the alcohol 370 was mesylated using methanesulfonyl chloride, triethylamine 
and DMAP, to hopefully enable more facile conversion to the iodide, which is a better 
leaving group for reaction with the chiral auxiliary (Scheme 149). The reaction mixture 
was  stirred  at  room  temperature  for  24  hours  and  following  purification  by  dry  flash 
column chromatography, 371 was isolated in 90% yield. New signals, integrating for 3 
protons, are observed at 3.09 ppm in the 
1H NMR spectrum corresponding to the mesylate 
CH3.  Also,  the  signals  for  1-H2  have  shifted  downfield  from  3.54  ppm  to  4.14  ppm, 
showing the increased electron withdrawing effect of the new mesylate group.  
The next step involved conversion of the mesylate 371 to the corresponding iodide 372. 
This reaction was first carried out using sodium iodide in acetone (Scheme 149).
185 The 
reaction was heated under reflux for 24 hours. Unfortunately, none of the desired iodide 
was  isolated  from  this  reaction.  Due  to  the  lack  of  reactivity  of  the  mesylate  in  this 
particular reaction, it was attempted to perform a halogenation with the alcohol 370 to give 
the  iodide  372  directly,  missing  out  the  mesylate  371.  This  was  performed  using 
triphenylphosphine, imidazole and iodine (Scheme 149). The reaction mixture was stirred 
at room temperature for 2 hours and following  purification, 7% of the iodide 372 was 
isolated. Unfortunately, despite repeating this reaction numerous times, no more of the 
iodide was isolated.  
 
 
 
 
 
 
 
Scheme 149 
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The mechanism for this conversion is a variation of the Appel reaction (Scheme 150). The 
initial step is formation of the phosphonium salt pair 370 through reaction of PPh3 with 
iodine. The alcohol displaces the iodine to give 375. With primary and secondary alcohols, 
the iodide anion reacts in an SN2 process to form the desired alkyl halide 377.     
 
 
 
 
 
Scheme 150 
The iodide 372 that was isolated from the reaction with PPh3, imidazole and iodine was 
used in the next step, where the chiral auxiliary was to be attached. This was attempted by 
reacting 372 with the (R)-Schöllkopf bis-lactim ether 45, and n-BuLi in THF at -78 
oC 
(Scheme 151).
186 The reaction was allowed to stir at -78 
oC for 5 hours. Unfortunately, 
none of the desired product 373 was isolated from this reaction. 
 
 
 
 
 
 
Scheme 151 
At this point, it was decided to couple the mesylate 371 directly with the chiral auxiliary 
45, due to both the low yield of the iodination reaction and the fact that no success was 
achieved when attempting to react the iodide with the chiral auxiliary. This reaction was 
attempted  with  the  chiral  auxiliary  and  n-BuLi  in  THF  at  -78 
oC  (Scheme  152).  The 
reaction was maintained at -78 
oC for 24 hours. Unfortunately, none of the coupled product 
373 was isolated. 
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Scheme 152 
Due to the lack of success with the coupling reactions, some test procedures were carried 
out to check the reactivity of the Schöllkopf bis-lactim ether 45. Methyl iodide 378, a very 
simple  substrate  with  the  same  leaving  group  as  before,  was  reacted  with  the  chiral 
auxiliary under the same conditions used previously (Scheme 153). Unusually, none of the 
coupled product 379 was isolated.  
 
 
 
 
 
Scheme 153 
Another coupling reaction was attempted using benzyl bromide 380 as the substrate. The 
conditions used were the same as before. Again, none of the desired product  381 was 
isolated. It was thought that the chiral auxiliary had decomposed slightly and that these 
decomposition products were preventing the coupling of the auxiliary and the substrate. 
Therefore, the auxiliary was purified by column chromatography using 30% ethyl acetate 
in  petroleum  ether  as  the  eluent.  This  purified  auxiliary  was  then  used  in  a  coupling 
reaction  with  benzyl  bromide  as  before  (Scheme  154).  The  desired  product  381  was 
isolated in 88% yield after purification. This was confirmed by the 
1H NMR spectrum in 
which the 5-H appears as a triplet at 4.26 ppm, showing that it is now adjacent to a CH2. 
The molecular ion was also observed in the high resolution mass spectrum. 
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The reaction of the iodide 372 was then re-attempted, this time with the purified auxiliary 
(see Scheme 151). Unfortunately, there was still no reaction. Due to the success of the 
reaction  with  the  benzyl  bromide,  it  was  attempted  to  convert  the  alcohol  370  to  the 
corresponding  bromide 382 and chloride 383, and use these substrates  in the coupling 
reaction with the chiral auxiliary (Scheme 155). To synthesise the bromide, two sets of 
conditions were used. Initially, the alcohol 370 was reacted with triphenylphosphine and 
N-bromosuccinimide in MeCN.
187 This mixture was warmed to 50 
oC for 1 hour, but no 
product was isolated following work-up. Another method was attempted to synthesise the 
bromide using triphenylphosphine and carbon tetrabromide in DCM but again, none of the 
desired bromide 382 was isolated.
188 For the chloride, the alcohol 370 was reacted with 
triphenylphosphine in carbon tetrachloride.
188 This reaction mixture was stirred at room 
temperature for 72 hours but unfortunately, none of the desired chloride 383 was isolated 
from this reaction.  
 
 
 
 
Scheme 155 
In order to synthesise the bromide 382 for reaction with the chiral auxiliary, it was decided 
to return to the  mesylate 371 and attempt to exchange the  leaving group for bromine. 
Therefore, the mesylate 371 was treated with sodium bromide in acetone and heated under 
reflux. After two days at reflux, a small amount product was observed when the 
1H NMR 
spectrum  of  the  crude  mixture  was  analysed,  but the  majority  of  the  starting  material 
remained. The reaction was attempted again using a solvent with a higher boiling point, 
hoping that the elevated temperature would drive the reaction to completion. The mesylate 
371 was reacted with sodium bromide using MeCN as solvent (Scheme 156). This was 
heated under reflux at 70 
oC for 24 hours and then at 95 
oC for 24 hours. The 
1H NMR 
spectrum of the crude material showed that the reaction had gone to completion and the 
crude bromide 382 was taken on to the coupling step with the chiral auxiliary without 
further purification. The reaction was carried out under the same conditions as before, but 
unfortunately, none of the desired coupled product 373 was obtained. This particular route 
using the  iodide 372  has  very recently  been successfully employed  in the  synthesis of 
photo-methionine  by  Kent  and  co-workers.
189  One  of  the  reasons  that  this  was  not 
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successful for us could be the purity of the iodide that was isolated. It was likely that it was 
contaminated with residual iodine which may have interfered with the coupling.  
 
 
 
 
Scheme 156 
At this point, despite attempting numerous reactions and routes, progress had not been 
made towards the target molecule and it was decided to modify the synthetic scheme. We 
still  wanted  to  begin  with  a  commercially  available  substrate  that  could  be  easily 
substituted to create all three photo-acids. The decision was also taken to introduce the 
diazirine  ring  late  in  the  synthesis,  to  minimise  any  problems  that  this  group  may  be 
causing. To this end, a new route was devised and is shown below for photo-methionine 
(Scheme 157). The route begins with commercially available L-glutamic acid 384, which 
is then protected as the di-ester di-Boc analogue 386. This is selectively reduced to the 
aldehyde 387.
164,166 This aldehyde 387 is then converted to the methyl ketone 388 using 
trimethylsilyldiazomethane . Following this, one of the Boc-groups is selectively removed 
to yield 389 and the ester is hydrolysed to the acid, so as to limit any interference at the 
aziridination step. Compound 390 is then aziridinated to give the diazirine 391 which is 
deprotected to give photo-methionine 360.   
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L-Glutamic acid 384 was treated with trimethylsilyl chloride, triethylamine and di-
tbutyl 
dicarbonate  and  this  first  step  proceeded  well,  with  385  being  isolated  in  88%  yield 
(Scheme 158).
162,163 In the 
1H NMR spectrum of 385, two sets of signals, each integrating 
for three protons, can be observed at 3.71 and 3.77 ppm, corresponding to the two esters. 
Also, a singlet integrating for 9 protons is observed at 1.47 ppm, corresponding to the Boc-
protecting group. Compound 385 was then protected with a second Boc-group by treating 
it with DMAP and di-tert-butyl dicarbonate and stirring at room temperature for 24 hours 
(Scheme  158).  After  purification  by  column  chromatography,  386  was  isolated  in  an 
excellent 98% yield. The singlet at 1.52 ppm in the 
1H NMR spectrum now integrates for 
18 protons and corresponds to the two Boc-groups. Also, the doublet seen previously for 
NH at 5.14 ppm in the 
1H NMR spectrum of 385 is no longer observed. 
 
 
 
 
 Scheme 158 
Following this, the reduction of 386 to 387 was attempted using 1.4 equivalents of DIBAL-
H at -78 
oC (Scheme 159). Initially, the reaction was  stirred at  -78 
oC  for between 5 
minutes  and  2  hours  (according  to  the  literature),  but  both  of  these  attempts  led  to  a 
mixture of 386 and 387. Next, the reaction was allowed to warm to room temperature 
overnight following addition of the DIBAL-H and a period at -78 
oC, but this led to over-
reduction  to  the  corresponding  alcohol  and  these  mixtures  were  extremely  difficult  to 
separate.  Following  a  number  of  attempts,  the  optimum  conditions  were  found  to  be 
maintenance of the reaction at -78 
oC for 24 hours. This ensured that no starting material 
remained and that there was no over-reduction to the corresponding alcohol. Interestingly, 
there was no reduction of the second ester observed in these reactions, showing complete 
regioselectivity was achieved. The semi-aldehyde intermediate 387 was isolated in 66% 
yield. Of note in the 
1H NMR spectrum is the triplet peak, integrating for one proton at 
9.81 ppm. This corresponds to the new aldehyde proton. In the 
13C spectrum, a new peak 
for CH is observed at 201.0 ppm, corresponding to the carbon of the aldehyde.  
 
 
 
Scheme 159 
HO2C CO2H
NH2
1. TMS-Cl
MeOH
2. Boc2O, 
NEt3, r.t., 2 h
88%
MeO2C CO2Me
NHBoc
MeO2C CO2Me
NBoc2
Boc2O,
DMAP,
MeCN, r.t., 
24 h, 98% 384 385 386
MeO2C CO2Me
NBoc2
CO2Me
NBoc2
H
O DIBAL-H,
Et2O
-78 
oC, 24 h
66% 386 387K. N. Fanning, Chapter 4, Page 112 
The next step involved conversion of the key semi-aldehyde 387 to the methyl ketone 388 
(Scheme  160).  This  conversion  was  attempted  by  treating  387  with 
trimethylsilyldiazomethane and trimethylaluminium in DCM at -78 
oC.
190 Unfortunately, 
none of the desired compound 388 was isolated from this reaction. The Lewis acid was 
changed to magnesium bromide and the reaction attempted again, however, a similar result 
was achieved.
191  
 
 
 
Scheme 160 
It came to our attention that Martín and co-workers had used lithium bromide to selectively 
remove one Boc-group from a number of di-protected compounds.
167 It was now believed 
that the second Boc-group was hindering the conversion of 387 to 392. Thus, 387 was 
treated with lithium bromide in MeCN and heated to 65 
oC for 10 hours as previously 
reported (Scheme 161). Unfortunately, 392 was not isolated from this reaction and the 
1H 
NMR spectrum of the crude material showed a mixture of di-protected 387 with a trace 
amount of mono-protected 392 and a number of unknown peaks.  
 
 
 
Scheme 161 
Work was concurrently being carried out to prepare photo-leucine 3. As this proved more 
successful  and  due  to  limited  time,  our  focus  shifted  to  the  synthesis  of  3.  The  new 
proposed route for the synthesis of photo-leucine 3 is shown below (Scheme 162). This is 
the same general scheme as used initially for photo-methionine 360. In the case of photo-
leucine,  L-aspartic  acid  319  is  protected  as the  di-ester  and  the  amino  functionality  is 
protected  with  two  Boc-groups  to  give  331.  As  before,  this  provides  the  necessary 
selectivity during the reduction of the β-ester to the aldehyde 332. This aldehyde 332 is 
then  converted  to  the  methyl  ketone  393  with  trimethylsilyldiazomethane  and 
trimethylaluminium.  Following  this,  one  of  the  Boc-groups  is  removed  with  lithium 
bromide and the ester  is  hydrolysed to the acid, so as to  limit any  interference at the 
aziridination step.  The aziridination is then carried out to give 396 which is deprotected to 
give photo-leucine 3. 
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Scheme 162 
Thus, L-aspartic acid 319 was treated with trimethylsilyl chloride in MeOH to yield the di-
ester (Scheme 163).
162 After 24 hours at room temperature, triethylamine and di-tert-butyl 
dicarbonate were added to mono-protect the amine.
163 This reaction was complete after 2 
hours and 330 was isolated in 83% yield. The experimental data collected correlates well 
with the literature data.
164 Due to the adjacent stereogenic centre, the 3-H2 protons are in 
chemically different environments, and thus appear as two separate doublet of doublet 
peaks at 2.85 and 3.03 ppm in the 
1H NMR spectrum. The di-Boc-protected amino acid 
331 was then prepared  in quantitative  yield using di-tert-butyl dicarbonate and DMAP 
(Scheme 163).
165 This reaction mixture was stirred for 24 hours at room temperature. The 
NH signals observed at 5.50 ppm in the 
1H NMR spectrum for 330 are now not seen and 
the peak for the Boc-groups at 1.53 ppm now integrates for 18 protons. The optical rotation 
obtained ([α]D
25 -61.0 (c 2.0, CHCl3)) corresponds exactly with the literature ([α]D
25 -61.0 
(c 2.0, CHCl3)).
164  
 
 
Scheme 163 
The reduction of 331 to 332 was carried out using 1.4 equivalents of DIBAL-H at -78 
oC 
(Scheme 164). These were the optimum conditions used when this reduction was carried 
out with the glutamic analogue in the synthesis of photo-methionine. The semi-aldehyde 
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intermediate 332 was isolated in 79% after purification. The experimental data correlates 
well with that obtained from the literature.
164 A new signal for the aldehyde proton is seen 
at 9.82 ppm in the 
1H NMR spectrum and at 198.5 ppm in the 
13C NMR spectrum.  
 
 
 
 
Scheme 164 
The next step was to convert the semi-aldehyde 332 to the methyl ketone 393 (Scheme 
165). Initially, this was attempted using a method that was used for the same reaction in the 
synthesis of photo-methionine i.e. trimethylsilyldiazomethane with magnesium bromide.
191 
While this reaction did work, the methyl ketone 393 was isolated in only 7% yield. A new 
CH3 singlet is observed in the 
1H NMR spectrum at 2.09 ppm and the aldehyde signals, 
previously at 9.82 ppm, are no longer observed. Also, in the 
13C NMR spectrum, there is a 
new quaternary  signal  at 206.5 ppm. One of the  main products formed was the TMS-
protected methyl ketone 397. This is characterised by two doublets for 5-H2, observed at 
2.08 and 2.13 ppm in the 
1H NMR spectrum.    
 
 
 
Scheme 165 
The  mechanism  for  this  transformation  is  shown  in  Scheme  166.  The  Lewis  acid 
coordinates  to  the  aldehyde  398  through  the  oxygen  of  the  carbonyl  group.  The 
trimethylsilyldiazomethane can then attack the electrophilic carbon of the carbonyl group 
399. Following a 1,2-hydride shift, N2 is displaced to yield the TMS-protected methyl 
ketone. The TMS-group is normally removed with an acidic workup.  
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Due to the low yield of the reaction when using magnesium bromide as the Lewis acid, 
other methods were investigated. Table 2 shows the other conditions used to convert the 
semi-aldehyde  332  into  the  methyl  ketone  393.  The  Lewis  acid  was  changed  to 
trimethylaluminium, as before, and a stronger acid was used in the work-up, as in reaction 
2 of Table 2, in an effort to decompose any 397 which had formed during the reaction.
190 
This led to an increased yield of 20% of the methyl ketone 393. Unfortunately, when the 
concentration of the acid was increased to 2M HCl, as in reaction 3, the major product 
isolated was 397 in 71% yield. It was then attempted to remove the TMS-group from 397 
by repeated washings with 6M HCl as in reaction 4. While this was successful to a degree, 
only 21% of 393 was isolated. We then reverted to milder 0.1M HCl in the work-up and 
maintained the reaction at -78 
oC, as in reaction 5, to give 397 as the major product in 14% 
yield. Finally, the Lewis acid was changed to tin dichloride and the reaction stirred at room 
temperature for 30 minutes, as in reaction 6.
190 Unfortunately, no product was isolated in 
this reaction. 
 
Reagent 
 
 
Lewis Acid 
 
 
Conditions 
 
 
Work-up 
 
 
Product 
 
1. TMS-CH2N2 
  MgBr2 
 
0 
oC for 1 h 
 
r.t. for 4 h 
 
0.1M HCl  7% 393 
 
2. TMS-CH2N2 
 
Me3Al 
 
-78 
oC for 1 h 
 
-40 
oC for 1 h 
 
1M HCl  20% 393 
 
3. TMS-CH2N2 
 
Me3Al 
 
-78 
oC for 1 h 
 
-40 
oC for 1 h 
2M HCl  71% 397 
 
4. TMS-CH2N2 
 
Me3Al 
 
-78 
oC for 1 h 
 
-40 
oC for 1 h 
 
6M HCl, 
repeated washings  21% 393 
 
5. TMS-CH2N2 
 
Me3Al 
 
-78
 oC for 5 h 
 
0.1M HCl  14% 397 
 
6. TMS-CH2N2 
 
SnCl2  r.t. for 30 min  0.1M HCl  No product 
 
Table 2 K. N. Fanning, Chapter 4, Page 116 
It was then attempted to deprotect the TMS-protected methyl ketone 397 in a separate 
reaction, as it seemed to be the major product recovered in a lot of the reactions (Scheme 
167). Compound 397 was reacted with TBAF in DMF at room temperature for 2 hours.
192 
Unfortunately, no product was isolated from this reaction.  
 
 
Scheme 167 
As  this  approach  did  not  allow  the  preparation  of  the  methyl  ketone  393  in  larger 
quantities, another method was attempted (Scheme 168). The semi-aldehyde 332 would be 
converted to the methyl alcohol 402 using a Grignard reaction.
193,194 Following this, the 
methyl alcohol 402 would be re-oxidised to the methyl ketone 393, and from here, the 
initial Scheme 162 could continue to produce the target molecule. 
 
 
 
Scheme 168 
A  solution  of  methyl  magnesium  bromide  (1.4M  in  THF)  was  used  for  the  Grignard 
reaction and this was stirred at 0 
oC for 2 hours (Scheme 169). It was quenched with a 
saturated solution of NaCl and following purification by column chromatography, 402 was 
isolated in 15%. A new doublet signal, integrating for 3 protons, is observed at 1.22 ppm in 
the 
1H NMR spectrum, corresponding to the terminal methyl group. The aldehyde signal, 
previously seen at 9.82 ppm, is now not observed and instead, a doublet signal for the 
hydroxyl proton is seen at 5.21 ppm in the 
1H NMR spectrum. Despite the low yield, the 
methyl alcohol 402 was taken to the oxidation step. 
 
 
Scheme 169 
A Swern oxidation was employed to convert the methyl alcohol 402 to the methyl ketone 
393 (Scheme 170). Compound 402 was reacted with DMSO, triethylamine and oxalyl 
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chloride  at  room  temperature  for  2  hours.  Following  purification  by  column 
chromatography only starting material was recovered. 
 
 
 
Scheme 170 
Another oxidation method was attempted; the Dess-Martin oxidation (Scheme 171).
193 The 
methyl alcohol 402 was reacted with Dess-Martin periodinane at room temperature for 3 
days. Once again though, this reaction did not work and none of the methyl ketone 393 was 
isolated.  
 
 
 
 
Scheme 171 
At this point we had limited quantities of the methyl ketone 393 as the only reaction to 
yield 393 was the methylation of 332 with trimethylsilyldiazomethane. Despite this, one of 
the Boc-protecting groups was removed by reacting 393 with trifluoroacetic acid in DCM 
(Scheme 172). The crude material was purified immediately by column chromatography to 
yield 90% of the mono-Boc protected methyl ketone 394. A new doublet signal for the 
amine is observed in the 
1H NMR spectrum at 5.53 ppm and the peak for the Boc-group at 
1.47 ppm, previously integrating for 18 protons, now integrates for 9 protons, showing that 
one Boc-group has been removed. 
 
 
 
 
Scheme 172 
This  compound  was  used  in  the  next  step  of  the  scheme  where  the  diazirine  ring  is 
introduced. Hydrolysis of the ester was not performed due to the limited quantities of 394. 
This reaction was carried out according to the procedure of Church and Weiss, using solid 
iodine as the oxidant (Scheme 173).
182 394 was reacted with anhydrous liquid ammonia in 
MeOH at -78 
oC for 4 hours. Hydroxylamine-O-sulfonic acid was dissolved in MeOH and 
added  slowly  to the  flask  to  give  the  diaziridine.  This  was  allowed  to  warm  to room 
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temperature overnight to evaporate the ammonia (boiling point: -33 
oC). The residue was 
re-dissolved in MeOH and triethylamine was added followed by solid iodine to oxidise the 
diaziridine to the diazirine. Unfortunately, there was no product isolated from this reaction 
and we no longer had any of the methyl ketone 394 to continue to investigate this reaction. 
 
 
 
 
Scheme 173 
Again, a re-think of the synthesis was carried out and it was decided that, perhaps in the 
second Boc-group was hindering the conversion of the semi-aldehyde 332 to the methyl 
ketone 393. As discussed for photo-methionine, Martín and co-workers have successfully 
used lithium bromide to selectively remove one Boc-group from a number of di-protected 
compounds.
167 It was therefore decided to employ this reaction again as shown below in 
Scheme 174 but the remainder of the route was to remain similar to that in Scheme 162. 
 
 
 
 
Scheme 174 
The semi-aldehyde 332 was treated with lithium bromide in MeCN and heated to 65 
oC for 
10 hours (Scheme 175). Following  immediate purification  by  column chromatography, 
334 was isolated in 89% yield. In the 
1H NMR spectrum, a new doublet signal is observed 
at 5.41 ppm, corresponding to NH. Also, the singlet at 1.47 ppm corresponding to the Boc-
group  now  integrates  for  only  9  protons,  indicating  that  one  of  the  groups  has  been 
removed.  
 
 
Scheme 175 
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Following this successful result, 334 was used in the next step where the methyl ketone 
would be introduced. Previously, this reaction was attempted using a number of methods 
and reagents, however, due to literature precedent, it was decided to use tin dichloride as 
the Lewis acid for this reaction.
190 Our tin dichloride was complexed with water but the 
reaction requires completely anhydrous conditions. Thus, the reagent was placed  in an 
oven at 110 
oC for 48 hours and then heated to 100 
oC under vacuum for 3 hours, to 
remove  all  the  water.  This  anhydrous  reagent  was  then  reacted  with  334, 
trimethylsilyldiazomethane and DCM at room temperature. Unfortunately, this reaction 
produced mixtures of 334, the TMS-protected analogue 404 and the desired methyl ketone 
394. As the TMS-protected methyl ketone 404 was generally the major fraction, it was 
decided to optimise the reaction for the synthesis of this compound and then remove the 
TMS-group after isolation. 
Thus, the optimised reaction conditions involved stirring the anhydrous tin dichloride and 
trimethylsilyldiazomethane with the semi-aldehyde 334 in DCM at room temperature for 
19 hours (Scheme 176). During purification, it was found that the desired compound 404 
decomposes when exposed to the silica gel on a column for extended periods. Purification 
therefore involved a short silica column and the crude mixture was passed through very 
quickly. Following this, 404 was isolated in 66% yield. A new singlet is observed in the 
1H 
NMR spectrum, integrating for 9 protons, at 0.0 ppm corresponding to the TMS-group. 
Also, the triplet for the aldehyde proton previously observed at 9.76 ppm is now not seen. 
Instead, a new singlet, integrating for 2 protons, is seen at 2.08 ppm corresponding to 5-H2.      
 
 
 
Scheme 176 
The next step was removal of the TMS-group to yield the methyl ketone 394. This was 
carried out by reacting 404 with a solution of 5% potassium hydroxide in MeOH at room 
temperature  for 1 hour (Scheme 177). This gave the desired  methyl ketone  394  in an 
excellent 92% yield, without the need for further purification. In the 
1H NMR spectrum, 
the singlet for the TMS-group at 0.0 ppm is no longer observed and the peak at 2.08 ppm 
for 5-H2 has now shifted to 2.20 ppm and integrates for 3 protons (5-H3).  
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Scheme 177 
Following this, 394 was used in the next step, where the methyl ester is hydrolysed to the 
acid. This was carried out in an effort to prevent any reaction with ammonia during the 
aziridination step. Initially, 394 was reacted with a 1M NaOH solution at 0 
oC for 1 hour.
195 
Unfortunately, none of the desired product 395 was isolated from this reaction. It was then 
attempted to react 394 with another base, lithium hydroxide, in THF at 0 
oC for 4 hours.
196 
Again, no product was isolated from this reaction. We then decided that a larger counter-
ion, such as cesium, would have a more diffuse charge and accordingly, would have looser 
ionic interactions and therefore would not interfere with the nucleophilic properties of the 
hydroxide ion. Thus, 394 was treated with cesium carbonate in MeOH:H2O 1:1 at room 
temperature for 24 hours (Scheme 178). Acid 395 was isolated in 94% yield without the 
need for further purification. The singlet for the OMe group, which previously appeared at 
3.76 ppm in the 
1H NMR spectrum, is no longer observed.  
 
 
 
 
 
 
Scheme 178 
Acid 395 was used  in the penultimate step of the scheme, where the diazirine ring  is 
introduced. This procedure was attempted initially using Church and Weiss’ conditions 
(Scheme 179).
182 Unfortunately, no product was isolated from this reaction. We decided to 
analyse the reaction as it progressed, by isolating the diaziridine 405 before the oxidation 
to the desired compound 396. From the crude 
1H NMR spectrum, diaziridine 405 was 
present. Thus, a second oxidation was attempted, instead of using solid iodine as is used in 
Church and Weiss’ procedure.  
 
 
 
Scheme 179 
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We assumed 100% conversion to the diaziridine 405 had taken place and attempted an 
oxidation using PCC at room temperature for 30 minutes (Scheme 180).
197 Unfortunately, 
no  product  was  isolated  from  this  reaction.  A  final  attempt  was  made  to  oxidise  the 
diaziridine to the diazirine 396, using silver oxide (Scheme 180).
198 This procedure had 
been used prior to Church and Weiss using solid iodine for the oxidation.
182 The silver 
oxide was freshly prepared by adding a 1M NaOH solution to a 1M boiling solution of 
silver nitrate. The precipitated silver oxide was then filtered off and washed with H2O, 
acetone and ether and used immediately. The silver oxide was added to a solution of the 
diaziridine in diethyl ether and this mixture was stirred in the dark for 4 hours. Again, 
unfortunately, no product was isolated from this reaction.   
 
 
 
 
 
 
 
Scheme 180 
Due to time constraints, this reaction could not be investigated further, although significant 
progress has been made towards a stereoselective route that is flexible and high-yielding. 
Although the desired diazirine-containing amino acids were not synthesised during this 
study, an interesting keto-silyl derived amino acid was unexpectedly isolated and this is 
now being used to investigate the Peterson reaction of these compounds. 
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5  Experimental  
5.1  General Experimental 
All reactions were performed under an atmosphere of nitrogen or argon unless otherwise 
noted. Reagents and starting materials were obtained from common commercial sources 
and  used  as  received.  THF  and  Et2O  were  distilled  from  sodium  and  benzophenone. 
Lithium bromide was oven dried (110 
oC) for at least 12 h before use. 
1H NMR and 
13C 
NMR spectra were recorded on a DPX 400 spectrometer with chemical shift values in ppm 
relative to residual chloroform (H 7.28 and C 77.2) as standard. Infrared spectra were 
recorded  using  Golden  Gate  apparatus  on  a  JASCO  FT/IR  410  spectrometer  and  mass 
spectra obtained using a JEOL JMS-700 spectrometer. Flash column chromatography was 
carried out using Fisher Matrix silica 60. Macherey-Nagel aluminium backed plates pre-
coated  with  silica  gel  60  (UV254)  were  used  for  thin  layer  chromatography  and  were 
visualised by staining with basic potassium permanganate solution. Optical rotations were 
determined as solutions irradiating with the sodium D line ( = 589 nm) using an AA series 
Automatic polarimeter. []D values are given in units 10
-1degcm
2g
-1. 
 
5.2  Chapter 2 
General Procedure 1: DIBAL-H Reduction 
 
 
 
 
DIBAL-H (1M solution in Et2O, 2.2 equiv.) was added dropwise to a solution of the ester 
(1.0 equiv.) in Et2O (30 mL) at -78 
oC. The reaction mixture was allowed to stir at -78 
oC 
for 4 h before being allowed to warm to room temperature overnight. The flask was then 
cooled  with  an  ice-bath  and  a  saturated  solution  of  NH4Cl  was  added  to  quench  the 
reaction. The flask was allowed again to warm to room temperature. A white precipitate 
was produced which was filtered through a pad of Celite
® and washed multiple times with 
Et2O.  The  filtrate  was  then  concentrated  in  vacuo  and  purified  using  flash  column 
chromatography.  
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General Procedure 2: One-Pot Swern/Horner-Wadsworth-Emmons 
 
 
 
 
DMSO (2.4 equiv.) was added dropwise to a solution of oxalyl chloride (1.2 equiv.) in 
DCM at -78 
oC. This was allowed to stir for 15 min before the alcohol (1.0 equiv.) was 
added and the solution allowed to stir for another 15 min. Triethylamine (5.0 equiv.) was 
added and the reaction mixture allowed to stir at room temperature for 2 h. Meanwhile, 
LiCl  (2.0  equiv.)  was  added  to  MeCN  and  allowed  to  stir  for  15  min.  Triethyl 
phosphonoacetate (2.0 equiv.) and DBU (2.0 equiv.) were added and the solution allowed 
to stir for 30 min. This phosphonoacetate solution was added to the alcohol solution and 
the reaction allowed to stir overnight. Saturated NaCl solution was added to quench the 
reaction, the solvent was removed and the product extracted with Et2O (3 x 50 mL). The 
extracts were combined, dried (MgSO4) and the solvent removed in vacuo. Purification 
was achieved using flash column chromatography.   
General Procedure 3: Trichloroacetimidate Synthesis 
 
 
 
 
 
The  allylic  alcohol  (1.0  equiv.)  was  dissolved  in  DCM  and  cooled  to  0 
oC. 
Trichloroacetonitrile (1.5 equiv.) was added followed by DBU (1.2 equiv.) and the reaction 
mixture allowed to stir at 0 
oC for 2 h. Flash column chromatography through a plug of 
silica and multiple washings with Et2O yielded a filtrate which was concentrated and taken 
onto the rearrangement step without further purification.  
General Procedure 4: PdCl2(MeCN)2-catalysed rearrangement 
 
 
 
 
 
The  trichloroacetimidate  (1.0  equiv.)  was  dissolved  in  THF  before 
bis(acetonitrile)palladium(II) chloride (0.1 equiv.) was added and the reaction stirred for 24 K. N. Fanning, Chapter 5, Page 124 
 
CO2H
OH
CO2Me
OH
h. Flash chromatography through a plug of silica and multiple washings with Et2O yielded 
a filtrate which was concentrated in vacuo. The product was purified using flash column 
chromatography through silica.  
 (2S)-2-Hydroxy-3-phenylpropanoic acid (237)
131 
 
 
 
 
L-Phenylalanine  (10.0  g,  60.6  mmol)  was  dissolved  in  2.5M  H2SO4  (50  mL)  and  the 
solution was cooled in an ice-bath. A solution of NaNO2 (8.36 g, 121.2 mmol) in water (50 
mL) was added dropwise and the reaction mixture was left to stir at 0 
oC for 3 h, then at 
room temperature for 48 h, followed by extraction with Et2O (3 x 50 mL) and chloroform 
(3 x 50 mL). The combined extracts were washed with a saturated NaCl solution and dried 
(MgSO4). The solvent was removed in vacuo to give beige crystals (6.44 g, 64%), which 
were suspended in petroleum ether and dried by suction filtration. νmax/cm
-1 (neat) 3435 
(OH), 2929 (CH), 1724 (CO), 1455, 1300, 1239, 1189, 1088, 1066, 794, 699; []D
21 -17.5 
(c 1.0, EtOH) (lit.
199 []D
20 -17.8 (c 0.5, MeOH)); H (400 MHz, CD3OD) 2.92 (1H, dd, J 
13.8, 8.0 Hz, 3-HH), 3.13 (1H, dd, J 13.8, 4.4 Hz, 3-HH), 3.33 (1H, s, 2-OH), 4.35 (1H, 
dd, J 8.0, 4.4 Hz, 2-H), 7.27-7.32 (5H, m, Ph); c (100 MHz, CD3OD) 41.6 (CH2), 78.2 
(CH), 127.5 (CH), 129.3 (CH), 130.6 (CH), 138.9 (C), 177.2 (C); m/z (EI) 166.0628 (M
+. 
C9H10O3 requires 166.0630), 148 (19%), 103 (10), 91 (100) and 77 (8). 
Methyl (2S)-2-hydroxy-3-phenylpropanoate (238)
132  
 
 
   
 
A stirred mixture of (2S)-2-hydroxy-3-phenylpropanoic acid (237) (2.69 g, 16.2 mmol), 
MeOH (50 mL), toluene (30 mL) and concentrated HCl (4 mL) were heated under reflux 
for 24 h. The mixture was neutralised with 5% NaHCO3 solution and the solvent removed 
in vacuo. The resulting residue was extracted with EtOAc (3 x 50 mL), washed with water 
(30  mL),  dried  (MgSO4)  and  concentrated  in  vacuo.  Purification  was  carried  out  by 
Kugelrohr distillation to give 238 as a colourless oil (2.32 g, 79%).
 νmax/cm
-1 (neat) 3260 
(OH), 2947 (CH), 2362, 1748 (CO), 1428, 1258, 1173, 1096, 1018 (OH); []D
21
 -5.9 (c 1.0, 
CHCl3) (lit.
200 []D
20 -7.3 (c 1.0, CHCl3)); H (400 MHz, CDCl3) 2.74 (1H, br s, 2-OH), 
3.00 (1H, dd, J 14.0, 6.8 Hz, 3-HH), 3.17 (1H, dd, J 14.0, 4.4 Hz, 3-HH), 3.81 (3H, s, K. N. Fanning, Chapter 5, Page 125 
 
CO2Me
OMOM
OMOM
OH
CO2Me), 4.49 (1H, dd, J 6.8, 4.4 Hz, 2-H), 7.23-7.36 (5H, m, Ph); c (100 MHz, CHCl3) 
40.6 (CH2), 52.5 (CH3), 71.3 (CH), 126.9 (CH), 128.5 (CH), 129.5 (CH), 136.3 (CH), 
174.6 (CH); m/z (EI) 188.0786 (M
+. C10H12O3 requires 188.0786), 162 (34%), 150 (7), 121 
(16) and 91 (100). 
Methyl (2S)-2-methoxymethoxy-3-phenylpropanoate (239) 
 
 
       
 
 
DIPEA (10.6 mL, 61.0 mmol) and methyl (2S)-2-hydroxy-3-phenylpropanoate (238) (5.49 
g, 30.5 mmol) were stirred at 0 
oC for 10 min in DCM (100 mL). MOM-Br (5 mL, 61.0 
mmol) was added dropwise and the solution was heated under reflux overnight. DCM was 
added for dilution and the solution was washed with dilute HCl (20 mL). The organic layer 
was separated, dried (MgSO4) and concentrated in vacuo. The yellow oil was purified by 
flash column chromatography (70% EtOAc/petroleum ether) to give 239 (6.83 g, quant.). 
νmax/cm
-1 (neat) 2952 (CH), 1747 (CO), 1435, 1279, 1205, 1147, 1110, 1017, 916, 699; 
[]D
21
 -56.6 (c 1.0, CHCl3) (lit.
201 []D
 +55.7 (c 0.8, CHCl3)) for opposite enantiomer); H 
(400 MHz, CDCl3) 3.01 (1H, dd, J 14.0, 9.2 Hz, 3-HH), 3.09 (3H, s, OMe), 3.13 (1H, dd, J 
14.0, 4.4 Hz, 3-HH), 3.76 (3H, s, CO2Me), 4.37 (1H, dd, J 9.2, 4.4 Hz, 2-H), 4.54 (1H, d, J 
6.8 Hz, OCHHO), 4.66 (1H, d, J 6.8 Hz, OCHHO), 7.24-7.37 (5H, m, Ph); c (100 MHz, 
CHCl3) 38.2 (CH2), 52.1 (CH3), 55.7 (CH3), 76.3 (CH), 96.0 (CH2), 126.8 (CH), 128.4 
(CH),  129.5  (CH),  137.0  (C),  172.6  (C);  m/z  (CI)  225.1124  (MH
+.  C12H17O4  requires 
225.1127), 193 (100%), 162 (12), 133 (39) and 85 (22). 
(2S)-2-Methoxymethoxy-3-phenylpropan-1-ol (246) 
 
 
 
 
The  reaction  was  carried  out  according  to  General  Procedure  1  using  methyl  (2S)-2-
methoxymethoxy-3-phenylpropanoate  (239)  (2.89  g,  12.9  mmol).  Purification  by  flash 
column chromatography (60% EtOAc/petroleum ether) gave 246 as an oil (1.43 g, 56%). 
νmax/cm
-1 (neat) 3386 (OH), 2930 (CH), 1494, 1454, 1145, 1104, 1028, 913, 699; []D
21 
+20.7 (c 1.0, CHCl3 ); H (400 MHz, CDCl3) 2.79-2.94 (3H, m, 3-H2 and 1-OH), 3.37 (3H, 
s, OMe), 3.53-3.58 (1H, m, 1-HH), 3.65-3.70 (1H, m, 1-HH), 3.82-3.92 (1H, m, 2-H), 4.59 K. N. Fanning, Chapter 5, Page 126 
 
OMOM
CO2Et
OMOM
OH
(1H, d, J 7.2 Hz, OCHHO), 4.70 (1H, d, J 7.2 Hz, OCHHO), 7.24-7.38 (5H, m, Ph); c 
(100 MHz, CHCl3) 38.2 (CH2), 55.6 (CH3), 64.9 (CH2), 82.1 (CH), 96.7 (CH2), 126.4 
(CH), 128.4 (CH), 129.4 (CH), 138.0 (C); m/z (CI) 197.1179 (MH
+. C11H17O3 requires 
197.1178), 165 (76%), 147 (100), 136 (12), 117 (15) and 105 (12). 
Ethyl (2E,4S)-4-methoxymethoxy-5-phenylpent-2-enoate (241) 
 
 
 
 
 
The  reaction  was  carried  out  according  to  General  Procedure  2  using  (2S)-2-
methoxymethoxy-3-phenylpropan-1-ol (246) (3.07 g, 15.7 mmol). Purification using flash 
column chromatography (50% EtOAc/petroleum ether) yielded 241 as a viscous oil (3.35 
g, 81%). νmax/cm
-1 (neat) 2924 (CH), 2087, 1716 (CO), 1267, 1149, 1016, 699; []D
21 -56.6 
(c 1.0, CHCl3); H (400 MHz, CDCl3) 1.32 (3H, t, J 7.2 Hz, OCH2CH3), 2.92 (2H, d, J 6.8 
Hz, 5-H2), 3.08 (3H, s, OMe), 4.23 (2H, q, J 7.2 Hz, OCH2CH3), 4.43-4.49 (2H, m, 4-H 
and OCHHO), 4.61 (1H, d, J 6.8 Hz, OCHHO), 6.01 (1H, dd, J 15.6, 1.2 Hz, 2-H), 6.90 
(1H, dd, J 15.6, 6.0 Hz, 3-H), 7.32-7.41 (5H, m, Ph); c (100 MHz, CHCl3) 14.3 (CH3), 
41.6 (CH2), 55.4 (CH3), 60.6 (CH2), 75.9 (CH), 94.5 (CH2), 122.1 (CH), 126.6 (CH), 128.4 
(CH), 129.6 (CH), 137.4 (C) 147.1 (CH), 166.2 (C); m/z (EI) 264.1363 (M
+. C15H20O4 
requires 264.1362), 203 (2%), 173 (21), 85 (63), 83 (100). 
(2E,4S)-4-Methoxymethoxy-5-phenylpent-2-en-1-ol (242) 
 
 
 
 
The reaction was carried out according the General Procedure 1 using ethyl (2E,4S)-4-
methoxymethoxy-5-phenylpent-2-enoate (1.15 g, 4.4 mmol) (241). Purification using flash 
column chromatography (50% EtOAc/petroleum ether) gave 242 as a colourless oil (0.8 g, 
83%). νmax/cm
-1 (neat) 3370 (OH), 2887 (CH), 1635 (C=C), 1495, 1453, 1092, 1027, 699; 
[]D
21 -86.3 (c 1.0, CHCl3); H  (400 MHz, CDCl3) 1.42 (1H, s, OH), 2.86 (1H, dd, J 13.6, 
5.6 Hz, 5-HH), 2.92 (1H, dd, J 13.6, 8.0 Hz, 5-HH), 3.08 (3H, s, OMe), 4.17 (2H, d, J 5.2 
Hz, 1-H2), 4.28-4.34 (1H, m, 4-H), 4.46 (1H, d, J 6.8 Hz, OCHHO), 4.68 (1H, d, J 6.8 Hz, 
OCHHO), 5.66 (1H, ddt, J 15.4, 7.6, 1.2 Hz, 3-H), 5.83 (1H, dt, J 15.4, 5.2 Hz, 2-H), 7.27-
7.36 (5H, m, Ph); c (100 MHz, CHCl3) 42.3 (CH2), 55.2 (CH3), 62.9 (CH2), 76.8 (CH), K. N. Fanning, Chapter 5, Page 127 
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93.6 (CH2), 126.3 (CH), 128.2 (CH), 129.7 (CH), 130.9 (CH), 132.3 (CH), 138.2 (C); m/z 
(CI) 205 (MH
+ − H2O, 32%), 175 (21), 161 (69), 143 (100) and 129 (8). 
(3R,4S)-3-(Trichloromethylcarbonylamino)-4-methoxymethoxy-5-phenylpent-1-ene 
(247)  
 
 
 
 
Method A 
 
The reaction was carried out according to General Procedures 3 and 4 using (2E,4S)-4-
methoxymethoxy-5-phenylpent-2-en-1-ol  (242)  (1.17  g,  5.3  mmol).  Purification  using 
flash column chromatography (20% EtOAc/petroleum ether) gave 247 as a colourless oil 
(0.7 g, 54%). νmax/cm
-1 (neat) 3273 (NH), 2943 (CH), 2102, 1711 (CO), 1512 (C=C), 1143, 
1026, 820, 699; []D
21 +59.1 (c 1.7, CH2Cl2); H (400 MHz, CDCl3) 2.82 (1H, dd, J 14.0, 
5.2 Hz, 5-HH), 2.93 (1H, dd, J 14.0, 8.8 Hz, 5-HH), 3.39 (3H, s, OMe), 3.86 (1H, ddd, J 
8.4, 4.8, 2.0 Hz, 4-H), 4.36 (1H, d, J 6.8 Hz, OCHHO), 4.45 (1H, br dt, J 7.6 Hz, 3-H), 
4.60 (1H, d, J 6.8 Hz, OCHHO), 5.42 (1H, d, J 7.6 Hz, 1-HH), 5.45 (1H, br s, 1-HH), 5.92-
6.02 (1H, m, 2-H), 7.21-7.36 (5H, m, Ph), 8.19 (1H, d, J 7.6 Hz, NH); c (100 MHz, 
CHCl3) 39.4 (CH2), 55.8 (CH), 56.7 (CH), 84.4 (CH3), 92.9 (CCl3), 98.1 (CH2), 119.7 
(CH2), 126.8 (CH), 128.6 (CH), 129.3 (CH), 131.4 (CH), 137.4 (C), 161.4 (C); m/z (CI) 
366.0431 (MH
+. C15H19O3N
35Cl3 requires 366.0431), 334 (100%), 300 (25), 272 (26), 236 
(19) and 173 (33). 
Method B (with p-benzoquinone) 
The  allylic  trichloroacetimidate  was  prepared  according  to  General  Procedure  3  using 
(2E,4S)-4-methoxymethoxy-5-phenylpent-2-en-1-ol (242) (0.80 g, 2.2 mmol). The allylic 
trichloroacetimidate  was  dissolved  in  THF  (15  mL)  and  bis(acetonitrile)palladium(II) 
chloride (0.05 g, 0.2  mmol) and  p-benzoquinone (0.47 g, 4.4  mmol) were added. The 
reaction  mixture  was  stirred  at  room  temperature  for  24  h.  The  reaction  mixture  was 
concentrated in vacuo followed by flash column chromatography (20% EtOAC/petroleum 
ether) gave 247 as a colourless oil (0.56 g, 70%). Characterisation data is consisitent with 
that shown above.  
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(2R,3S)-2-(Trichloromethylcarbonylamino)-3-methoxymethoxy-4-phenylbutanoic  acid 
(250)
137  
 
 
 
 
 
NaIO4 (0.33 g, 1.7 mmol) was dissolved in water (5 mL) and added to a stirred solution of 
(3R,4S)-3-(trichloromethylcarbonylamino)-4-methoxymethoxy-5-phenylpent-1-ene  (247) 
(0.15 g, 0.4 mmol) in CCl4 (3.7 mL) and MeCN (3.7 mL). Ruthenium trichloride (4.6 mg, 
0.02 mmol) was added and the mixture stirred vigorously for 6 h before a further portion of 
NaIO4 (0.16 g, 0.8 mmol) was added and the solution allowed to stir for 24 h. The solution 
was filtered through a short column of silica to remove ruthenium residues. The acid was 
extracted  with  DCM  (3  x  20  mL),  the  organic  layers  combined,  dried  (MgSO4)  and 
concentrated in vacuo to give 250 (0.1 g, 69%). This was used without further purification.  
(2R,3S)-2-Amino-3-hydroxy-4-phenylbutanoic acid (251) 
 
 
 
 
(2R,3S)-2-(Trichloromethylcarbonylamino)-3-methoxymethoxy-4-phenylbutanoic  acid 
(250) (0.20 g, 0.5 mmol) was dissolved in 6M HCl (13 mL) and heated under reflux for 24 
h. The reaction mixture was extracted with Et2O (2 x 10 mL) and the aqueous layer was 
concentrated in vacuo to give the amino acid 251 as a cream solid (0.09 g, 80%). νmax/cm
-1 
(neat) 3364 (NH and OH), 2489 (CH), 1719 (CO), 1197, 1068, 747, 696; []D
21 +8.6 (c 
1.0, 1M HCl) (lit.
137 []D
 +9.1 (c 1.0, 1M HCl)); H (400 MHz, CDCl3) 2.83 (1H, dd, J 
14.0, 9.2 Hz, 4-HH), 2.93 (1H, dd, J 14.0, 4.8 Hz, 4-HH), 4.03 (1H, d, J 2.8 Hz, 2-H), 
4.19-4.24 (1H, m, 3-H), 7.18-7.32 (5H, m, Ph); c (100 MHz, CHCl3) 38.5 (CH2), 57.0 
(CH), 71.0 (CH), 126.9 (CH), 128.7 (CH), 129.3 (CH), 137.3 (C), 169.6 (C);  m/z (CI) 
196.0974 (MH
+. C10H13O3N requires 196.0974), 167 (16%), 139 (37) and 121 (21). 
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Methyl (2Z,4S)-4-methoxymethoxy-5-phenylpent-2-enoate (252)  
 
 
 
   
 
DMSO (0.9 mL, 12.9 mmol) was added dropwise to a solution of oxalyl chloride (0.6 mL, 
6.4 mmol) in DCM (30 mL) at -78 
oC. This was allowed to stir for 15 min before (2S)-2-
methoxymethoxy-3-phenylpropan-1-ol  (246)  (1.05  g,  5.4  mmol)  was  added  and  the 
solution allowed to stir for another 15 min. NEt3 (3.7 mL, 26.8 mmol) was added and the 
reaction mixture allowed to stir at room temperature for 2 h. After TLC, the reaction was 
quenched with a saturated solution of NaHCO3 (20 mL) and the solvent was removed in 
vacuo  to  give  (2S)-2-methoxymethoxy-3-phenylpropionaldehyde  (1.04  g,  5.4  mmol). 
Methyl (triphenylphosphoranylidene)acetate bromide (4.45 g, 10.7 mmol) was dissolved in 
DCM. NaOH (0.86 g, 21.4 mmol) was dissolved in water and this was added to the DCM 
solution  to  give  methyl  (triphenylphosphoranylidene)acetate.  To  a  solution  of  (2S)-2-
methoxymethoxy-3-phenylpropionaldehyde  (1.04  g,  5.4  mmol)  in  MeOH  (25  mL)  was 
added  methyl  (triphenylphosphoranylidene)acetate  (3.71  g,  11.1  mmol)  at  0 
oC.  This 
mixture was allowed to stir at 0
 oC for 7.5 h before the solvent was evaporated to give a tan 
solid.  Flash column chromatography (30% EtOAc/petroleum ether) gave 252 as an oil 
(0.21 g, 16%). νmax/cm
-1 (neat) 2939 (CH), 1717 (CO), 1436, 1398, 1177, 1097, 1041, 917, 
826, 700; []D
21 -30.8 (c 1.0, CHCl3); H (400 MHz, CDCl3) 2.85 (1H, dd, J 13.6, 8.8 Hz, 
5-HH), 2.97 (1H, dd, J 13.6, 3.6 Hz, 5-HH), 3.05 (3H, s, OMe), 3.76 (3H, s, CO2Me), 4.44 
(1H, d, J 6.6 Hz, OCHHO), 4.58 (1H, d, J 6.6 Hz, OCHHO), 5.43-5.49 (1H, m, 4-H), 5.91 
(1H, d, J 11.6 Hz, 2-H), 6.26 (1H, dd, J 11.6, 8.0 Hz, 3-H), 7.26-7.39 (5H, m, Ph); c (100 
MHz, CHCl3) 41.3 (CH2), 51.5 (CH3), 55.2 (CH3), 74.2 (CH), 95.2 (CH2), 120.3 (CH), 
126.3 (CH), 128.2 (CH), 129.7 (CH), 138.1 (C), 150.8 (CH), 166.1 (C); m/z (EI) 189 (M
+ − 
OCH2OCH3, 26%), 173 (35), 130 (62) and 61 (100).  
(2Z,4S)-4-Methoxymethoxy-5-phenylpent-2-en-1-ol (253)  
 
 
 
 
 
The reaction was carried out according to General Procedure 1 using methyl (2Z,4S)-4-
methoxymethoxy-5-phenylpent-2-enoate (252) (0.15 g, 0.6 mmol). The colourless oil 253 K. N. Fanning, Chapter 5, Page 130 
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(0.11 g, 79%) was characterised without further purification. νmax/cm
-1 (neat) 3372 (OH), 
2925 (CH), 2110, 1495, 1454, 1145, 1094, 1023, 917, 698; []D
21 -88.0 (c 1.0, CHCl3); H 
(400 MHz, CDCl3) 1.48 (1H, s, 1-OH), 2.59 (1H, dd, J 13.6, 7.0 Hz, 5-HH), 2.83 (1H, dd, 
J 13.6, 6.6 Hz, 5-HH), 3.07 (3H, s, OMe), 3.59-3.66 (1H, m, 1-HH), 3.87-3.93 (1H, m, 1-
HH), 4.35 (1H, d, J 6.8 Hz, OCHHO), 4.44-4.49 (1H, m, 4-H), 4.54 (1H, d, J 6.8 Hz, 
OCHHO), 5.25-5.31 (1H, m, 2-H), 5.58-5.95 (1H, m, 3-H); c (100 MHz, CHCl3) 42.0 
(CH2), 55.2 (CH3), 58.2 (CH2), 72.1 (CH), 93.6 (CH2), 126.5 (CH), 128.3 (CH), 129.7 
(CH), 131.6 (CH), 132.4 (CH), 137.8 (C); m/z (EI) 161.0965 (M
+ – OCH2OCH3 requires 
161.0966), 205 (20%), 161 (22), 143 (46), 91 (100), 69 (59) and 45 (69). 
(2Z,4S)-1-(Trichloromethylcarbonylamino)-4-methoxymethoxy-5-phenylpent-2-ene 
(255) 
 
 
 
The reaction was carried out according to General Procedures 3 and 4 using (2Z,4S)-4-
methoxymethoxy-5-phenylpent-2-en-1-ol (253) (0.09 g, 0.4 mmol). The reaction mixture 
was allowed to stir for 17 days. Flash column chromatography was performed to give 255 
as an oil (0.04 g, 19%). νmax/cm
-1 (neat) 2924 (CH), 2154, 1727 (CO), 1495, 1454, 1253, 
1145, 1095, 1022, 915, 778, 745, 699; []D
21 -57.9 (c 1.0, CHCl3); H (400 MHz, CDCl3) 
2.72 (1H, dd, J 13.4, 6.0 Hz, 5-HH), 2.88 (1H, dd, J 13.4, 7.4 Hz, 5-HH), 3.05 (3H, s, 
OMe), 3.75-3.38 (1H, m 1-HH), 3.84-3.89 (1H, m 1-HH), 4.39 (1H, d, J 6.8 Hz, OCHHO), 
4.49-4.56 (1H, m, 4-H), 4.55 (1H, d, J 6.8 Hz, OCHHO), 5.41-5.46 (1H, m, 3-H), 5.68-
5.77 (1H, m, 2-H), 7.11-7.24 (5H, m, Ph); c (100 MHz, CHCl3) 39.0 (CH2), 41.9 (CH2), 
55.3 (CH3), 71.5 (CH), 93.7 (CH2), 126.5 (CH), 128.3 (CH), 128.8 (CH), 129.7 (CH), 
133.6 (CH), 135.6 (C); m/z (CI) 306 (MH
+ - OCH3OCH2, 1%), 214 (11), 173 (27), 143 
(43), 91 (26) and 81 (85). 
Methyl (2S)-2-(tert-butyldimethylsilyloxy)-3-phenylpropanoate (257)  
 
 
Methyl  (2S)-2-hydroxy-3-phenylpropanoate  (238)  (2.0  g,  11.1  mmol)  was  dissolved  in 
THF (40 mL). TBDMS-Cl (2.0 g, 13.3 mmol) and imidazole (1.89 g, 27.8 mmol) were K. N. Fanning, Chapter 5, Page 131 
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added and the reaction mixture allowed to stir for 24 h. The reaction mixture was filtered 
and  the  solid  formed  was  washed  with  Et2O.  The  solvent  was  removed  in  vacuo  and 
purification by flash column chromatography (10% Et2O /petroleum ether) yielded 257 as 
a pale yellow oil (2.88 g, 88%). νmax/cm
-1 (neat) 3360, 2928 (CH), 2855, 2156, 1756 (CO), 
1436, 1251, 1120, 1022, 942, 830, 778, 696; []D
21 -27.8 (c 1.0, CHCl3); H (400 MHz, 
CDCl3) 0.01 (3H, s, SiCH3CH3), 0.08 (3H, s, SiCH3CH3), 1.01 (9H, s, Si
tBu), 3.10 (1H, dd, 
J 13.4, 9.2 Hz, 3-HH), 3.30 (1H, dd, J 13.4, 3.8 Hz, 3-HH), 3.95 (3H, s, CO2Me), 4.56 (1H, 
dd, J 9.2, 3.8 Hz, 2-H), 7.40-7.57 (5H, m, Ph); c (100 MHz, CHCl3) -5.5 (CH3), -5.4 
(CH3), 18.4 (C), 26.0 (CH3), 41.8 (CH2), 52.1 (CH3), 74.0 (CH), 126.8 (CH), 128.4 (CH), 
130.0  (CH),  137.6  (C),  173.8  (CH);  m/z  (CI)  295.1727  (MH
+.  C16H26O3Si  requires 
295.1729), 279 (5%), 327 (10) and 163 (4). 
(2S)-2-(tert-Butyldimethylsilyloxy)-3-phenylpropan-1-ol (258) 
 
 
 
The reaction was carried out according to General Procedure 1 using methyl (2S)-2-(tert-
butyldimethylsilyloxy)-3-phenylpropanoate (257)  (3.57  g,  12.1  mmol).  Purification  was 
achieved by flash column chromatography (50% EtOAc/petroleum ether) to give 258 as a 
colourless oil (2.39 g, 74%). νmax/cm
-1 (neat) 3390 (OH), 2857 (CH), 2162, 2092, 1254, 
1033,  835,  774,  697;  []D
21  -15.3  (c  1.2,  CHCl3);  H  (400  MHz,  CDCl3)  0.01  (3H,  s, 
SiCH3CH3), 0.08 (3H, s, SiCH3CH3), 1.01 (9H, s, Si
tBu), 2.04-2.07 (1H, br s, 1-OH), 2.78 
(1H, dd, J 13.6, 3.2 Hz, 3-HH), 2.81 (1H, dd, J 13.6, 3.6 Hz, 3-HH), 3.45 (1H, dd, J 11.2, 
4.4 Hz, 1-HH), 3.53 (1H, dd, J 11.2, 3.6 Hz, 1-HH), 3.88-3.94 (1H, m, 2-H), 7.31-7.47 
(5H, m, Ph); c (100 MHz, CHCl3) -4.8 (CH3), -4.7 (CH3), 18.2 (C), 26.0 (CH3), 40.7 
(CH2), 65.8 (CH2), 74.3 (CH), 126.5 (CH), 128.5 (CH), 129.8 (CH), 138.5 (C); m/z (CI) 
367.1782 (MH
+. C15H26O2Si requires 267.1780), 249 (10%), 135 (31) and 117 (23). 
Ethyl (2E,4S)-4-(tert-butyldimethylsilyloxy)-5-phenylpent-2-enoate (260) 
 
 
 
The  reaction  was  carried  out  according  to  General  Procedure  2  using  (2S)-2-(tert-
butyldimethylsilyloxy)-3-phenylpropan-1-ol (258) (1.23 g, 4.6 mmol). Purification by flash K. N. Fanning, Chapter 5, Page 132 
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column chromatography (40% EtOAc/petroleum ether) gave 260 as a colourless oil (1.40 
g, 91%). νmax/cm
-1 (neat) 2929 (CH), 2857, 1721 (CO), 1659, 1471, 1366, 1258, 1115; 
[]D
21 -2.3 (c 1.1, CHCl3); H (400 MHz, CDCl3) -0.25 (3H, s, SiCH3CH3), -0.08 (3H, s, 
SiCH3CH3), 0.86 (9H, s, Si
tBu), 1.30 (3H, t, J 7.4 Hz, OCH2CH3), 2.85 (2H, dd, J 13.4, 7.8 
Hz, 5-HH), 2.93 (1H, dd, J 13.4, 5.6 Hz, 5-HH), 4.25-4.33 (2H, m, OCH2CH3), 4.50-4.55 
(1H, m, 4-H), 6.07 (1H, d, J 15.4 Hz, 2-H), 7.02 (1H, dd, J 15.4, 4.4 Hz, 3-H), 7.26-7.45 
(5H, m, Ph); c (100 MHz, CHCl3) -5.3 (CH3), -4.7 (CH3), 14.4 (CH3), 18.3 (C), 26.0 
(CH3), 44.5 (CH2), 60.5 (CH2), 73.3 (CH), 120.2 (CH), 126.7 (CH), 128.4 (CH), 130.1 
(CH), 137.9 (C), 150.5 (CH), 166.9 (CH); m/z (CI) 335.2041 (MH
+. C19H30O3Si requires 
335.2042), 277 (6%), 203 (20) and 133 (11). 
(2E,4S)-4-(tert-Butyldimethylsilyloxy)-5-phenylpent-2-en-1-ol (261) 
 
 
 
 
This reaction was carried out according to General Procedure 1 using methyl (2E,4S)-4-
(tert-butyldimethylsilyloxy)-5-phenylpent-2-enoate (260) (2.05 g, 6.2 mmol). Purification 
by flash column chromatography (50% EtOAc/petroleum ether) gave 261 as a colourless 
oil (1.68 g, 94%). νmax/cm
-1 (NaCl) 3336 (OH), 3028, 2928 (CH), 1603, 1471, 1361, 1254, 
1092, 941; []D
21 -1.8 (c 0.6, CHCl3); H (400 MHz, CDCl3) -0.13 (3H, s, SiCH3CH3), 0.00 
(3H, s, SiCH3CH3), 0.94 (9H, s, Si
tBu), 1.35 (1H, t, J 6.8 Hz, 1-OH), 2.86 (2H, d, J 6.8 Hz, 
5-H2), 4.21-4.23 (2H, m, 1-H2), 4.38-4.42 (1H, m, 4-H), 5.84-5.87 (2H, m, 2-H and 3-H), 
7.27-7.39 (5H, m, Ph); c (100 MHz, CHCl3) -5.3 (CH3), -4.7 (CH3), 18.2 (C), 25.9 (CH3), 
45.2 (CH2), 63.2 (CH2), 74.0 (CH), 126.2 (CH), 128.1 (CH), 128.6 (CH), 129.9 (CH), 
134.7 (CH), 138.6 (C); m/z (CI) 275.1828 (MH
+ - OH, C17H27OSi requires 275.1831), 293 
(4%), 235 (6), 201 (8), 161 (11) and 143 (26). 
(3R,4S)-3-(Trichloromethylcarbonylamino)-4-hydroxy-5-phenylpent-1-ene (264) 
 
 
 
 
The  allylic  trichloroacetimidate  was  prepared  according  to  General  Procedure  3  using 
(2E,4S)-4-(tert-butyldimethylsilyloxy)-5-phenylpent-2-en-1-ol  (261)  (0.20  g,  0.7  mmol). 
To  remove  the  TBDMS-group  before  the  rearrangement,  (2E,4S)-4-(tert-K. N. Fanning, Chapter 5, Page 133 
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butyldimethylsilyloxy)-5-phenyl-2-pentene-1-yl  trichloroethanimidate  (262)  (0.31  g,  0.7 
mmol) was dissolved in THF (10 mL) and cooled to 0 
oC. TBAF (0.3 mL, 1.1 mmol) was 
slowly added and the solution returned to room temperature and allowed to stir for 2 h. The 
reaction was monitored by TLC every 30 min. After 2 h, TBAF (0.1 mL, 0.4 mmol) was 
added and the reaction left to stir for 24 h. The solvent was removed in vacuo and the 
residue was dissolved in EtOAc. This was washed with water and then the aqueous layers 
were extracted with EtOAc. The organic layers were combined, dried (MgSO4) and the 
solvent removed in vacuo. The crude precursor was passed through a short silica plug 
(15% EtOAc/petroleum ether) to give 263 which was taken to the rearrangement without 
further purification. The rearrangement was carried out according to General Procedure 4 
using  (2E,4S)-1-(trichloromethylcarbonylamino)-4-hydroxy-5-phenylpenta-2-ene  (263). 
The  reaction  was  allowed  to  stir  for  48  h.  Flash  chromatography  through  silica  (15% 
Et2O/petroleum ether) gave 264 as an oil (0.04 g, 12%). νmax/cm
-1 (neat) 3315 (OH), 2922 
(CH), 1685 (CO), 1495, 1227, 1051 (OH), 925, 817, 740; []D
29 +15.9 (c 0.7, CHCl3); H 
(400 MHz, CDCl3) 1.85 (1H, s, OH), 2.66 (1H, dd, J 13.6, 9.4 Hz, 5-HH), 2.77 (1H, dd, J 
13.6, 4.0 Hz, 5-HH), 3.96-3.97 (1H, m, 4-H), 4.37-4.42 (1H, m, 3-H), 5.32-5.37 (2H, m, 1-
H2), 5.87-5.96 (1H, m, 2-H), 7.13-7.28 (5H, m, Ph); c (100 MHz, CHCl3) 40.6 (CH2), 57.4 
(CH), 73.7 (CH), 120.1 (CH2), 127.1 (CH), 128.9 (CH), 129.4 (CH), 131.1 (CH), 137.0 
(C),  161.2  (C);  m/z  (CI)  324.0137  (MH
+.  C13H15O2N
35Cl2
37Cl  requires  324.0140),  304 
(50%), 201 (77), 166 (91), 143 (60) and 91 (67). 
(2E,4S)-4-(tert-Butyldimethylsilyloxy)-5-phenyl-1-methoxymethoxypent-2-ene (267)  
 
 
 
 
(2E,4S)-4-(tert-Butyldimethylsilyloxy)-5-phenylpent-2-en-1-ol (261) (3.88 g, 13.3 mmol) 
was dissolved in DCM (70 mL) and cooled to 0 
oC. DIPEA (4.6 mL, 26.5 mmol) was 
added and the mixture stirred at 0 
oC for 15 mins. MOM-Br (2.2 mL, 26.5 mmol) was 
added dropwise and the reaction heated under reflux for 24 h. DCM (25 mL) and HCl (25 
mL) were added. Following extraction with Et2O (3 x 50 mL), removal of solvent in vacuo 
and purification by flash column chromatography (10% EtOAc/petroleum ether) gave 267 
as a pale yellow oil (4.08 g, 91%). νmax/cm
-1 (neat) 2927 (CH), 1471, 1361, 1254, 1041, 
833, 775, 698; []D
25 +0.7 (c 1.0, CHCl3); H (400 MHz, CDCl3) -0.13 (3H, s, SiCH3CH3), 
0.00 (3H, s, SiCH3CH3), 1.66 (9H, s, Si
tBu), 2.86 (2H, d, J 6.4 Hz, 5-H2), 3.46 (3H, s, 
OMe), 4.14 (2H, d, J 5.2 Hz, 1-H2), 4.37-4.42 (1H, m, 4-H), 4.71 (2H, s, OCH2O), 5.78 K. N. Fanning, Chapter 5, Page 134 
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(1H, dt, J 15.2, 5.2 Hz, 2-H), 5.87 (1H, dd, J 15.2, 5.2 Hz, 3-H), 7.26-7.38 (5H, m, Ph); c 
(100 MHz, CHCl3) -5.3 (CH3), -4.7 (CH3), 18.2 (C), 25.8 (CH3) 45.2 (CH2), 55.2 (CH3), 
67.2 (CH2), 74.1 (CH), 95.3 (CH2), 125.7 (CH), 126.1 (CH), 128.0 (CH), 129.9 (CH), 
136.2 (CH), 138.6 (C); m/z (CI) 275.1832 (MH
+ - OCH2OCH3 requires 275.1831), 245 
(66%), 213 (92), 143 (75), 89 (73) and 73 (100). 
(2E,4S)-4-Hydroxy-5-phenyl-1-methoxymethoxypent-2-ene (268) 
 
 
 
(2E,4S)-4-(tert-Butyldimethylsilyloxy)-5-phenyl-1-methoxymethoxypent-2-ene  (267)  (0.1 
g, 0.3 mmol) was dissolved in THF (3 mL) and cooled to 0 
oC. TBAF (0.6 mL, 0.6 mmol) 
was slowly added, the solution allowed to return to room temperature and stirred for 24 h. 
The solvent was removed in vacuo and the residue was dissolved in EtOAc. This was 
washed with water and then extracted with EtOAc (3 x 15 mL). The organic layers were 
combined,  dried  (MgSO4)  and  the  solvent  removed.  Following  flash  column 
chromatography to purify (25% EtOAc/petroleum ether), 268 was obtained as a colourless 
oil (0.07 g, quant.). νmax/cm
-1 (neat) 3392 (OH), 2882 (CH), 1494, 1455, 1147, 1104, 1028, 
970, 918, 747, 700; []D
25 +7.6 (c 1.0, CHCl3); H (400 MHz, CDCl3) 1.78 (1H, s, OH), 
2.89 (1H, dd, J 13.6, 8.0 Hz, 5-HH), 2.98 (1H, dd, J 13.6, 4.8 Hz, 5-HH), 3.47 (3H, s, 
OMe), 4.17 (2H, d, J 1.2 Hz, 1-H2), 4.46-4.52 (1H, m, 4-H), 4.72 (2H, s, OCH2O), 5.90-
5.94 (2H, m, 2-H and 3-H), 7.31-7.44 (5H, m, Ph); c (100 MHz, CHCl3) 43.9 (CH2), 55.3 
(CH3), 67.1 (CH2), 72.8 (CH), 95.6 (CH2), 126.6 (CH), 127.0 (CH), 128.6 (CH), 129.5 
(CH),  135.0  (C),  137.7  (CH);  m/z  (CI)  205.1227  (MH
+-  OH  requires  205.1229),  173 
(100%), 161 (35), 143 (52) and 129 (42). 
(2E,4S)-4-Acetyl-5-phenyl-1-methoxymethoxypent-2-ene (269)  
 
 
 
 
 
 
(2E,4S)-4-Hydroxy-5-phenyl-1-methoxymethoxypent-2-ene (268) (0.1 g, 0.5 mmol) was 
dissolved in DCM (5 mL) and stirred at 20 
oC. Acetic anhydride (0.1 mL, 0.7 mmol) was 
added dropwise followed by DIPEA (0.2 mL, 1.4 mmol) and the reaction allowed to stir K. N. Fanning, Chapter 5, Page 135 
 
O
OH
O
for 24 h. The solvent was removed in vacuo and the product purified by flash column 
chromatography (25% EtOAc/petroleum ether) to give 269 as a colourless oil (0.1 g, 89%). 
νmax/cm
-1  (neat)
  3050,  1780  (CO),  1585,  1481,  1419,  1103,  891;
  []D
24  +10.2  (c  0.9, 
CHCl3); H (400 MHz, CDCl3) 2.03 (3H, s, COCH3), 2.91 (1H, dd, J 13.6, 6.0 Hz, 5-HH), 
2.99 (1H, dd, J 13.6, 7.2 Hz, 5-HH), 3.36 (3H, s, OMe), 4.04 (2H, d, J 3.6 Hz, 1-H2), 4.62 
(2H, s, OCH2O), 5.49-5.53 (1H, m, 4-H), 5.75-5.77 (2H, m, 2-H and 3-H), 7.21-7.33 (5H, 
m, Ph); c (100 MHz, CHCl3) 21.2 (CH3), 41.0 (CH2), 55.3 (CH3), 66.8 (CH2), 74.3 (CH), 
95.6 (CH2), 126.6 (CH), 128.3 (CH), 129.2 (CH), 129.5 (CH), 130.3 (CH), 136.9 (C), 
170.1 (C); m/z (CI) 205.1228 (MH
+- OAc requires 205.1229), 173 (100%), 143 (22) and 
129 (33). 
(2E,4S)-4-Acetyl-5-phenylpent-2-en-1-ol (270) 
 
 
 
 
 
(2E,4S)-4-Acetyl-5-phenyl-1-methoxymethoxypent-2-ene  (269)  (0.21  g,  0.8  mmol)  was 
dissolved  in  DCM  (20  mL).  TFA  (0.09  mL,  1.2  mmol)  was  added  dropwise  and  the 
mixture heated under reflux for 24 h. The solvent was removed in vacuo and the residue 
was dissolved in Et2O and washed with a saturated solution of NaHCO3. This was then 
dried  (MgSO4)  and  the  solvent  removed  in  vacuo.  Purification  was  achieved  by  flash 
column chromatography (15% Et2O/petroleum ether) to give 270 (0.11 g, 61%). νmax/cm
-1 
(neat) 3028 (OH), 2157 (CH), 1738 (CO), 1346, 1220, 1141, 1023, 968, 699; []D
26 +0.6 (c 
0.5, CHCl3); H (400 MHz, CDCl3) 1.96 (3H, s, COCH3), 2.79 (1H, dd, J 13.6, 6.4 Hz, 5-
HH), 2.91 (1H, dd, J 13.6, 7.2 Hz, 5-HH), 4.69 (2H, d, J 5.6 Hz, 1-H2), 5.41 (1H, ddd, J 
7.2, 6.4, 6.2 Hz, 4-H), 5.65 (1H, dt, J 15.6, 5.6 Hz, 2-H), 5.77 (1H, dd, 15.6, 6.4 Hz, 3-H), 
7.06-7.28 (5H, m, Ph); c (100 MHz, CHCl3) 21.1 (CH3), 40.7 (CH2), 67.2 (CH2), 73.6 
(CH), 123.8 (CH), 126.8 (CH), 128.4 (CH), 129.5 (CH), 134.6 (CH), 136.2 (C), 169.8 (C); 
m/z (CI) 203.1070 (MH
+ - OH requires 203.1072) and 143 (100%). 
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 (3E)-1-(Trichloromethylcarbonylamino)-2-hydroxy-5-phenylpent-3-ene (272) 
 
 
 
 
The reaction was carried out according to General Procedures 3 and 4 using (2E,4S)-4-
acetate-5-phenyl-2-pentene-1-ol (270) (0.08 g, 0.4  mmol). Purification by  flash column 
chromatography (10% EtOAc/petroleum ether)  yielded  272 as a colourless oil (0.02 g, 
17% yield over 2 steps). νmax /cm
-1 (neat) 3407 (OH and NH), 2926 (CH), 2854, 2253, 
1714 (CO), 1597 (C=C); []D
18 + 0.9 (c 0.9, CHCl3); H (400 MHz, CDCl3) 1.58 (1H, br s, 
OH), 3.36 (2H, d, J 6.8 Hz, 5-H2), 3.70 (1H, dd, J 11.0, 4.2 Hz, 1-HH), 3.75 (1H, dd, J 
11.0, 3.4 Hz, 1-HH), 4.44-4.49 (1H, m, 2-H), 5.47 (1H, dd, J 15.2, 6.2 Hz, 3-H), 5.88 (1H, 
dt, J 15.2, 6.8 Hz 4-H), 7.01 (1H, s, NH), 7.14-7.25 (5H, m, Ph); c (100 MHz, CHCl3) 
38.6 (CH2), 54.4 (CH), 64.3 (CH2), 92.9 (C), 126.4 (CH), 128.6 (CH), 128.7 (CH), 133.46 
(CH), 139.3 (C), 161.7 (C); m/z (CI) 322.0172 (MH
+. C13H15O2N
35Cl3 requires 322.0168), 
288 (30%), and 162 (31). 
Methyl (2S)-2-(tert-butoxycarbonylamino)-3-phenylpropanoate (281)
131 
 
  
 
 
(2S)-2-(tert-Butoxycarbonylamino)-3-phenylpropionic  acid  (7.38  g,  27.8  mmol)  was 
dissolved in acetone (150 mL). K2CO3 (7.69 g, 55.7 mmol) was added and the reaction 
allowed to stir at room temperature for 1 h. MeI (4.2 mL, 66.8 mmol) was added and the 
reaction heated under reflux for 24 h. The mixture was filtered and the solvent removed in 
vacuo. The residue was acidified with 2M HCl (40 mL) and extracted using EtOAc (3 x 50 
mL).  The  organic  layers  were  combined,  dried  (MgSO4)  and  concentrated  in  vacuo. 
Purification by flash column chromatography (25% EtOAc/petroleum ether) gave 281 as a 
white solid (6.51 g, 84%). νmax/cm
-1 (NaCl) 3182 (NH), 1774 (CO), 1628, 1412, 1319, 
1111, 964; []D
18 +52.8 (c 1.4, CHCl3) (lit.
173 []D
27 -51.4 (c 1.7, CHCl3)  for opposite 
enantiomer); H (400 MHz, CDCl3) 1.44 (9H, s, 
tBu), 3.07 (1H, dd, J 14.0, 6.2 Hz, 3-HH), 
3.13 (1H, dd, J 14.0, 5.8 Hz, 3-HH), 3.73 (3H, s, OMe), 4.61 (1H, dd, J 6.2, 5.8 Hz, 2-H), 
4.97 (1H, s, NH), 7.14-7.34 (5H, m, Ph); c (100 MHz, CHCl3) 28.3 (CH3), 38.4 (CH2), 
52.2 (CH3), 54.4 (CH), 80.0 (C), 127.0 (CH), 128.6 (CH), 129.3 (CH), 136.0 (C), 155.1 K. N. Fanning, Chapter 5, Page 137 
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(C), 172.4 (C); m/z (EI) 279.1472 (M
+. C15H21O4N requires 279.1471), 179 (9%), 162 
(100), 120 (27) and 91 (50). 
(2S)-2-(tert-Butoxycarbonylamino)-3-phenylpropan-1-ol (282) 
 
 
 
 
The reaction was carried out according to General Procedure 1 using methyl (2S)-2-(tert-
butoxycarbonylamino)-3-phenylpropanoate  (281)  (6.40  g,  22.9  mmol).  Purification  by 
flash column chromatography (30% EtOAc/petroleum ether) gave 282 as a colourless oil 
(5.76 g, 100%). νmax/cm
-1 (neat) 3351 (OH), 2976 (CH), 1684 (CO), 1525, 1365, 1165, 
1004, 699; []D
20 -19.4 (c 0.8, CHCl3) (lit.
202 []D
26 -19.5 (c 1.0, CHCl3)); H (400 MHz, 
CDCl3) 1.44 (9H, s, 
tBu), 2.23 (1H, s, OH), 2.86 (2H, d, J 7.2 Hz, 3-H2), 3.58 (1H, dd, J 
11.0, 5.4 Hz, 1-HH), 3.69 (1H, dd, J 11.0, 3.6 Hz, 1-HH), 3.85-3.93 (1H, m, 2-H), 4.79 
(1H, s, NH), 7.26-7.36 (5H, m, Ph); c (100 MHz, CHCl3) 28.4 (CH3), 37.4 (CH2), 53.7 
(CH), 64.1 (CH2), 79.7 (C), 126.5 (CH), 128.5 (CH), 129.4 (CH), 137.9 (C), 156.2 (C), m/z 
(EI) 251.1521 (M
+. C14H21O3N requires 251.1519), 220 (61%), 134 (40), 120 (100) and 91 
(98). 
Ethyl (2E,4S)-4-(tert-butoxycarbonylamino)-5-phenylpent-2-enoate (284) 
 
 
 
 
The  reaction  was  carried  out  according  the  General  Procedure  2  using  (2S)-2-(tert-
butoxycarbonylamino)-3-phenylpropan-1-ol (282) (5.94 g, 23.7 mmol). Purification was 
achieved using flash column chromatography (40% EtOAc/petroleum ether) to yield 284 
as a pale yellow oil (5.54 g, 70%). νmax/cm
-1 (neat) 3357 (NH), 2977 (CH), 1694 (CO), 
1495 (C=C), 1365, 1246, 1158, 1030, 698; []D
20 +20.5 (c 0.8, CHCl3); H (400 MHz, 
CDCl3) 1.42 (9H, s, 
tBu), 1.59 (3H, t, J 7.2 Hz, OCH2CH3), 2.91-2.96 (2H, m, 5-H2), 4.20 
(2H, q, J 7.2 Hz, OCH2CH3), 4.46-4.56 (1H, m, 4-H), 4.63 (1H, br s, NH), 5.88 (1H, d, J 
15.6 Hz, 2-H), 6.93 (1H, dd, J 15.6, 5.2 Hz, 3-H), 7.18-7.39 (5H, m, Ph); c (100 MHz, 
CHCl3) 14.2 (CH3), 20.1 (CH), 28.3 (CH3), 40.1 (CH2), 60.5 (CH2), 121.1 (CH), 126.9 
(CH), 128.6 (CH), 129.4 (CH), 136.4 (C), 147.6 (CH), 154.9 (C), 166.2 (C);  m/z (CI) 
320.1860 (MH
+. C18H25O4N requires 320.1862), 264 (100%), 220 (41) and 174 (11). 
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(2E,4S)-4-(tert-Butoxycarbonylamino)-5-phenylpent-2-en-1-ol
 (285) 
 
 
 
 
Ethyl  (2E,4S)-4-(tert-butoxycarbonylamino)-5-phenylpent-2-enoate  (284)  (0.12  g,  0.3 
mmol)  was  dissolved  in  DCM  (4  mL)  and  was  stirred  for  10  min  at  -78 
oC.  Boron 
trifluoride diethyl etherate (0.05 mL, 0.4 mmol) was added and the reaction was allowed to 
stir for 30 min at -78 
oC. DIBAL-H (0.9 mL, 0.9 mmol) was added and the reaction was 
allowed to stir at -78 
oC for 45 min. The reaction was quenched with a 5M DCM solution 
of acetic acid (0.6 mL) and allowed to warm to room temperature. The mixture was poured 
into 10% aqueous tartaric acid before being extracted with DCM (3 x 10 mL). The organic 
layers were combined, washed with a  saturated NaHCO3 solution and then a  saturated 
NaCl solution, dried (MgSO4) and concentrated in vacuo. Purification by flash column 
chromatography (30% EtOAc/petroleum ether)  yielded  285 as a colourless oil (0.04 g, 
43%). νmax/cm
-1 (neat) 3318 (NH and OH), 2976 (CH), 1684 (CO), 1496 (C=C), 1365, 
1247, 1163, 1012, 699; []D
20 -3.5 (c 0.9, CHCl3) (lit.
203 []D
29 -4.8 (c 1.0, MeOH)); H 
(400 MHz, CDCl3) 1.41 (9H, s, 
tBu), 2.84 (2H, d, J 6.4 Hz, 5-H2), 4.11 (2H, d, J 3.6 Hz, 1-
H2), 4.44 (1H, s, OH), 4.58-4.63 (1H, m, 4-H), 5.67 (1H, dd, J 15.4, 4.4 Hz, 3-H), 5.73 
(1H, dt, J 15.4, 3.6 Hz, 2-H), 7.18-7.32 (5H, m, Ph); c (100 MHz, CHCl3) 28.4 (CH3), 
41.9 (CH2), 63.0 (CH2), 126.5 (CH), 128.4 (CH), 129.5 (CH), 129.7 (CH), 131.6 (CH), 
137.4  (C),  155.2  (C);  m/z  (FAB)  278.1740  (MH
+.  C16H23O3N  requires  278.1756),  222 
(42%), 204 (100), 186 (36) and 131 (37). 
(3R,4S)-3-(Trichloromethylcarbonylamino)-4-(tert-butoxycarbonylamino)-5-
phenylpent-1-ene (278) 
 
 
 
The reaction was carried out according to General Procedures 3 and 4 using (2E,4S)-4-
(tert-butoxycarbonylamino)-5-phenylpent-2-en-1-ol
  (285)  (0.06  g,  0.2  mmol).  Flash 
chromatography through silica (15% Et2O/petroleum ether) gave 278 as a pale yellow oil 
(0.03 g, 30%). νmax/cm
-1 (neat) 3345 (NH), 2929 (CH), 1683 (CO), 1529, 1442, 1170, 832; 
[]D
20 +17.3 (c 0.55, CHCl3); H (400 MHz, CDCl3) 1.33 (9H, s, 
tBu), 2.68 (1H, dd, J 14.2, 
7.6 Hz, 5-HH), 2.80 (1H, dd, J 14.2, 7.6 Hz, 5-HH), 4.15 (1H, dd, J 14.0, 6.6 Hz, 3-H), K. N. Fanning, Chapter 5, Page 139 
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4.26-4.29 (1H, m, 4-H), 4.46 (1H, s, 3-NH), 5.28-5.36 (1H, m, 1-H2), 5.68-5.77 (1H, m, 2-
H), 7.12-7.28 (5H, m, Ph), 8.52 (1H, d, J 6.6 Hz, 4-NH); c (100 MHz, CHCl3) 8.5 (CH), 
28.2 (CH3), 38.4 (CH2), 54.4 (CH), 57.8 (CH), 80.8 (C), 92.8 (C), 119.9 (CH2), 127.2 
(CH),  128.6  (CH),  136.3  (C),  157.1  (C),  161.5  (C);  m/z  (CI)  423.0825  (MH
+. 
C18H24O3N2
35Cl2
37Cl requires 423.0822), 367 (100%), 323 (75), 287 (30) and 164 (60). 
5.3  Chapter 3 
2-(N-Benzyloxycarbonyloxazolidin-5-on-4-yl)ethanoic acid (321)
204 
 
 
 
 
                   
N-Benzyloxycarbonyl-L-aspartic acid (10.0 g, 37.5 mmol) was dissolved in benzene (125 
mL). Paraformaldehyde (22.5 g, 0.8 mmol) was added along with a catalytic amount of p-
TsOH (0.36 g, 1.9 mmol). The reaction was heated under reflux for 6 h using a Dean-Stark 
apparatus  to  remove  water.  The  reaction  was  cooled  and  concentrated  in  vacuo.  The 
resulting residue was dissolved in EtOAc, washed twice with both water and a saturated 
solution of NaHCO3 and the basic layer acidified to pH 2 using 6M HCl. This was then 
extracted with EtOAc, dried (MgSO4) and concentrated to give 321 as a white solid (9.1 g, 
87%). This was taken to the next step without further purification. νmax/cm
-1 (NaCl) 3255 
(OH), 2924 (CH), 1717 (CO), 1419, 1176, 751; [α]D
25 +96.2 (c 0.5, CHCl3); H (400 MHz, 
CDCl3) 3.09-3.13 (2H, m, 2-H2), 3.38-3.45 (1H, m, 2-CH2CH), 4.39 (1H, s, OH), 5.22 (2H, 
s, CH2Ph), 5.31-5.37 (1H, m, NCHHO), 5.52-5.62 (1H, m, NCHHO), 7.38-7.43 (10H, m, 2 
x Ph); c (100 MHz, CDCl3) 34.0 (CH2), 51.4 (CH), 68.3 (CH2), 78.4 (CH2), 128.2 (CH), 
128.4 (CH), 128.8 (CH), 135.1 (C), 152.8 (C), 171.5 (C), 174.5 (C); m/z (CI) 280.0819 
(MH
+. C13H15O5N requires 280.0821), 236 (100%), 178 (5) and 91 (22).  
2-(N-Benzyloxycarbonyloxazolidin-5-on-4-yl)ethanol (322)
161 
 
 
 
2-(N-Benzyloxycarbonyloxazolidin-5-on-4-yl)ethanoic acid (321) (0.2 g, 0.7 mmol) was 
dissolved in THF (10 mL) and cooled to -15 
oC. 1M Borane.THF complex (1.4 mL, 1.4 
mmol) was added dropwise over 10 min and the solution was then stirred at 4 
oC for 20 h. K. N. Fanning, Chapter 5, Page 140 
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The reaction mixture was poured into water and extracted with EtOAc. The organic layer 
was washed with saturated solutions of NaHCO3 and NaCl. It was dried (MgSO4) and 
concentrated in vacuo. Purification  by  column chromatography (30% EtOAc/petroleum 
ether) yielded 322 as a colourless viscous oil (0.1 g, 53%). νmax/cm
-1 (NaCl) 3446 (OH), 
2957 (CH), 1699 (CO), 1540, 1256, 1024; [α]D
25 -6.8 (c 1.5, CHCl3); H (400 MHz, CDCl3) 
2.41-2.58 (2H, m, 2-H2), 3.67-3.88 (1H, m, 2-CH2CH), 4.18-4.31 (1H, m, 1-HH), 4.55 
(1H, m, 1-HH), 4.84 (1H, d, J 11.6 Hz, NCHHO), 4.96 (1H, d, J 11.6 Hz, NCHHO), 5.20 
(2H, s, CH2Ph), 7.32-7.40 (5H, m, Ph); c (100 MHz, CDCl3) 27.3 (CH2), 56.3 (CH), 66.0 
(CH2), 68.2 (CH2), 71.8 (CH2), 128.2 (CH), 128.5 (CH), 128.8 (CH), 135.6 (C), 155.1 (C), 
175.2 (C); m/z (EI) 265.0952 (M
+. C13H15O5N requires 265.0950), 235 (41%), 203 (97), 
130 (20), 108 (97), 91 (100) and 65 (83). 
2-(N-Benzyloxycarbonyloxazolidin-5-on-4-yl)ethanal (323) 
 
 
 
 
 
2-(N-Benzyloxycarbonyloxazolidin-5-on-4-yl)ethanol  (322)  (0.1  g,  0.4  mmol)  was 
dissolved in DCM (15 mL) and cooled to 0 
oC. PCC (0.12 g, 0.6 mmol) was added and the 
reaction  was  allowed  to  stir  at  room  temperature  for  3  h.  The  reaction  was  then 
concentrated in vacuo. The resulting residue was dissolved in EtOAc and washed through a 
pad of silica. The organic layer was washed with NaHCO3, dried (MgSO4) and the solvent 
removed in vacuo. Purification by column chromatography (40% EtOAc/petroleum ether) 
yielded 323 as a colourless oil (0.08 g, 77%). νmax/cm
-1 (NaCl) 2966 (CH), 1698 (CO), 
1218, 1019, 754; [α]D
25 -26.1 (c 1.9, CHCl3); H (400 MHz, CDCl3) 2.51-2.56 (2H, m, 2-
H2),  4.25-4.37  (1H,  m,  2-CH2CH),  4.52-5.27  (1H,  br  m,  NCH2O),  5.33-5.37  (2H,  m, 
CH2Ph), 7.40-7.47 (5H, m, Ph), 9.26 (1H, s, 1-H);
 c (100 MHz, CDCl3) 25.9 (CH2), 65.6 
(CH2), 70.0 (CH2), 77.3 (CH), 128.8 (CH), 128.9 (CH), 129.2 (CH), 133.8 (C), 161.8 (CH), 
172.6 (C); m/z (EI) 263.0793 (M
+. C13H13O5N requires 263.0794), 118 (77%), 107 (66), 91 
(100) and 65 (54). 
Dimethyl (2S)-N-(tert-butoxycarbonyl)-2-aminobutane-1,4-dioate (330)
164 
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To a stirred suspension of L-aspartic acid (5.0 g, 37.6 mmol) in MeOH (100 mL), TMS-Cl 
(21.2 mL, 165.4 mmol) was added slowly at 0 
oC. The reaction was allowed to stir for 1 h 
at 0 
oC and then at room temperature for 24 h. NEt3 (34.0 mL, 244.4 mmol) and Boc2O 
(9.02  g,  41.4  mmol)  were  added  slowly  and  the  reaction  stirred  for  2  h.  The  reaction 
mixture was concentrated in vacuo and the resulting residue dissolved in Et2O and filtered 
to remove the white precipitate. The filtrate was concentrated in vacuo and purified using 
flash column chromatography (35% EtOAc/petroleum ether) to yield 330 as a white solid 
(7.46 g, 76%). νmax/cm
-1 (NaCl) 3406 (NH), 2927 (CH), 2360, 1704 (CO), 1458, 1159, 
1045; [α]D
25 +35.8 (c 1.0, CHCl3), (lit.
164 [α]D +30.8 (c 2.1, CHCl3)); H (400 MHz, CDCl3) 
1.47 (9H, s, 
tBu), 2.85 (1H, dd, J 16.8, 4.2 Hz, 3-HH), 3.03 (1H, dd, J 16.8, 4.2 Hz, 3-HH), 
3.72 (3H, s, OMe), 3.78 (3H, s, OMe), 4.58-4.61 (1H, m, 2-H), 5.50 (1H, br s, NH); c 
(100 MHz, CDCl3) 28.3 (CH3), 36.7 (CH2), 49.9 (CH), 52.1 (CH3), 52.8 (CH3), 80.2 (C), 
155.4 (C), 171.5 (C), 171.6 (C); m/z (CI) 262.1293 (MH
+. C11H20O6N requires 262.1291), 
206 (100%), 162 (36) and 85 (13). 
Dimethyl (2S)-N,N-di-(tert-butoxycarbonyl)-2-aminobutane-1,4-dioate (331)
164 
 
 
 
 
Dimethyl (2S)-N-(tert-butoxycarbonyl)-2-aminobutane-1,4-dioate (0.9 g, 3.5 mmol) (330) 
was dissolved in MeCN (50 mL). DMAP (0.08 mg, 0.7 mmol,) and Boc2O (0.8 g, 3.8 
mmol) were added and the reaction was allowed to stir at room temperature for 3 h. Boc2O 
(0.4 g, 1.9 mmol) was added and the reaction was allowed to stir at room temperature for 
24 h. The solvent was removed in vacuo and the crude product was purified using flash 
column chromatography (20% EtOAc/petroleum ether) to yield 331 as a white solid (1.25 
g, 100%). νmax/cm
-1 (NaCl) 2857 (CH), 1747 (CO), 1458, 1375, 1145; [α]D
25 -61.0 (c 2.0, 
CHCl3), (lit.
164 [α]D
25 -61.0 (c 2.0, CHCl3)); H (400 MHz, CDCl3) 1.53 (18H, s, 2 x 
tBu), 
2.77 (1H, dd, J 16.4, 6.4 Hz, 3-HH), 3.29 (1H, dd, J 16.4, 7.2 Hz, 3-HH), 3.73 (3H, s, 
OMe), 3.76 (3H, s, OMe), 5.48 (1H, dd, J 7.2, 6.4 Hz, 2-H); c (100 MHz, CDCl3) 27.9 
(CH3), 35.7 (CH2), 51.9 (CH3), 52.5 (CH3), 54.9 (CH), 83.6 (C), 151.6 (C), 170.3 (C), 
171.1 (C); m/z (CI) 362.1817 (MH
+. C16H28O8N requires 362.1815), 306 (38%), 250 (33), 
206 (100) and 162 (50). 
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Methyl (2S)-N,N-di-(tert-butoxycarbonyl)-2-amino-4-oxobutanoate (332)
205 
 
 
 
 
Dimethyl (2S)-N,N-di-(tert-butoxycarbonyl)-2-aminobutane-1,4-dioate (331) (6.9 g, 19.1 
mmol) was dissolved in Et2O (150 mL) and cooled to -78 
oC. DIBAL-H (26.8 mL, 26.8 
mmol) was added dropwise and the solution was allowed to stir at -78 
oC for 24 h. A 
saturated NH4Cl solution was added (40 mL) and the reaction allowed to warm to room 
temperature. It was filtered through a pad of Celite
® with Et2O and concentrated in vacuo. 
Following purification by column chromatography (10% EtOAC/petroleum ether) 332 was 
obtained as a colourless oil (5.0 g, 79%). νmax/cm
-1 (NaCl) 3132, 2796 (CH), 1782 (CO), 
1678, 1199, 1072; [α]D
26 -49.2 (c 3.4, CHCl3); H (400 MHz, CDCl3) 1.53 (18H, s, 2 x 
tBu), 
2.86 (1H, ddd, J 18.0, 6.0, 1.2 Hz, 3-HH), 3.45 (1H, ddd, J 18.0, 6.8, 1.2 Hz, 3-HH), 3.76 
(3H, s, OMe), 5.57 (1H, dd, J 6.8, 6.0 Hz, 2-H), 9.82 (1H, dd, J 1.2, 1.2 Hz, 4-H); c (100 
MHz, CDCl3) 27.9 (CH3), 45.0 (CH2), 52.6 (CH3), 52.9 (CH), 83.7 (C), 151.7 (C), 170.2 
(C), 198.4 (C); m/z (CI) 332.1708 (MH
+. C15H26O7N requires 332.1709), 276 (60%), 236 
(51), 220 (100), 192 (98), 176 (100) and 132 (26).   
Methyl (2S)-N,N-di-(tert-butoxycarbonyl)-2-aminohexan-4-enoate (333) 
 
 
 
Methyl  (2S)-N,N-di-(tert-butoxycarbonyl)-2-amino-4-oxobutanoate  (332)  (0.1  g,  0.3 
mmol) was dissolved in THF and triphenylphosphoranylidene-acetaldehyde (0.14 g, 0.4 
mmol) was added. The mixture was heated under reflux for 3 days. Purification by column 
chromatography gave 333 as a colourless oil (14 mg, 13%). νmax/cm
-1 (NaCl) 3378, 2979 
(CH), 1746 (CO), 1458, 1368, 1252, 1163, 853; [α]D
27 -16.2 (c 1.3, CHCl3); H (400 MHz, 
CDCl3) 1.49 (18H, s, 2 x 
tBu), 2.92-3.02 (1H, m, 3-HH), 3.11-3.18 (1H, m, 3-HH), 3.75 
(3H, s, OMe), 5.11 (1H, dd, J 10.4, 5.4 Hz, 2-H), 6.15 (1H, dd, J 15.6, 7.6 Hz, 5-H), 6.84 
(1H, ddd, J 15.6, 8.8, 6.4 Hz, 4-H), 9.50 (1H, d, J 7.6 Hz, 6-H); c (100 MHz, CDCl3) 27.9 
(CH3), 33.6 (CH2), 52.5 (CH3), 56.7 (CH), 83.7 (C), 135.2 (CH), 151.9 (C), 153.3 (CH), 
170.1  (C),  193.6  (CH);  m/z  (CI)  358.1863  (MH
+.  C17H28O7N  requires  358.1866),  258 
(26%), 222 (81), 202 (66) and 140 (100). K. N. Fanning, Chapter 5, Page 143 
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Methyl (2S)-N-(tert-butoxycarbonyl)-2-amino-4-oxobutanoate (334)
167 
 
 
 
 
 
Methyl  (2S)-N,N-di-(tert-butoxycarbonyl)-2-amino-4-oxobutanoate  (332)  (2.7  g,  8.1 
mmol) was dissolved in MeCN (150 mL) and LiBr was added (2.1 g, 24.3 mmol). The 
mixture  was  warmed  to  65 
oC  for  10  h.  The  solvent  was  then  removed  in  vacuo. 
Purification  by  column  chromatography  (20%  EtOAc/petroleum  ether)  gave  334  as  a 
colourless oil (1.7 g, 89%). νmax/cm
-1 (NaCl) 3364 (NH), 2978 (CH), 1717 (CO), 1507, 
1166, 860; [α]D
25 +33.2 (c 0.9, CHCl3); H (400 MHz, CDCl3) 1.47 (9H, s, 
tBu), 3.05 (1H, 
dd, J 18.4, 5.2 Hz, 3-HH), 3.15 (1H, dd, J 18.4, 4.8 Hz, 3-HH), 3.78 (3H, s, OMe), 4.61-
4.65 (1H, m, 2-H), 5.41 (1H, d, J 7.6 Hz, NH), 9.76 (1H, s, 4-H); c (100 MHz, CDCl3) 
28.3 (CH3), 46.1 (CH2), 48.6 (CH), 52.8 (CH3), 80.3 (C), 155.4 (C), 171.5 (C), 199.5 (CH); 
m/z (CI) 232.1181 (MH
+. C10H18O5N requires 232.1185), 176 (100%) and 132 (79). 
Methyl (2S)-N-(tert-butoxycarbonyl)-2-aminohexan-4-enoate (335) 
 
 
 
 
Methyl  (2S)-N,N-di-(tert-butoxycarbonyl)-2-amino-4-oxobutanoate  (334)  (0.6  g,  2.7 
mmol) was dissolved in THF (50 mL) and triphenylphosphoranylidene-acetaldehyde (1.2 
g, 4.0 mmol) was added. The reaction mixture was allowed to stir at 35 
oC for 2 days. The 
reaction  mixture  was  concentrated  in  vacuo  and  purification  by  flash  column 
chromatography (25% EtOAc/petroleum ether) gave 335 as a colourless oil (0.6 g, 92%). 
νmax/cm
-1 (NaCl)  3369  (NH),  2926  (CH),  1698 (CO),  1507,  1165;  [α]D
25  +48.2  (c  1.1, 
CHCl3); H (400 MHz, CDCl3) 1.37 (9H, s, 
tBu), 2.60-2.68 (1H, m, 3-HH), 2.82-2.87 (1H, 
m, 3-HH), 3.71 (3H, s, OMe), 4.47-4.49 (1H, m, 2-H), 5.08 (1H, d, J 6.0 Hz, NH), 6.10 
(1H, dd, J 15.4, 8.0 Hz, 5-H), 6.65-6.72 (1H, dt, J 15.4, 7.2 Hz, 4-H), 9.44 (1H, d, J 8.0 Hz, 
6-H); c (100 MHz, CDCl3) 27.2 (CH3), 34.9 (CH2), 51.3 (CH3), 51.7 (CH), 79.4 (C), 
134.5  (CH),  150.6  (CH),  154.1 (C),  170.7 (C), 192.5  (CH);  m/z  (CI)  258.1333  (MH
+. 
C12H20O5N requires 258.1341), 240 (52%), 176 (100), 140 (98) and 132 (53). 
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Methyl (2S)-1-(tert-butoxycarbonyl)piperidine-2-carboxylate (340) 
 
 
 
 
 
 
Methyl (2S)-N-(tert-butoxycarbonyl)-2-aminohexan-4-enoate (335) (0.3 g, 1.2 mmol) was 
dissolved in EtOAc (10 mL). 10% Palladium on carbon (0.25 g, 0.2 mmol) was added and 
H2 gas was allowed to bubble though the solution. The reaction mixture was then placed 
under a H2 atmosphere and allowed to stir at room temperature for 24 h. The reaction 
mixture was filtered through Celite
® with EtOAc and concentrated in vacuo. Purification 
by column chromatography (10% EtOAc/petroleum ether) gave 340 as a colourless oil 
(0.13 g, 44%). The 
1H NMR spectrum showed significant rotamers which were resolved to 
some degree using high temperature (55 
oC) NMR spectroscopy. νmax/cm
-1 (NaCl)
 2941 
(CH), 1747 (CO), 1393, 1158, 1045, 876; [α]D
26 -45.9 (c 1.1, CHCl3) (lit.
169 [α]D
20 -48.1 (c 
1.1, CHCl3)); H (400 MHz, CDCl3) 1.26-1.34 (2H, m, 4-H2), 1.48 (9H, s, 
tBu), 1.65-1.74 
(3H, m, 5-H2 and 3-HH), 2.20-2.23 (1H, m, 3-HH), 2.94-3.03 (1H, m, 6-HH), 3.75 (3H, s, 
OMe), 3.96-4.02 (1H, m, 6-HH), 4.79-4.85 (1H, br m, 2-H); c (100 MHz, CDCl3) 20.8 
(CH2), 24.8 (CH2), 26.8 (CH2), 28.4 (CH3), 42.1 (CH2), 52.1 (CH3), 53.8 (CH), 80.0 (C), 
155.6  (C),  172.5  (C);  m/z  (CI)  244.1547  (MH
+.  C12H22O4N  requires  244.1549),  188 
(100%), 144 (50), 137 (16), 107 (16) and 85 (25). 
Methyl (2S)-N-(
tbutoxycarbonyl)-2-aminohexan-4-en-6-ol (343) 
 
 
 
Methyl (2S)-N-(tert-butoxycarbonyl)-2-aminohexan-4-enoate (335) (1.55 g, 6.0 mmol) was 
dissolved in MeOH (100 mL) and NaBH4 (0.25 g, 6.6 mmol) was added. The reaction was 
allowed to stir at room temperature for 2 h. The reaction was quenched with water (20 mL) 
and the mixture extracted with EtOAc. This was dried (MgSO4) and concentrated in vacuo 
to give 343 as a colourless oil (1.36 g, 87%). No further purification was required. νmax/cm
-
1 (NaCl) 3371 (NH and OH), 2978 (CH), 1714 (CO), 1517, 1367, 1169, 1021; [α]D
27 +18.2 
(c 1.9, CHCl3) (lit.
205 []D
22 -22.3 (c 1.4, CHCl3) for opposite enantiomer); H (400 MHz, 
CDCl3) 1.37 (9H, s, 
tBu), 2.36-2.42 (1H, m, 3-HH), 2.46-2.53 (1H, m, 3-HH), 3.68 (3H, s, 
OMe), 4.03 (2H, d, J 5.4 Hz, 6-H2), 4.28-4.33 (1H, m, 2-H), 5.04 (1H, d, J 8.0 Hz, NH), 
5.48-5.56 (1H, m, 4-H), 5.68 (1H, dt, J 15.6, 5.4 Hz, 5-H); c (100 MHz, CDCl3) 28.3 K. N. Fanning, Chapter 5, Page 145 
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(CH3), 35.4 (CH2), 52.4 (CH3), 53.1 (CH), 63.1 (CH2), 80.1 (C), 125.7 (CH), 133.7 (CH), 
155.3 (C), 172.6 (C); m/z (CI) 260.1495 (MH
+. C12H22O5N requires 260.1498), 204 (74%), 
186 (100) and 160 (11). 
Methyl (2S)-N-(tert-butoxycarbonyl)-2-aminohexanoate (345)
173 
 
 
 
Methyl  (2S)-N-(
tbutoxycarbonyl)-2-aminohexan-4-en-6-ol  (343)  (0.6  g,  2.5  mmol)  was 
dissolved in EtOAc (15 mL). 10% Palladium on carbon (0.5 g, 0.5 mmol) was added and 
H2 gas was allowed to bubble though the solution. The reaction was then placed under a H2 
atmosphere and allowed to stir at room temperature for 24 h. The reaction mixture was 
filtered through Celite
® with EtOAc and concentrated in vacuo. Purification by column 
chromatography (10% EtOAc/petroleum ether) gave 345 as a colourless oil (0.27 g, 44%). 
[α]D
27 -5.1 (c 1.0, CHCl3); H (400 MHz, CDCl3) 0.90 (3H, t, J 7.0 Hz, 6-H3), 1.30-1.36 
(4H, m, 4-H2 and 5-H2), 1.47 (9H, s, 
tBu), 1.56-1.78 (4H, m, 3-H2), 3.74 (3H, s, OMe), 
4.24-4.34 (1H, m, 2-H), 4.97-5.00 (1H, d, J 8.4 Hz, NH); c (100 MHz, CDCl3) 13.9 
(CH3), 22.3 (CH2), 27.4 (CH2), 28.3 (CH3), 32.5 (CH2), 52.2 (CH3), 53.4 (CH), 80.0 (C), 
155.4  (C),  173.6  (C);  m/z  (CI)  246.1703  (MH
+.  C12H24O4N  requires  246.1705),  190 
(100%), 188 (21) and 146 (13). 
Methyl (2S)-N-(tert-butoxycarbonyl)-2-aminohexan-6-ol (344) 
 
 
 
Methyl  (2S)-N-(tert-butoxycarbonyl)-2-aminohexan-4-en-6-ol  (343)  (0.47  g,  1.8  mmol) 
was dissolved in EtOAc (15 mL). PtO2 (0.02 g, 0.09 mmol) was added and H2 gas was 
allowed to bubble though the solution. The reaction mixture was then placed under a H2 
atmosphere and allowed to stir at room temperature for 24 h. The reaction mixture was 
filtered through Celite
® with EtOAc and concentrated in vacuo. Purification by column 
chromatography (15% EtOAc/petroleum ether) gave 344 as a colourless oil (0.46 g, 97%). 
νmax/cm
-1 (NaCl) 3368 (NH and OH), 2936 (CH), 2360, 1699 (CO), 1522, 1367, 1167, 
1023; [α]D
25 -4.1 (c 1.0, CHCl3); H (400 MHz, CDCl3) 1.43 (9H, s, 
tBu), 1.54-1.84 (6H, m, 
3-H2, 4-H2 and 5-H2), 3.64 (2H, t, J 6.4 Hz, 6-H2), 3.74 (3H, s, OMe), 4.30 (1H, dd, J 12.8, K. N. Fanning, Chapter 5, Page 146 
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7.4 Hz, 2-H), 5.10 (1H, d, J 7.4 Hz, NH); c (100 MHz, CDCl3) 21.6 (CH2), 28.3 (CH3), 
32.1 (CH2), 32.6 (CH2), 52.3 (CH3), 53.3 (CH), 62.4 (CH2), 80.0 (C), 155.5 (C), 173.4 (C); 
m/z (CI) 262.1652 (MH
+. C12H24O5N requires 262.1654), 206 (100%), 162 (85) and 146 
(10). 
Methyl (2S)-N-(tert-butoxycarbonyl)-2-amino-6-(methylsulfonyloxy)hexanoate (346) 
 
 
 
 
Methyl  (2S)-N-(tert-butoxycarbonyl)-2-aminohexan-6-ol  (343)  (0.03  g,  0.1  mmol)  was 
dissolved in DCM (10 mL). NEt3 (0.02 mL, 0.15 mmol) was added followed by DMAP 
(0.01 g, 0.02 mmol) and MeSO2Cl (0.01 mL, 0.12 mmol). The reaction was allowed to stir 
at room temperature for 24 h. The reaction was washed with 0.1M HCl and extracted with 
DCM. The organic layer was dried (MgSO4) and concentrated in vacuo. Purification by 
column chromatography (30% EtOAc/petroleum ether) gave 346 as a colourless oil (0.03 
g, 86%). νmax/cm
-1 (NaCl) 3383 (NH), 2977 (CH), 1711 (CO), 1517, 1353, 1172, 936; 
[α]D
25 +4.4 (c 0.7, CHCl3); H (400 MHz, CDCl3) 1.47 (9H, s, 
tBu), 1.63-1.92 (6H, m, 3-H2, 
4-H2 and 5-H2), 3.01 (3H, s, OSO2CH3), 3.75 (3H, s, OMe), 4.24 (2H, t, J 6.4 Hz, 6-H2), 
4.39-4.40 (1H, m, 2-H), 5.05 (1H, br s, NH); c (100 MHz, CDCl3) 21.4 (CH2), 28.3 (CH3), 
28.6 (CH2), 32.2 (CH2), 37.4 (CH3), 52.4 (CH3), 53.0 (CH), 69.5 (CH2), 80.0 (C), 155.4 
(C), 173.1 (C); m/z (CI) 340.1431 (MH
+. C13H26O7NS requires 340.1430), 284 (100%), 
240 (100), 180 (28) and 144 (26).   
Methyl (2S)-N-(tert-butoxycarbonyl)-2-amino-9-(4-imidazolyl)-7-azanonanoate (339) 
 
 
 
Methyl  (2S)-N-(tert-butoxycarbonyl)-2-amino-6-(methylsulfonyl)hexanoate  (346)  (0.1  g, 
0.3 mmol) was dissolved in MeOH (10 mL) and DBU (0.07 mL, 0.5 mmol) and histamine 
(0.1 g, 0.8 mmol) were added. The mixture was heated under reflux for 24 h. The reaction 
was concentrated in vacuo and the residue was dissolved in EtOAc, washed with water, 
dried (MgSO4) and concentrated in vacuo to give 339 as a pale yellow oil (0.07 g, 66%). 
This was used in the next step without further purification. K. N. Fanning, Chapter 5, Page 147 
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Methyl  (2S)-N-(tert-butoxycarbonyl)-2-amino-9-(4-imidazolyl)-7-azanonanoate  (339) 
(0.07 g, 0.2 mmol) was dissolved in 6M HCl and heated under reflux for 24 h. The reaction 
mixture was extracted with EtOAc and the aqueous layer was concentrated in vacuo to 
give 2 as a colourless oil (0.05 mg, 100%). [α]D
23 +10.0 (c 0.2, H2O) (lit.
152 [α]D
22 +10.3 (c 
1.3,H2O)); H (400MHz, D2O) 1.28-1.36 (2H, m, 4-H2), 1.48-1.58 (2H, m, 3-H2), 1.66-1.78 
(2H, m, 5-H2), 2.84 (2H, t, J 7.0 Hz, 6-H2) 2.90 (2H, t, J 7.6 Hz, 8-H2), 3.15 (2H, t, J 7.6 
Hz, 9-H2), 3.47 (1H, t, J 6.0 Hz, 9-CHCNH), 3.83-3.91 (1H, m, 2-H), 6.90 (1H, s, 9-
CCHN), 7.58 (1H, s, 9-CNHCH); c (100 MHz, D2O) 21.6 (CH2), 23.7 (CH2), 25.3 (CH2), 
31.0 (CH2), 46.9 (CH2), 47.1 (CH2), 54.7 (CH), 115.8 (CH), 133.7 (C), 136.3 (CH), 177.2 
(C); m/z (FAB) 241 (MH
+. 1%), 190 (50), 96 (100) and 76 (41). 
5.4  Chapter 4 
3,3’-Azo-butanol (370)
182 
 
 
 
 
3-Ketobutanol (l4.9 mL, 56.8 mmol) was dissolved in MeOH (100 mL) and cooled to -78 
oC.  Liquid  NH3  (100  mL)  was  added  and  the  solution  was  stirred  at  -78 
oC  for  4  h. 
NH2OSO3H  (7.38  g,  65.3  mmol)  was  added,  the  cooling  bath  was  removed  and  the 
solution was heated under reflux with a dry ice condenser for 1 h. The NH3 was then 
allowed to evaporate overnight. The resulting slurry was filtered and the filter cake was 
washed with MeOH. The filtrate was reduced in vacuo, diluted with MeOH and cooled to 0 
oC. NEt3 (15 mL) was added and the solution was brought to room temperature. Solid 
iodine was added until the red colour persisted. The solution was concentrated in vacuo, 
diluted with a saturated solution of NaCl (50 mL) to twice the volume and extracted with 
Et2O  (3  x  75  mL).  The  organic  layer  was  washed  with  Na2S2O3,  dried  (MgSO4)  and 
concentrated.  The  crude  product  was  purified  using  column  chromatography  (25% 
EtOAc/petroleum ether) to yield 370 as a colourless oil (2.2 g, 39%). νmax/cm
-1 (NaCl) 
3325 (OH), 2928 (CH), 1589, 1387, 1052, 862; H (400 MHz, CDCl3) 1.08 (3H, s, 4-H3), K. N. Fanning, Chapter 5, Page 148 
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1.65 (3H, m, 2-H2 and OH), 3.54 (2H, t, J 6.4 Hz, 1-H2); c (100 MHz, CDCl3) 20.3 (CH3), 
24.3 (C), 36.9 (CH2), 57.8 (CH2); m/z (CI) 101.0703 (MH
+. C4H9ON2 requires 101.0715).  
3,3’-Azo-1-(methylsulfonyloxy)butane (371) 
 
 
 
 
 
3,3-Azo-butanol (370) (0.1 g, 1.0 mmol) was dissolved in DCM (10 mL). NEt3 (0.2 mL, 
1.5 mmol) was added followed by DMAP (0.02 g, 0.2 mmol) and MeSO2Cl (0.1 mL, 1.2 
mmol). The reaction was allowed to stir at room temperature for 24 h. The reaction was 
washed with 2M HCl and extracted with DCM. The organic layer was dried (MgSO4) and 
concentrated  in  vacuo.  Purification  by  dry  flash  column  chromatography  using  EtOAc 
gave 371 as a yellow oil (0.16 g, 90%). νmax/cm
-1 (NaCl) 2928 (CH), 1717, 1353, 1175, 
960, 806; H (400 MHz, CDCl3) 1.11 (3H, s, 4-H3), 1.81 (2H, t, J 6.2 Hz, 2-H2), 3.09 (3H, 
s, OSO2CH3), 4.14 (2H, t, J 6.2 Hz, 1-H2); c (100 MHz, CDCl3) 19.9 (CH3), 23.4 (C), 34.3 
(CH2), 37.7 (CH3), 64.4 (CH2); m/z (CI) 179.0491 (MH
+. C5H11O3N2S requires 179.0490), 
169 (53%), 151 (100) and 113 (17). 
3, 3’-Azo-1-iodo-butane (372) 
 
 
 
 
3,3’-Azo-butanol (370) (0.5 g, 5.0 mmol) was dissolved in MeCN (50 mL) and Et2O (50 
mL). PPh3 (1.1 g, 20 mmol) and imidazole (1.4 g, 20 mmol) were added and the reaction 
mixture allowed to stir for 10 min. Iodine (3.8 g, 15 mmol) was added and the reaction was 
stirred at room temperature for 2 h. It was then washed with a saturated Na2S2O3 solution, 
the organic layer dried (MgSO4) and the solvent removed in vacuo. Purification by column 
chromatography  (20%  EtOAc/petroleum  ether)  gave  372  as  a  brown  oil  (0.08  g,  7%). 
νmax/cm
-1 (NaCl) 2924 (CH), 1652, 1172, 842; H (400 MHz, CDCl3) 1.12 (3H, s, 4-H3), 
1.68 (2H, t, J 6.4 Hz, 2-H2), 3.57 (2H, t, J 6.4 Hz, 1-H2); c (100 MHz, CDCl3) 20.3 (CH3), 
24.5 (C), 37.0 (CH2), 57.8 (CH2); m/z (EI) 83 (M
+ – I, 100%), 127 (19) and 41 (88). 
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MeO2C CO2Me
NHBoc
(2R,5S)-2-Isopropyl-3,6-dimethoxy-5-benzyl-2,5-dihydropyrazine (381) 
 
 
 
(2R,5S)-2-Isopropyl-3,6-dimethoxy-2,5-dihydropyrazine (0.1 mL, 0.6 mmol) was added to 
a  dry  flask  followed  by  THF  (5  mL).  This  was  cooled  to  -40 
oC  and  BuLi  (2.5M  in 
hexanes) (0.3 mL, 0.7 mmol) was added and the reaction allowed to stir at -40 
oC for 1 h. 
BnBr (1.0 mL, 0.7 mmol) was dissolved in THF (3 mL) and cooled to -40 
oC. This was 
added  to  the  BuLi  solution  which  had  been  cooled  to  -78 
oC.  The  reaction  was  then 
allowed  to  stir  at  -78 
oC  for  5  h  and  at  room  temperature  for  24  h.  The  solvent  was 
removed in vacuo and the residue was dissolved in Et2O. This was then washed with water 
and extracted with Et2O (2 x 5 mL). The organic layers were combined, dried (MgSO4) and 
concentrated in vacuo. Purification  by  column chromatography (25% EtOAc/petroleum 
ether) yielded 381 as a yellow oil (0.14 g, 88%). νmax/cm
-1 (NaCl) 2960 (CH), 1696, 1437, 
1239, 1014, 701; [α]D
25 +33.4 (c 2.0, CHCl3); H (400 MHz, CDCl3) 0.53 (3H, d, J 6.8 Hz, 
2-CHCH3CH3), 0.87 (3H, d, J 6.8 Hz, 2-CHCH3CH3), 2.07 (1H, septet of d, J 6.8, 3.2 Hz, 
2-CH(CH3)2), 3.02 (2H, d, J 4.8 Hz, 5-CH2Ph), 3.20 (1H, d, J 3.2 Hz, 2-H), 3.61 (3H, s, 
OMe), 3.65 (3H, s, OMe), 4.26 (1H, t, J 4.8 Hz, 5-H), 6.93-7.20 (5H, m, Ph); c (100 MHz, 
CDCl3) 16.4 (CH3), 19.0 (CH3), 31.2 (CH), 40.0 (CH2), 52.2 (CH3), 52.4 (CH3), 56.6 (CH), 
60.2 (CH), 126.3 (CH), 127.8 (CH), 130.0 (CH), 137.0 (C), 162.1 (C), 163.8 (C); m/z (CI) 
275.1757 (MH
+. C16H22O2N2 requires 275.1760), 243 (4%), 183 (9) and 141 (5). 
Dimethyl (2S)-N-(tert-butoxycarbonyl)-2-aminopentan-1,4-dioate (385)
164 
 
 
To a stirred suspension of L-glutamic acid (5.0 g, 34.0 mmol) in MeOH (100 mL), TMS-Cl 
(19.2 mL, 149.6 mmol) was added slowly at 0 
oC. The reaction was allowed to stir for 1 h 
at 0 
oC and then at room temperature for 24 h. NEt3 (30.7 mL, 221.1 mmol) and Boc2O 
(8.16  g,  37.4  mmol)  were  added  slowly  and  the  reaction  stirred  for  2  h.  The  reaction 
mixture was concentrated in vacuo and the resulting residue dissolved in Et2O and filtered 
to remove the white precipitate. The filtrate was concentrated in vacuo and purified using 
flash column chromatography (30% EtOAc/petroleum ether), to give 385 as a white solid K. N. Fanning, Chapter 5, Page 150 
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(8.2 g, 88%). νmax/cm
-1 2986 (CH), 1778 (CO), 1753 (CO), 1731 (CO), 1368, 1135, 1082, 
853; [α]D
27 -37.3 (c 1.1, CHCl3); H (400 MHz, CDCl3) 1.46 (9H, s, 
tBu), 1.91-2.02 (1H, m, 
3-HH), 2.17-2.26 (1H, m, 3-HH), 2.43 (2H, dd, J 15.6, 7.6 Hz, 4-H2), 3.71 (3H, s, OMe), 
3.77 (3H, s, OMe), 4.34-4.39 (1H, m, 2-H), 5.14 (1H, d, J 8.0 Hz, NH); c (100 MHz, 
CDCl3) 27.8 (CH2), 28.3 (CH3), 30.1 (CH2), 51.8 (CH3), 52.4 (CH3), 52.9 (CH), 80.1 (C), 
155.4 (C), 172.7 (C), 173.2 (C); m/z (CI) 276.1445 (MH
+. C12H22O6N requires 276.1447), 
220 (100%) and 176 (17). 
Dimethyl (2S)-N,N-di-(tert-butoxycarbonyl)-2-aminopentan-1,4-dioate (386)
164 
 
 
 
 
Dimethyl  (2S)-N-(tert-butoxycarbonyl)-2-aminopentan-1,4-dioate  (385)  (8.70  g,  31.8 
mmol) was dissolved in MeCN (180 mL). DMAP (0.78 g, 6.4 mmol) and Boc2O (7.63 g, 
35.0 mmol) were added and the reaction was allowed to stir at room temperature for 3 h. 
Boc2O  (3.47  g,  15.9  mmol)  was  added  and  the  reaction  was  allowed  to  stir  at  room 
temperature  for  24  h.  The  solvent  was  removed  in  vacuo  and  the  crude  product  was 
purified using flash column chromatography (20% EtOAc/petroleum ether)  to give 386 as 
a white solid (11.7 g, 98%). νmax/cm
-1 2981 (CH), 2360, 1795 (CO), 1747 (CO), 1369, 
1142; [α]D
27 -35.6 (c 0.7, CHCl3); (lit.
164 [α]D
25 -37.2 (c 2.2, CHCl3)); H (400 MHz, CDCl3) 
1.52 (18H, s, 2 x 
tBu), 2.16-2.26 (1H, m, 3-HH), 2.38-2.47 (2H, m, 4-H2), 2.48-2.55 (1H, 
m, 3-HH), 3.69 (3H, s, OMe), 3.74 (3H, s, OMe), 4.96 (1H, dd, J 9.6, 4.8 Hz, 2-H); c (100 
MHz, CDCl3) 25.2 (CH2), 27.9 (CH3), 30.6 (CH2), 51.7 (CH3), 52.2 (CH3), 57.3 (CH), 83.3 
(C), 151.9 (C), 170.8 (C), 173.1 (C); m/z (CI) 376 (MH
+. 8%), 338 (46), 320 (41), 276 
(40), 220 (98), 176 (100) and 128 (93). 
Methyl (2S)-N,N-di-(tert-butoxycarbonyl)-2-amino-4-oxopentanoate (387)
164 
 
 
Dimethyl  (2S)-N,N-di-(tert-butoxycarbonyl)-2-aminopentan-1,4-dioate  (386)  (1.0  g,  2.8 
mmol) was dissolved in Et2O (50 mL) and cooled to -78 
oC. DIBAL-H (3.9 mL, 3.9 mmol) 
was added dropwise and the solution was allowed to stir at -78 
oC for 24 h. A saturated 
NH4Cl  solution  was  added  (10  mL)  and  the  reaction  was  allowed  to  warm  to  room 
temperature. It was filtered through a pad of Celite
® with Et2O and concentrated in vacuo. K. N. Fanning, Chapter 5, Page 151 
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Following purification by column chromatography (15% EtOAC/petroleum ether) 387 was 
obtained as a colourless oil (0.6 g, 68%). νmax/cm
-1 2981 (CH), 1793 (CO), 1734 (CO), 
1367, 1125, 854; [α]D
27 -49.0 (c 0.2, CHCl3); H (400 MHz, CDCl3) 1.53 (18H, s, 2 x 
tBu), 
2.15-2.23 (1H, m, 3-HH), 2.49-2.67 (3H, m, 3-HH and 4-H2), 3.76 (3H, s, OMe), 4.92 (1H, 
dd, J 9.6, 5.0 Hz, 2-H), 9.81 (1H, t, J 1.2, 5-H); c (100 MHz, CDCl3) 22.5 (CH2), 28.0 
(CH3), 40.5 (CH2), 52.3 (CH), 57.3 (CH3), 83.5 (C), 151.9 (C), 170.8 (C), 201.0 (CH); m/z 
(CI) 346.1865 (MH
+. C16H28O7N requires 346.1866), 345 (38), 228 (55), 207 (74) and 128 
(100). 
Methyl (2S)-N,N-di-(tert-butoxycarbonyl)-2-amino-5-(trimethylsilyl)-4-oxopentanoate 
(397) 
 
Method A
190 
Methyl  (2S)-N,N-di-(tert-butoxycarbonyl)-2-amino-4-oxobutanoate  (332)  (0.1  g,  0.3 
mmol) was added to a solution of Me3Al (0.2 mL, 0.4 mmol) in DCM (10 mL) at -78 
oC. 
TMS-CH2N2 (0.2 mL, 0.3 mmol) was added and the reaction mixture stirred at -78 
oC for 1 
h and then at -40 
oC for 1 h. The solution was then poured into 2M HCl and extracted using 
DCM (3 x 15 mL). The organic layers were combined, dried (MgSO4) and concentrated in 
vacuo to give 397 as a pale yellow oil (0.09 g, 71%). νmax/cm
-1 (NaCl) 2980 (CH), 1795 
(CO), 1747 (CO), 1144, 853; [α]D
25 -72.5 (c 0.4, CHCl3); H (400 MHz, CDCl3) 0.01 (9H, 
s, 
tBu), 1.56 (18H, s, 2 x 
tBu), 2.08 (1H, d, J 10.4 Hz, 5-HH), 2.13 (1H, d, J 10.4 Hz, 5-
HH), 2.62 (1H, dd, J 18.0, 5.6 Hz, 3-HH), 3.22 (1H, dd, J 18.0, 6.8 Hz, 3-HH), 3.56 (3H, s, 
OMe), 5.35-5.40 (1H, m, 2-H); c (100 MHz, CDCl3) 0.0 (CH3), 24.1 (CH3), 39.3 (CH2), 
46.7 (CH2), 52.5 (CH), 55.2 (CH3), 84.4 (C), 152.9 (C), 171.9 (C), 206.2 (C); m/z (CI) 
418.2262 (MH
+. C19H36NO7Si requires 418.2261), 346 (53%), 318 (78), 262 (95), 234 
(99), 218 (25), 190 (100) and 146 (89).  
Method B
190 
Methyl  (2S)-N,N-di-(tert-butoxycarbonyl)-2-amino-4-oxobutanoate  (332)  (0.1  g,  0.3 
mmol) was dissolved in DCM (10 mL). SnCl2 (2.9 mg, 0.02 mmol) and TMS-CH2N2 (0.15 
mL, 0.3 mmol) were added and the solution was allowed to stir at room temperature for 30 
min. The reaction was quenched with 0.1M HCl and extracted with DCM (20 mL). The 
organic layers were combined, washed with a saturated solution of NaCl, dried (MgSO4) K. N. Fanning, Chapter 5, Page 152 
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and  concentrated  in  vacuo.  397  was  the  main  product  isolated  (89  mg,  85%). 
Characterisation data for this product was consistent with that shown above. 
Methyl (2S)-N,N-di-(tert-butoxycarbonyl)-2-amino-4-oxopentanoate (393) 
 
 
Method A
192 
Methyl  (2S)-N,N-di-(tert-butoxycarbonyl)-2-amino-4-oxobutanoate  (332)  (0.1  g,  0.3 
mmol) was dissolved in Et2O (10 mL) and cooled to 0 
oC. MgBr2 (0.08 g, 0.45 mmol) was 
added followed by TMS-CH2N2 (2M solution in Et2O) (0.2 mL, 0.4 mmol) and the reaction 
mixture was then stirred at 0 
oC for 30 min and at room temperature for 4 h. The reaction 
mixture was cooled again to 0 
oC, MeOH (3 mL) and 0.1M HCl (3 mL) were added and it 
was warmed to room temperature. The mixture was diluted with Et2O (50 mL), washed 
with  water  (50  mL)  and  the  organic  layer  dried  (MgSO4)  and  concentrated  in  vacuo. 
Following purification by column chromatography (10% EtOAc/petroleum ether), 393 was 
obtained as a dark yellow oil (7.5 mg, 7%). νmax/cm
-1 2980 (CH), 1749 (CO), 1368, 1236, 
1144, 1044, 866; [α]D
27 -77.1 (c 0.5, CHCl3); H (400 MHz, CDCl3) 1.38 (18H, s, 2 x 
tBu), 
2.09 (3H, s, 5-H3), 2.56 (1H, dd, J 17.6, 4.8 Hz, 3-HH), 3.34 (1H, dd, J 17.6, 7.6 Hz, 3-
HH), 3.58 (3H, s, OMe), 5.38 (1H, dd, J 7.6, 4.8 Hz, 2-H); c (100 MHz, CDCl3) 29.7 
(CH3), 31.9 (CH3), 46.2 (CH2), 54.2 (CH), 55.9 (CH3), 85.2 (C), 153.5 (C), 172.4 (C), 
206.5 (C); m/z (FAB) 346.1867 (MH
+. C16H28O7N requires 346.1866), 290 (28%), 234 
(61), 190 (50), 147 (100) and 89 (30). 
Method B
190  
Methyl  (2S)-N,N-di-(tert-butoxycarbonyl)-2-amino-4-oxobutanoate  (332)  (0.1  g,  0.3 
mmol) was added to a solution of Me3Al (0.2 mL, 0.4 mmol) in DCM (10 mL) at -78 
oC. 
The reaction mixture was stirred at -78 
oC for 1 h and at -40 
oC for 1 h. The mixture was 
poured into 1M HCl and extracted with DCM (3 x 15 mL). The organic layer was dried 
(MgSO4)  and  concentrated  in  vacuo.  Purification  by  column  chromatography  (30% 
EtOAc/petroleum ether) gave 393 as a dark yellow oil (0.02 g, 21%). Characterisation data 
for this product was consistent with that shown above.     
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Methyl (2S)-N,N-di-(tert-butoxycarbonyl)-2-amino-4-hydroxy-pentanoate (402) 
 
 
Methyl  (2S)-N,N-di-(tert-butoxycarbonyl)-2-amino-4-oxobutanoate  (332)  (0.1  g,  0.3 
mmol) was dissolved in THF (10 mL) and cooled to 0 
oC. The solution was treated with 
MeMgBr  (0.2  mL,  0.3  mmol)  and  stirred  for  2  h.  The  reaction  was  quenched  with  a 
saturated solution of NaCl and extracted with EtOAc (3 x 15 mL). The organic layers were 
combined, washed with a saturated solution of NaHCO3, dried (MgSO4) and concentrated 
in vacuo. Purification by column chromatography (15% EtOAc/petroleum ether) gave 402 
as a dark yellow oil (0.02 g, 15%). νmax/cm
-1 3377 (OH), 2980 (CH), 1742 (CO), 1500, 
1283, 1165, 945, 734; [α]D
25 +28.9 (c 1.1, CHCl3); H (400 MHz, CDCl3) 1.22 (3H, d, J 6.4 
Hz, 5-H3), 1.37 (9H, s, 
tBu), 1.41 (9H, s, 
tBu), 1.92-1.98 (1H, m, 3-HH), 2.00-2.11 (1H, m, 
3-HH), 3.68 (3H, s, OMe), 4.31 (1H, dd, J 13.2, 6.0 Hz, 2-H), 4.71-4.79 (1H, m, 4-H), 5.21 
(1H, d, J 7.6 Hz, OH); c (100 MHz, CDCl3) 20.2 (CH3), 27.8 (CH3), 38.2 (CH2), 50.8 
(CH), 52.4 (CH3), 70.0 (CH), 80.0 (C), 152.8 (C), 172.5 (C); m/z (CI) 348.2019 (MH
+. 
C16H30O7N requires 348.2022), 292 (22%), 236 (100), 192 (23), 174 (45) and 148 (17). 
Methyl (2S)-N-(tert-butoxycarbonyl)-2-amino-4-oxo-5-trimethylsilylpentanoate (404) 
 
 
 
 
SnCl2 (5 mg, 0.02 mmol) was placed in a round bottomed flask and dried in an oven at 100 
oC for 48 h. It was then heated to 100 
oC under vacuum for 3 h and cooled under an argon 
atmosphere. TMS-CH2N2 (0.2 mL, 0.4 mmol) was added to the flask followed by methyl 
(2S)-N-(tert-butoxycarbonyl)-2-amino-4-oxobutanoate (334) (0.1 g, 0.4 mmol) dissolved in 
DCM (5 mL). This was allowed to stir at room temperature for 19 h. The reaction was 
quenched with 0.1M HCl (3 mL) and extracted with Et2O (3 x 10 mL). The organic layers 
were combined, dried (MgSO4) and concentrated in vacuo. Purification by a short silica 
column  (30%  EtOAc/petroleum  ether)  gave  404  as  a  pale  yellow  oil  (0.07  g,  66%). 
νmax/cm
-1 (NaCl) 3370 (NH), 2956 (CH), 1718 (CO), 1499, 1167, 854; [α]D
27 +30.3 (c 0.3, 
CHCl3); H (400 MHz, CDCl3) 0.0 (9H, s, (CH3)3Si), 1.31 (9H, s, 
tBu), 2.08 (2H, s, 5-H2), 
2.79 (1H, dd, J 18.4, 4.0 Hz, 3-HH), 3.02 (1H, dd, J 18.4, 4.0 Hz, 3-HH), 3.60 (3H, s, 
OMe), 4.28-4.31 (1H, m, 2-H), 5.43 (1H, d, J 8.4 Hz, NH); c (100 MHz, CDCl3) 0.0 
(CH3), 29.5 (CH3), 39.2 (CH2), 47.2 (CH2), 50.1 (CH), 53.7 (CH3), 81.0 (C), 156.7 (C), K. N. Fanning, Chapter 5, Page 154 
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173.2  (C),  208.4  (C);  m/z  (CI)  318.1738  (MH
+.  C14H28O5NSi  requires  318.1737),  279 
(31%), 262 (100), 218 (46), 207 (71) and 146 (21). 
 
Methyl (2S)-N-(tert-butoxycarbonyl)-2-amino-4-oxopentanoate (394) 
 
 
Methyl (2S)-N-(tert-butoxycarbonyl)-2-amino-4-oxo-5-trimethylsilylpentanoate (404) (0.1 
g, 0.3 mmol) was dissolved in a 5% KOH in MeOH (10 mL). This mixture was allowed to 
stir at room temperature for 1 h. The solvent was then removed in vacuo. The residue was 
dissolved in EtOAc, dried (MgSO4) and concentrated. Immediate purification by column 
chromatography  (50%  EtOAc/petroleum  ether)  gave  394  as  a  pale  yellow  oil  (67  mg, 
92%). [α]D
25 +25.5 (c 2.1, CHCl3) (lit.
195 [α]D
22 +32.7 (c 1.0, CHCl3)); νmax/cm
-1 3420 (NH), 
3082 (CH), 1774 (CO), 1612, 1466, 1111, 945; H (400 MHz, CDCl3) 1.47 (9H, s, 
tBu), 
2.20 (3H, s, 5-H3), 2.98 (1H, dd, J 18.4, 4.2 Hz, 3-HH), 3.22 (1H, dd, J 18.4, 4.4 Hz, 3-
HH), 3.76 (3H, s, OMe), 4.49-4.54 (1H, m, 2-H), 5.53 (1H, d, J 8.4 Hz, NH); c (100 MHz, 
CDCl3) 28.3 (CH3), 29.9 (CH3), 45.4 (CH2), 49.4 (CH), 52.7 (CH3), 80.1 (C), 155.6 (C), 
171.9  (C),  206.7  (C);  m/z  (FAB)  246.1343  (MH
+.  C11H20O5N  requires  246.1341),  190 
(100%), 147 (67) and 89 (23).  
 (2S)-N-(tert-butoxycarbonyl)-2-amino-4-oxopentanoic acid (395) 
 
 
Methyl (2S)-N-(
tbutoxycarbonyl)-2-amino-4-oxopentanoate (394) (0.2 g, 0.7 mmol) was 
dissolved  in  MeOH:water  1:1  (20  mL).  CsCO3  (0.3  g,  0.9  mmol)  was  added  and  the 
reaction mixture stirred at room temperature for 24 h. The mixture was acidified with 1M 
HCl and extracted with DCM. The organic  layers were combined, dried (MgSO4) and 
concentrated in vacuo to give 395 as a colourless oil (0.15 g, 94%). No further purification 
was required. νmax/cm
-1 3357 (NH), 3030 (CH), 1743 (CO), 1688, 1456, 1138; [α]D
27 +26.1 
(c 0.3, CHCl3); H (400 MHz, CDCl3) 1.38 (9H, s, 
tBu), 2.13 (3H, s, 5-H3), 2.88 (1H, dd, J 
18.2, 4.8 Hz, 3-HH), 3.14 (1H, dd, J 18.2, 3.6 Hz, 3-HH), 4.46 (1H, ddd, J 8.4, 4.8, 3.6 Hz, 
2-H), 5.48 (1H, d, J 8.4 Hz, NH); c (100 MHz, CDCl3) 28.3 (CH3), 30.0 (CH3), 45.1 K. N. Fanning, Chapter 5, Page 155 
 
(CH2), 49.3 (CH), 80.5 (C), 155.8 (C), 175.1 (C), 207.3 (C); m/z (CI) 232.1189 (MH
+. 
C10H18O5N requires 232.1185), 176 (100%), 158 (33), 132 (95), 130 (36) and 73 (40). 
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